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This thesis describes the development of asymmetric synthesis of furan and 
oxindole derivatives with tertiary amine thiourea organocatalysts, including 
enantioselective synthesis of 3(2H)-furanones and 2,3-dihydrofurans with novel L-
threonine derived bifunctional catalysts, asymmetric formation of 3-spirocyclopropyl-
2-oxindoles and 3-heteroatom-substituted-oxindoles with L-threonine-incorporating 
multifunctional catalysts, and a quinine-derived bifunctional catalyst catalyzed chiral 
3-fluorooxindoles synthesis.  
Chapter 1 gave a brief introduction and development of asymmetric 
organocatalysis. Particularly, chiral hydrogen bonding based organocatalysis is 
introduced in detail. Selected examples showing recent advancements in this field of 
catalysis are described. 
Chapter 2 described the first organocatalytic asymmetric synthesis of 3(2H)-
furanones derivatives. In the presence of L-threonine-based bifunctional 
tertiaryamine thiourea catalysts, a highly enantioselective modified FeistBénary 
reaction between ethyl 4-bromoacetoacetate and nitroolefins afforded optically 
enriched 3(2H)-furanone derivatives. Moreover, the furanone derivatives could be 
easily transformed into tetronic acid and -lactam derivatives. 
Chapter 3 further studied the utilization of modified FeistBénary reaction for 
furan derivative synthesis. L-Threonine-based bifunctional tertiaryamine thiourea 
catalysts promoted the reaction between acyclic -ketoesters and β,β-
bromonitrostyrenes, affording synthetically useful 2,3-dihydrofurans with excellent 
enantioselectivities  and complete trans-diastereoselectivity. 
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Chapter 4 disclosed the first direct asymmetric cyclopropanation reaction of 
oxindoles. By engaging DABCO as a nucleophilic catalyst, a stereochemically 
retentative conversion of different diastereomers of cyclopropyl spirooxindoles was 
discovered. Highly diastereodivergent and enantioselective synthesis of 3-
spirocyclopropyl-2-oxindoles was achieved by using L-threonine-incorporating 
multifunctional tertiaryamine thiourea catalysts.  
Chapter 5 presented a novel method to conveniently access various 3-
heteroatom-substituted oxindoles from 3-chlorooxindoles. With the employment of L-
threonine-incorporating multifunctional catalysts, the Michael addition of oxindoles 
containing various 3-heteroatom substituents to nitroolefins proceeded in a highly 
stereoselective manner, leading to the formation of oxindoles with a 3-heteroatom-
substituted quaternary center in high diastereoselectivity (up to >25:1 dr) and 
excellent enantioselectivity (up to 99% ee). Synthetic values of the oxindole adducts 
were demonstrated, and useful oxindoles, indolines and indole derivatives were 
asymmetrically prepared. 
Chapter 6 showed the first asymmetric conjugate addition of prochiral 3-
fluorinated oxindoles to vinyl sulfones catalyzed by quinine-derived bifunctional 
tertiaryamine thiourea catalyst, furnishing biologically important chiral 3-fluoro-3-
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Chapter 1 Introduction 
 
1.1 Asymmetric Organocatalysis 
1.1.1 Introduction 
Chiral molecules are optically active compounds that lack an internal plane of 
symmetry and have a non-superimposable mirror image. 1  Such molecules are 
extremely important in human life. Firstly, they play a critical role in biological 
systems. Secondly, molecular chirality has shown its great importance in 
pharmaceutical industry.2 Enantiopure molecules provide unique pharmacological 
activities as well as pharmacokinetic and pharmacodynamic effects, compared with 
their racemic counterparts, and thus lead to different therapeutic activities.3 Hence, 
preparation of enantiopure molecules has now become an extremely important topic 
in organic synthesis. 
Due to the importance of chiral molecules, synthetic methods leading to their 
synthesis have been intensively studied over the last several decades. In the early days, 
resolution of racemic compounds and employment of chiral auxiliaries4 were the 
main approaches to access chiral molecules. However, both approaches suffered from 
severe drawbacks, the former yielded only up to 50% of the desired enantiomer, while 
the latter required stoichiomeric amounts of suitable chiral auxiliaries and the 
                                                             
1 M. A. Fox, J. K. Whitesell, Eds. Organic Chemistry (3rd Edition), Jones & Bartlett Publishers, 2004. 
2 a) M. Gardner, The New Ambidextrous, 3rd Rev. Ed, W. H. Freeman & Co: New York, 1990; b) E. Francotte, W. 
Lindner, Eds. Chirality in drug research, Wiley-VCH, Weinheim, 2006. 
3 a) P. I. Dalko, L. Moisan, Angew. Chem. Int. Ed. 2001, 40, 3726; b) P. I. Dalko, L. Moisan, Angew. Chem. Int. Ed. 
2004, 43, 5138.  
4 a) G. Roos, Eds. Compendium of chiral auxiliary applications, Academic Press, New York, 2002; b) Y. Gnas, F. 
Glorius, Synthesis, 2006, 12, 1899. 
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auxiliaries need be cleaved after the reaction. Furthermore, both approaches have 
limited applications in terms of substrate scopes and reaction types. Asymmetric 
catalysis has emerged as a more effective and promising method for the synthesis of 
optically enriched molecules.5 In general, only a catalytic amount of chiral catalyst is 
required, which temporarily binds to the substrates to induce chirality. Based on the 
catalyst used, asymmetric catalysis can be further divided into three catagories: 
enzyme catalysis, metal-based catalysis and organocatalysis. 
Enzymes are proteins that are capable of producing small molecules in 
enantiomerically pure form. Therefore, enzyme catalysis becomes a choice for 
preparation of chiral compounds in organic synthesis. 6  However, the types of 
available enzymes are quite limited, and specific reaction conditions are required 
when enzymes are employed as the catalysts, which limites their application in 
organic synthesis. 
Transition metal based catalysis is widely used nowadays by chemists for the 
preparation of optically pure compounds. Great progress has been made since the 
1980s, thanks to the contributions made by Sharpless,7 Noyori,8 Jacobsen9 and 
                                                              
5 a) R. Noyori, R. Asymmetric Catalysis in Organic Synthesis, Wiley: New York, 1994; b) E. N. Jacobsen, A. Pfaltz, 
H. Yamamoto, Eds. Comprehensive Asymmetric Catalysis, 1st Ed, Springer: Berlin, 1999; c) I. Ojima, Catalytic 
Asymmetric Synthesis, 2nd Ed. Wiely-VCH: New York, 2000.  
6 K. Drauz, H. Groger, O. May, Eds. Enzyme catalysis in organic synthesis, John Wiley & Sons Inc, 2010. 
7 a) T. Katsuki, K. B. Sharpless, J. Am. Chem. Soc. 1980, 102, 5974; b) V. S. Martin, S. S. Woodard, T. Katsuki, Y. 
Yamada, M. Ikeda, K. B. Sharpless, J. Am. Chem. Soc. 1981, 103, 6237; c) Y. Gao, R. M. Hanson, J. M. Klunder, S. 
Y. Ko, H. Masamune, K. B. Sharpless, J. Am. Chem. Soc. 1987, 109, 5765; d) D. J. Berrisford, C. Bolm, K. B. 
Sharpless, Angew. Chem. Int. Ed. 1995, 34, 1059.  
8 a) A. Miyashita, A. Yasuda, H. Takaya, K. Toriumi, T. Ito, T. Souchi, R. Noyori, J. Am. Chem. Soc. 1980, 102, 7932; 
b) T. Ohta, H. Takaya, M. Kitamura, K. Nagai, R. Noyori, J. Org. Chem. 1987, 52, 3174; c) H. Takaya, T. Ohta, N. 
Sayo, H. Kumobayashi, S. Akutagawa, S. Inoue, I. asahara, R. Noyori, J. Am. Chem. Soc. 1987, 109, 1596; d) R. 
Noyori, T. Ohkuma, M. Kitamura, H. Takaya, N. Sayo, H. Kumobayashi, S. Akutagawa, J. Am. Chem. Soc. 1987, 
109, 5856; e) M. Kitamura, T. Ohkuma, S. Inoue, N. Sayo, H. Kumobayashi, S. Akutagawa, T. Ohta, H. Takaya, R. 
Noyori, J. Am. Chem. Soc. 1987, 109, 1596. 
9 W. Zhang, J. L. Loebach, S. R. Wilson, E. N. Jacobsen, J. Am. Chem. Soc. 1990, 112, 2801. 
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others.10  Metal catalysis succeeded in almost all types of reactions, and good 
selectivities can often be achieved by combining chiral ligands and suitable metals. 
However, high cost and toxicity of the metals, and stringent reaction conditions are 
the key drawbacks of metal-based catalytic methods. 
Organocatalysis has emerged as as another important method for the asymmetric 
preparation of chiral molecules in the past decade. 11  Organocatalysis is the 
acceleration of chemical reactions with a substoichiometric amount of an organic 
compound which does not contain a metal atom.3b The advantages of organic catalysts 
are notable: they are usually non-toxic, readily available from natural products, 
inexpensive, insensitive to reaction conditions in most cases. Furthermore, 
multi-component, tandem or domino multi-step reactions are also suitable in 
organocatalysis, allowing rapid and enantioselective constructions of structurally 
complex products. All these advantages make organocatalysis an indispensable 
method for the synthesis of chiral compounds. 
 
1.1.2 Development of Asymmetric Organocatalysis 
The asymmetric organocatalytic reactions have a rich history. 12  However, 
considerably less attention had been paid to this approach, and asymmetric 
                                                             
10 a) R. E. Lowenthal, A. Abiko, S. Masamune, Tetrahedron Lett. 1990, 31, 6005; b) D. A. Evans, M. M. Faul, M. T. 
Bilodeau, B. A. Anderson, D. M. Barnes, J. Am. Chem. Soc. 1993, 115, 5328; c) D. S. La, J. B. Alexander, D. R. 
Cefalo, D. D. Graf, A. H. Hoveyda, R. R. Schrock, J. Am. Chem. Soc. 1998, 120, 9720; d) A. El-Qisairi, O. Hamed, 
P. M. Henry, J. Org. Chem. 1998, 63, 2790; e) D. A. Evans, M. C. Kozlowski, J. A. Murry, C. S. Burgey, K. R. 
Campos, B. T. Connell, R. J. Staples, J. Am. Chem. Soc. 1999, 121, 669. 
11 a) A. Berkessel, H. Gröger, Asymmetric organocatalysis: from biomimetic concepts to applications in asymmetric 
synthesis, Wiley-VCH, Weinheim, 2005; b) P. I. Dalko, Enantioselective organocatalysis, Wiley-VCH, Weinheim, 
2006; c) C. E. Song, Cinchona alkaloids in synthesis and catalysis, Wiley-VCH, Weinheim, 2009; d) B. List, S. 
Arseniyadis, Asymmetric organocatalysis, Springer, 2010. 
12 a) G. Breding, R. W. Balcom, Ber. Deutsch. Chem. Ger. 1908, 41, 740; b) G. Breding, P. S. Fiske, Biochem. Z. 
1912, 46, 7; c) M. M. Vavon, P. Peignier, Bull Soc. Fr. 1929, 45, 293; d) H. Pracejus, Justus Liebigs Ann. Chem. 1960, 
643, 9; e) G. Stork, R. Terrell, J. Szmuszkovicz, J. Am. Chem. Soc. 1954, 76, 2029; f) G. Stork, H. Landesman, J. Am. 
Chem. Soc. 1956, 78, 5128; g) U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed. 1971, 10, 496; h) Z. G. Hajos, 
D. R. Parrish, J. Org. Chem. 1974, 39, 1615.  
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organocatalytic reactions were considered to be inefficient and limited in scope for a 
long time. The revival of modern asymmetric organocatalysis did not begin until the 
late 1990s and 2000s. The research groups of Jacobsen,13 Denmark,14 List and 
Barbas, 15  MacMillan, 16  Maruoka 17  developed a number of different organic 
catalysts to mediate various types of reactions. Inspired by their elegant studies, the 
interest in the field of organocatalysis has increased spectacularly in the past decade. 
To date, organoatalysis has developed into its own subdiscipline within organic 
chemistry and organocatalytic reactions are becoming powerful tools in the 
construction of enantioly pure compounds and complex molecular skeletons.  
As one of the core issues in organocatalysis, the development of different organic 
catalysts is always the focus and therefore numerous organic catalysts have appeared 
in the past few years, and some selected examples are shown in Figure 1.1. The 
known organic catalysts can be divided into the following categories according to 
their activation modes and structural specialty. 
                                                              
13 a) M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 4901; b) M. S. Sigman, P. Vachal, E. N. Jacobsen, 
Angew. Chem. Int. Ed. 2000, 39, 1279; c) P. Vachal, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 10012; d) P. Vachal, 
E. N. Jacobsen, Org. Lett. 2000, 2, 867. 
14 a) S. E. Denmark, R. A. Stavenger, T. K. Wong, X. P. Su, J. Am. Chem. Soc. 1999, 121, 4982; b) S. E. Denmark, J. 
P. Fu, J. Am. Chem. Soc. 2000, 122, 12021; c) S. E. Denmark, R. A. Stavenger, Acc. Chem. Res. 2000, 33, 432; d) S. 
E. Denmark, J. P. Fu, Org. Lett. 2002, 4, 1951. 
15 a) B. List, R. A. Lerner, C. F. Barbas III, J. Am. Chem. Soc. 2000, 122, 2395; b) B. List, J. Am. Chem. Soc. 2000, 
122, 9336; c) B. List, Synlett 2001, 1675; d) B. List, J. Am. Chem. Soc. 2002, 124, 5656; e) B. List, Tetrahedron 2002, 
58, 5573. 
16 a) K. A. Ahrendt, C. J. Borths, D. W. C. MacMillan, J. Am. Chem. Soc. 2000, 122, 4243; b) N. A. Paras, D. W. C. 
MacMillan, J. Am. Chem. Soc. 2001, 123, 4370; c) N. A. Paras, D. W. C. MacMillan, J. Am. Chem. Soc. 2002, 124, 
7894. 
17 a) O. Ooi, M. Kameda, K. Maruoka, J. Am. Chem. Soc.1999, 121, 6519; b) O. Ooi, E. Tayama, K. Doda, M. 
Takeuchi, K. Maruoka, Synlett 2000, 1500; c) O. Ooi, M. Takeuchi, K. Maruoka, Synthesis 2001, 1716; d) O. Ooi, Y. 
Uematsu, M. Kameda, K. Maruoka, Angew. Chem. Int. Ed. 2002, 41, 1551; e) O. Ooi, M. Kameda, K. Maruoka, J. 
Am. Chem. Soc. 2003, 125, 5139. 
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Figure 1.1 Selected examples of chiral organocatalysts  
 
a) Aminocatalysts that contain a secondary amine or primary amine moiety. The 
activation modes for this type of catalysts are mainly through enamine or iminium 
activation, and aldehydes and ketones are the typical substrates used in this catalytic 
system. 
b) Phase transfer catalysts (PTC). The PTC catalysts are normally chiral 
quaternary ammonium and phosphonium salts derived from cinchona alkaloids or 
binaphthyl derivatives. The enantiomeric control of the reaction is usually mediated 
by an ion-pairing interaction between the catalyst and substrate. 
c) Nucleophilic amine catalysts. Examples of these catalysts include DMAP type 
catalysts, imidazole type catalysts and some cinchona alkaloid derivatives. The 
nucleophilic nature of amine was utilized for acylation reactions, resolution of 
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alcohols, amines and other reactions.  
d) Organic phosphine catalysts. The difference in nucleophilicity and Brønsted 
basicity of the trivalent phosphines compared to the amine function makes them 
unique and powerful catalysts in a number of reactions, including various 
cycloaddition reactions, Morita-Baylis-Hillman reaction and its aza-counterpart, 
kinetic resolution reactions, as well as Michael additions and -additions. 
e) N-Heterocyclic carbene (NHC) catalysts. The NHC catalysts can induce 
inversion of the classical reactivity (e.g. conjugate umpolung of ,-unsaturated 
aldehydes), which opens up new synthetic pathways. NHC catalysis has found wide 
applications in many useful transformations like benzoin condensation, Stetter 
reaction and 1,2-additions.  
f) Hydrogen bonding based organic catalysts. In this catalytic system, hydrogen 
bonding interaction is essential for both of substrate activation and the high selectivity. 
The chiral catalysts usually contain hydrogen bond donors such as alcohols, urea or 
thiourea moiety.  
In the following sections of this Chapter, typical hydrogen bonding based 
organocatalytic methods will be reviewed, and focuses will be given to thiourea/urea 
based hydrogen bonding organocatalysts and their applications in organic synthesis.   
 
1.2 Chiral Hydrogen Bonding Based Organocatalysis 
1.2.1 Introduction 
Although the importance of hydrogen bonding interactions has been recognized 
in the scientific community for a long time, the term 'hydrogen bond' was not coined 
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until the year of 1931 in Pauling's seminal paper on the nature of the chemical bond.18  
Desipite its wide existence in chemical and biological systems, hydrogen bonding has 
been rarely used as the design principle for asymmetric catalysts. The enormous 
potential of hydrogen bonding as an activating interaction and its application in 
asymmetric synthesis has only been recognized recently.19 It was found that hydrogen 
bonding interactions constitute a major driving force in the formation of specific 
molecular and complex geometries in the transition states. Nowadays hydrogen 
bonding based organocatalysis has emerged as a frontier in the field of asymmetric 
catalysis.  
Although a large number of hydrogen bonding based organic catalysts appeared 
in the past few years, the vast majority of them contains certain hydrogen bond donors 
like thiourea/urea, alcohols, guanidinium ions and strong Brønsted acid (e.g. 
phosphoric acid, phenols) (Scheme 1.1). Moreover, they were mainly derived from 
some 'priviledged' chiral scaffold such as amino acids, 1,2-diaminocyclohexane, 
cinchona alkaloids, binaphthyl, TADDOL, indane and others. In the following part, 
hydrogen bonding based organocatalysts and their applications in asymmetric 
transformations will be reviewed based on the hydrogen bond donors. In particular, 
thiourea/urea based organocatalysis will be reviewed in detail according to the chiral 
scaffold of the catalysts.  
 
                                                             
18 L. Pauling, J. Am. Chem. Soc. 1931, 53, 1367. 
19 P. M. Pinko, Hydrogen Bonding in Organic Synthesis, Wiley, Weinhein, 2009. 
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Scheme 1.1 Typical hydrogen bond donors in organocatalysts 
 
1.2.2 Hydrogen Bonding Organocatalysis Based on Thiourea/Urea 
The systematic study of thiourea/urea as the hydrogen bond donors for the 
promotion of racemic organic reactions began in the 1980s. The Etter group reported 
that achiral diaryl ureas were good complexing agents for a number of proton 
acceptors, and well-defined crystalline complexs were formed. They proposed that the 
stability of the complex derived from a two-point hydrogen bonding interactions 
between the urea N-H bonds and the oxygen (Scheme 1.2).20 
 
 
Scheme 1.2 Etter's urea mediated hydrogen bonding interactions 
 
In 1994, the first report on the application of Etter's ureas as Lewis acids was 
disclosed by Curran and co-workers. They showed that the outcome of radical 
allylation reactions could be altered in the presence of ureas. The activation of the 
radical intermediate through hydrogen bonding interactions was believed to be 
                                                              
20 a) M. C. Etter, T. W. Panunto, J. Am. Chem. Soc. 1988, 110, 5896; b) M. C. Etter, Acc. Chem. Res. 1990, 23, 120; 
c) M. C. Etter, Z. Urbanczyk-Lipkowska, M. Zia-Ebrahimi, T. W. Panunto, J. Am. Chem. Soc. 1990, 112, 8415. 
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without 1-3: trans:cis = 2.5:1







Scheme 1.3 Urea catalyzed radical allylation reaction 
 
Shortly after, the same group reported the dipolar Claisen rearrangement using 
diaryl urea as catalyst. The reaction was found to be accelerated via the bis-hydrogen 
























1-5 1-634 times faster
 
Scheme 1.4 Urea catalyzed Claisen rearrangement 
 
Other examples appeared in the early 2000, the Schreiner group used the 
Etter-type ureas for the promotion of Diels-Alder reactions.23 The utilization of 
                                                             
21 D. P. Curran, L. H. Kuo, J. Org. Chem. 1994, 59, 3259. 
22 D. P. Curran, L. H. Kuo, Tetrahedron Lett. 1995, 36, 6647. 
23 P. R. Schreiner, A. Wittkopp, Org. Lett. 2002, 4, 217. 
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thioureas for the activation of nitrones was also reported by Takemoto and 
co-workers.24 
Numerous chiral organic catalysts containg a thiourea/urea as the hydrogen bond 
donor were prepared in the past few years, and they were mainly derived from the 
'priviledged' chiral scaffold such as 1,2-diaminocyclohexane, amino acids, cinchona 
alkaloids, binaphthyl, indane and others. 
 
1.2.2.1 Diamines Derived Thiourea/Urea Organocatalysts 
One early success in the field of hydrogen bonding based organocatalysis came 
from Jacobsen and co-workers. In 1998, a library of trans-1,2-diaminocyclohexane 
derived Schiff base thiourea/urea catalysts were introduced.25 These catalysts were 
initially designed as ligands for metal-based catalysis, but the study revealed that the 
catalysts themselves were efficient for the asymmetric Strecker reaction of hydrogen 
cyanide with N-allylaldimine (Scheme 1.5). The computational and experimental 
studies indicated that the hydrogen bonding between the imine lone electron pair and 
the acidic thiourea/urea NH proton was formed as the activation model.26 
 
                                                              
24 T. Okino, Y. Hoashi, Y. Takemoto, Tetrahedron Lett. 2003, 44, 2817. 
25 a) M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 4901; b) M. S. Sigman, P. Vachal, E. N. Jacobsen, 
Angew. Chem. Int. Ed. 2000, 39, 1279; c) P. Vachal, E. N. Jacobsen, Org. Lett. 2000, 2, 867; d) J. T. Su, P. Vachal, E. 
N. Jacobsen, Adv. Synth. Catal. 2001, 343, 197. 
26 P. Vachal, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 10012. 
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Scheme 1.5 Jacobsen's thiourea/urea catalyst and its application in Strecker reaction 
 
Subsequently, these catalysts were found to be also applicable to other types of 
reactions, such as Mannich-type reaction of N-Boc-aldimines with ketene silyl 


























































Scheme 1.6 Jacobsen's thiourea/urea catalysts catalyzed reactions 
 
                                                             
27 A. G. Wenzel, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 12964. 
28 G. D. Joly, E. N. Jacobsen, J. Am. Chem. Soc. 2004, 126, 4102. 
29 I. T. Raheem, E. N. Jacobsen, Adv. Synth. Catal. 2005, 347, 1701. 
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In contrast to most organometallic catalysts, the vast majority of the efficient 
catalysts currently used in organocatalysis have more than one active center. In 
thiourea/urea based organocatalysts, most of them are bifunctional and have another 
functional site, commonly a Lewis base center. Such catalysts are able to activate both 
the donor and acceptor and thus increase the reaction rate and selectivity. The first 
elegant example of bifunctional thiourea tertiary amine catalyst was developed by 
Takemoto in 2003. 30  The catalyst was derived from chiral 
trans-1,2-diaminocyclohexane with one amino group transformed to thiourea while 
the other converted to tertiary amine. Such a bifunctional catalyst was found to be 
highly efficient for the enantioselective Michael addition of malonate esters to 
nitroolefins (Scheme 1.7).  
 
Scheme 1.7 Michael addition reaction catalyzed by Takemoto's bifunctional catalyst 
 
In Takemoto's initial report, the high selectivity was attributed to two hydrogen 
bonding interactions, one between thiourea moiety and the nitro goup, and another 
one resulted from tertiary amine moiety and the enol form of malonate ester (Scheme 
1.8). Pápai et al proposed an alternative mode of this reaction based on density 
                                                              
30 a) T. Okino, Y. Hoashi, Y. Takemoto, J. Am. Chem. Soc. 2003, 125, 12672; b) T. Okino, Y. Hoashi, T. Furukawa, X. 
Xu, Y. Takemoto, J. Am. Chem. Soc. 2005, 127, 119. 
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functional theory calculations in 2006.31
 
They believed that the electrophile nitro 
olefin was activated via hydrogen bonding with the protonated tertiary amine, and the 
nucleophile enolate was activated by thiourea group through double hydrogen 
bonding interaction (Scheme 1.8). Interestingly, predictions by both activation modes 





























Takemoto Model Papai Model
Scheme 1.8 Proposed activation models for Takemoto catalyst 
 
The Takemoto group also demonstrated the applications of bifunctional tertiary 
amine thiourea catalyst 1-24 in other reactions, including 1,4-addition of malonitrile 
to ,-unsaturated imides, 32  aza-Henry reactions 33  and conjuate addition of 
,-unsaturated -ketoesters to nitroolefins.34 
The Takemoto catalyst was also employed by other research groups for a variety 
of reactions. Representative examples include asymmetric 1,4-addition of aryl thiols 
to ,-unsaturated cyclic enones and imides, conjugate addition/asymmetric 
                                                             
31 A. Hamza, G. Schubert, T. Soós, I. Pápai, J. Am. Chem. Soc. 2006, 128, 13151. 
32 a) Y. Hoashi, T. Okino, Y. Takemoto, Angew. Chem. Int. Ed. 2005, 44, 4032; b) T. Inokuma, Y. Hoashi, Y. 
Takemoto, J. Am. Chem. Soc. 2006, 128, 9413. 
33 a) T. Okino, S. Nakamura, T. Furukawa, Y. Takemoto, Org. Lett. 2004, 6, 625; b) X. Xu, T. Furukawa, T. Okino, H. 
Miyabe, Y. Takemoto, Chem. Eur. J. 2006, 12, 466. 
34 Y. Hoashi, T. Yabuta, P. Yuan, H. Miyabe, Y. Takemoto, Tetrahedron Lett. 2006, 62, 365. 
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protonation of -prochiral imide.35 In the latter case, the ammonium group of the 
catalyst serves as a chiral proton source for the stablized enone intermediate after 
initial 1,4-addition of the thiol group (Scheme 1.9).  
 
Scheme 1.9 Various reactions catalyzed by Takemoto catalyst 
Jacobsen also prepared Takemoto-type urea catalyst 1-34 to promote 
enantioselective iodolactonization reaction of hexenoic acid derivatives. Preliminary 
computational studies supported the intermediacy of an iodonium ion complex 1-36, 
which maintained a tertiary amino-iodonium ion interaction (Scheme 1.10).36 
                                                              
35 B. J. Li, L. Jiang, M. Liu, Y. C. Chen, L. S. Ding, Y. Wu, Synlett 2005, 603. 
36 G. E. Veitch, E. N. Jacobsen, Angew. Chem. Int. Ed. 2010, 49, 7332. 
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Scheme 1.10 Enantioselective iodolactonization reaction catalyzed by Takemoto type catalyst 
 
Other bifunctional thiourea catalysts based on trans-1,2-diaminocyclohexane 
were also developed by the Jacobsen group, and they were versatile catalysts in 
acyl-Pictet-Spengler reaction of imines,37 aza-Henry reaction,38 cyanosilylation of 
ketones, 39  acyl-Mannich reactions of isoquinolines 40  and Pictet-Spengler-type 
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37 M. S. Taylor, E. N. Jacobsen, J. Am. Chem. Soc. 2004, 126, 10558. 
38 T. P. Yoon, E. N. Jacobsen, Angew. Chem. Int. Ed. 2005, 44, 466. 
39 D. E. Fuerst, E. N. Jacobsen, J. Am. Chem. Soc. 2005, 127, 8964. 
40 M. S. Taylor, N. Tokunaga, E. N. Jacobsen, Angew. Chem. Int. Ed. 2005, 44, 6700. 
41 I. T. Raheem, P. S. Thiara, E. A. Peterson, E. N. Jacobsen, J. Am. Chem. Soc. 2007, 129, 13404. 
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Scheme 1.11 Jacobsen's bifuntional thiourea catalysts and application 
 
Multifunctional tertiary amine thiourea catalyst based on 
trans-1,2-diaminocyclohexane was developed in 2008. Wang and co-workers reported 
a highly anti-selective asymmetric nitro-Mannich reaction catalyzed by a 
Multifunctional thiourea catalyst (Scheme 1.12).42 The multiple hydrogen bonding 
interactions in the catalysis were important for the observed high selectivity. 
 
Scheme 1.12 Nitro-Mannich reaction catalyzed by a multifunctional catalyst 
 
Functionalities other than the tertiary amino group were also introduced to the 
                                                              
42 C.-J. Wang, X.-Q. Dong, Z.-H. Zhang, Z.-Y. Xue, H.-L. Teng, J. Am. Chem. Soc. 2008, 130, 8606. 
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diamine based thiourea/urea catalytic systems. In 2006, bifunctional primary amine 
urea catalyst 1-55 was reported by Jacobsen for the conjugate addition of branched 
aldehydes to nitroolfeins, affording the adducts in excellent diastereoselectivities (up 
to >50:1 dr) and very high enantioselectivities (up to 99% ee) (Scheme 1.13). It was 
hypothesized that nitroolefin was activated by the hydrogen bonding interaction 
between the urea function and the nitro moiety, and the aldehyde was activated via the 
enamine intermediate. The observed stereochemical control was believed due to the 




















> 50/1 dr, 92->99% ee




Scheme 1.13 Bifunctional primary amine urea catalyst mediated conjugate addition  
 
In 2004, Nagasawa el al. reported the use of diamine based chiral bis-thiourea 
1-59 as a co-catalyst with DMAP to promote the MoritaBaylisHillman addition of 
cyclohexenone to aldehydes (Scheme 1.14).44 The observed high enantioselectivity 
was apparently due to the chiral bis-thiourea catalyst since non-chiral DMAP was 
employed, it was proposed that bis-thiourea moiety interacting with the substrate 
during the transition state of the reaction. 
 
                                                             
43 M. P. Lalonde,Y. Chen, E. N. Jacobsen, Angew. Chem. Int. Ed., 2006, 45, 6366. 
44 Y. Sohtome, A. Tanatani, Y. Hashimoto, K. Nagasawa, Tetrahedron Lett. 2004, 45, 5589. 
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Scheme 1.14 Bis-thiourea catalyst mediated MBH reaction  
 
In addition to trans-1,2-diaminocyclohexane, other diamines were also used as 
the  chiral diamine framework for construction of thiourea/urea organocatalysts. 
Chen reported the conjugate addition of α-substituted α-cyanoacetates to vinyl sulfone 
catalyzed by catalyst 1-63 (Scheme 1.15).45 With the Takemoto catalyst 1-24, the 
addition of α-substituted α-cyanoacetates 1-64 to vinyl sulfone 1-65 proceeded well. 
However, catalyst 1-63 led to better results when α-aliphatic substituted 
α-cyanoacetates were used. It was believed that double hydrogen bonding interactions 
were involved between thiourea function and vinyl sulfone substrate. 
Scheme 1.15 Different diamine based bifunctional catalyst mediated conjugate addition  
1.2.2.2 Cinchona Alkaloids Derived Thiourea/Urea Organocatalysts 
Recently, cinchona alkaloids derived bifunctional thiourea/urea organocatalysts 
                                                              
45 T.-Y. Liu, J. Long, B.-J. Li, L. Jiang, R. Li, Y. Wu, L. Ding, Y.-C. Chen, Org. Biomol. Chem. 2006, 4, 2097. 
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have been developed. In such catalytic systems the thiourea/urea moiety serves as the 
hydrogen bond donor, and the teitiary amine from the alkaloid is a Lewis base 
functional center.  
The first cinchona alkaloids derived thiourea catalyst was developed by Soós and 
co-workers in 2005. Enantioselective conjugate addition of nitromethane to 
trans-chalcones was efficiently promoted by hydroquinine-derived thiourea catalyst 
1-68, and high yields and high enantioselectivities were attainable (Scheme 1.16).46 
The synergistic interplay in the spatial orientation of the thiourea-enone complex and 

























Scheme 1.16 Conjugate addition catalyzed by cinchona alkaloid derived thiourea catalyst  
 
In 2006, the Wang group utilized the hydroquinine derived thiourea catalyst to 
catalyze conjugate addition of a broad spectrum of nucleophilic enol species to enones. 
Excellent enantioselectivities and high yields were obtained for a diverse array of 
nucleophiles, including malonate esters, ketoesters, 1,3-diketones, nitroesters and 
malonitrile. Conjugate addition reaction of diethyl malonate to different enones was 
thoroughly studied, and consistently high yields as well as good enantioselectivities 
                                                             
46 B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967. 
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were attainable (Scheme 1.17).47 
 
Scheme 1.17 Conjugate addition of malonate ester to enones catalyzed by cinchona alkaloid 
derived thiourea catalyst  
 
Dixon and Connon independently reported 1,4-addition of malonate esters to 
nitroolefins with the same catalysts in 2005.48 One year later, Deng disclosed 
enantioselective addition of malonate esters and indoles to imines49 (Scheme 1.18). 
Hiemstra and co-workers developed another type of thiourea catalyst from 
cinchona alkaloid; hydrogen bond donor was placed at the C6' positionby by 
replacing the phenolic group with a thiourea. Henry reaction between aromatic 
aldehydes and nitromethane could be protmoted efficiently and high yields and good 
enantiomeric excesses were obtained (Scheme 1.19). 50  Subsequently, the Deng 
grioup employed the same catalyst for the asymmetric conjugate addition of simple 
alkyl thiols to ,-unsaturated N-acylated oxazolidin-2-ones (Scheme 1.19).51 
 
                                                              
47 J. Wang, H. Li, L. Zu, W. Jiang,, H. Xie, W. Duan, W. Wang, J. Am. Chem. Soc. 2006, 128, 12652. 
48 a) J. Ye, D. J. Dixon, P. S. Hynes, Chem. Commun. 2005, 4481; b) S. H. McCooey, S. J. Connon, Angew. Chem. Int. 
Ed. 2005, 44, 6367. 
49 a) J. Song, Y. Wang, L. Deng, J. Am. Chem. Soc. 2006, 128, 6048; b) Y.-Q. Wang, J. Song, R. Hong, H. Li, L. Deng, 
J. Am. Chem. Soc. 2006, 128, 8156. 
50 T. Marcelli, R. N. S. Haas, J. H. Maarseveen, H. Hiemstra, Angew. Chem. Int. Ed. 2006, 45, 929. 
51 Y. Liu, B. Sun, B. Wang, M. Wakem, L. Deng, J. Am. Chem. Soc. 2009, 131, 418. 
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1-68: R = CH2CH3










1-68 (2-5 mol%): toluene, -20 oC, 63-95% yield, 75-99% ee



















































1-82: R = Bn
























Scheme 1.19 A new type of cinchona alkaloid derived thiourea catalyst and application 
 
The cinchona alkaloid derived thiourea catalysts were also efficient in the 
domino type reactions. In an example reported by Wang et al. in 2007, bifunctional 
thiourea catalyst 1-74 was shown to effectively promote the cascade Michaelaldol 
reaction between 2-mercaptobenzaldehyde and ,-unsaturated oxazolidinones.52 In 
the presence of only 1 mol % catalyst, the product was formed as a single 
diastereoisomer and with excellent enantioselectivity (Scheme 1.20). 
 
                                                             
52 L. Zu, J. Wang, H. Li, H. Xie, W. Jiang, W. Wang, J. Am. Chem. Soc. 2007, 129, 1036. 
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Scheme 1.20 Cinchona alkaloid derived thiourea catalyst mediated cascade reaction 
 
1.2.2.3 Binaphthyl Derived Thiourea/Urea Organocatalysts 
As one of the best chiral scaffolds in the design of chiral ligands, binaphthyl 
derivatives were well studied in metal based asymmetric catalysis. However, their 
application as chiral motifs for construction of organic thiourea/urea catalysts was 
only explored recently. In 2005, Wang and co-workers devised novel chiral 
amine-thiourea bifucntional catalysts 1-92 from (R)-binaphtyl diamine 1-91, which 
was demonstrated to promote the asymmetric MBH reactions of cyclohexenone with 
a variety of aldehydes.. 53  Catalyst 1-92 was also found to be useful in 



































Scheme 1.21 Binaphthyl derived thiourea amine catalyst 
                                                              
53 J. Wang, H. Li, X. Yu, L. Zu, W. Wang, Org. Lett. 2005, 7, 4293. 
54 J. Wang, H. Li, W. Duan, L. Zu, W. Wang, Org. Lett. 2005, 7, 4713. 
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Application of binaphthyl derived bis-thiourea catalyst as organocatalyst was 
also investigated. Conon et al. utilized catalyst 1-96 to the asymmetric FriedelCrafts 
addition of N-methyl indole to nitroolefins.55 Although only low enantioselectivity 
(up to 50% ee) was obtained, high reactivity was observed, and the application of this 



























Scheme 1.22 Binaphthyl derived bis-thiourea catalyst mediated FriedelCrafts reaction 
 
The value of bis-urea catalyst was demonstrated very recently in asymmetric 
formal carbonyl-ene reaction. The binaphthyl derived bis-urea 1-99 and 1-100 
allowed highly enantioselective addition of tert-butyl hydrazone to aromatic 

















































Scheme 1.23 Binaphthyl derived bis-urea catalyst mediated formal carbonyl-ene reaction 
                                                             
55 E. M. Fleming, T. Macabe, S. J. Connon, Tetrahedron Lett. 2006, 47, 7073. 
56 A. Crespo-Peňa, D. Monge, E. Martín-Zamora, E. Álvarez, R. Fernández, J. M. Lassaletta, J. Am. Chem. Soc. 
2012, 134, 12912. 
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1.2.2.4 Indane Derived Thiourea/Urea Organocatalysts 
Chiral indane amino alcohol is another useful structure employed in the design of 
organocatalysts. In 2005, novel indane thiourea catalysts were introduced by Ricci's 
group via simple derivatization of commercially available chiral indane amino 
alcohols. The hydrogen bonding interactions between thiourea and nitro group as well 
as free alcohol and indole proton were proved to be crucial for the observed high 
reactivity and selectivity (Scheme 1.24).57 
Recently, Wang and co-workers developed a series of chiral indane amino 
alcohol derived tertiary amine thiourea catalysts. These catalyst were found superior 
to other traditional bifunctional catalysts in the domino reactions of 
benzylidenechroman-4-ones with 2-mercaptobenzaldehydes, 1-107 showed the best 
selectivity and affored spiro chromanone-thiochroan complexes with high yields and 




NO2 1-104 (20 mol%)































Scheme 1.24 Chiral indane thiourea catalyst mediated FriedelCrafts reaction 
 
                                                              
57 R. P. Herrera, V. Sgarzani, L. Bernardi, A. Ricci, Angew. Chem. Int. Ed. 2005, 44, 6576. 
58 Y. Gao, Q. Ren, H. Wu, M. Li, J. Wang, Chem. Commun. 2010, 46, 9232. 
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Subsequent study of the same group showed that indane amino thiourea 1-107 
was also the most efficient catalyst in the cascade 
Micheal-oxa-Michael-tautomerization reactions of malononitrile to enones, the 
densely functionalized chiral pyranochromenes were obtained in high yields and with 
















































 Scheme 1.25 Wang's chiral indane tertiary amine thiourea catalyst 
 
1.2.2.5 Amino Acids Derived Thiourea/Urea Organocatalysts 
Amino acids are arguably the most abundant chiral compounds from the existing 
chiral pools, and the revival of organocatalysis could also be attributed to L-proline 
mediated enamine catalysis. As one of the privileged scaffold, the amino acids derived 
thiourea/urea system was also investigated in recent years. 
Jacobsen and co-workers developed the thiourea amide catalysts from unnatural 
amino acid L-tert-leucine, these catalysts were successfully applied in the 
enantioselective additions to oxocarbenium ions and cationic polycyclization reaction 
(Scheme 1.26). It is believed the anion binding ability of thiourea group and 
cation-interactions from the aromatic moiety of catalyst are essential for the 
                                                             
59 Q. Ren, Y. Gao, J. Wang, Chem. Eur. J. 2010, 16, 13594. 
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Scheme 1.26 Jacobsen's thiourea catalyzed reactions of cationic species 
 
 In 2008, Pedrosa first disclosed amino acids based thiourea tertiary amine 
catalysts. A series of bifunctional amino thiourea/urea catalysts were prepared from 
amino acids, and L-valine derived catalyst 1-107 was identified as one of the best 
catalysts to promote the asymmetric nitro-Michael reaction of malonates and 
diketones (Scheme 1.27).61 
 
 
Scheme 1.27 L-Valine derived bifunctional thiourea catalyst 
 
In the following year, our group developed a tryptophan derived bifunctional 
                                                              
60 a) S. E. Reisman, A. G. Doyle, E. N. Jacobsen, J. Am. Chem. Soc. 2008, 130, 7198; b) R. P. Knowles, S. Lin, E. N. 
Jacobsen, J. Am. Chem. Soc. 2010, 132, 5030. 
61 J. M. Andrés, R. Manzano, R. Pedrosa, Chem. Eur. J. 2008, 14, 5116.  
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thiourea catalyst 1-110 and applied it successfully to the asymmetric Mannich 
reaction of fluorinated ketoesters (Scheme 1.28). The indole moiety of tryptophan was 
found to crucial for the observed high selectivity, an additional NH--O hydrogen 






























 Scheme 1.28 L-Tryptophan derived bifunctional thiourea catalyst 
 
The tyrosine derived amino thiourea catalyst 1-113 was reported by Zhao et al.,  
which promoted an asymmetric Michael addition of -substituted cyano ketones to 
,-unsaturated -ketoesters. The desired dihydropyrans were obtained in high yields 



























Scheme 1.29 L-Tyrosine derived bifunctional thiourea catalyst 
                                                             
62 X. Han, J. Kwiatkowski, F. Xue, K.-W. Huang, Y. Lu, Angew. Chem. Int. Ed. 2009, 48, 7604. 
63 S.-L. Zhao, C.-W. Zheng, H.-F. Wang, G. Zhao, Adv. Synth. Catal. 2009, 351, 2811. 
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Other examples of amino acids derived thiourea catalysts include Wang's 
asymmetric coumarin synthesis 64  and Jiang's asymmetric vinylogous conjugate 
additions of -aryl- and alkyl-substituted butenolides65 (Scheme 1.30). 
 Scheme 1.30 L-tert-Leucine derived bifunctional thiourea catalyst 
 
1.2.3 Hydrogen Bonding Organocatalysis Based on Other H-Bond Donors 
Hydrogen bonding donors such as alcohols, guanidinium ions, phenols, acids and 
amides were also intensively investigated in the field of hydrogen bonding based 
organocatalysis over the past years. In this section, the representative examples will 
be discussed. 
Alcohol is one of the earliest studied hydrogen bond donors in hydrogen bonding 
based organocatalysis. In 2003, Rawal et al. reported a TADDOL-derived 1-124 
catalyzed hetero-Diels-Alder reaction of aminosiloxydiene and benzaldehyde, and 
cycloadduct 1-127 was formed as a single diastereomer. Treatment of 1-127 with 
AcCl afforded hetero-Diels-Alder product in good yield and with excellent 
                                                              
64 Y. Gao, Q. Ren, L. Wang, J. Wang, Chem. Eur. J. 2010, 16, 13068. 
65 W. Zhang, D. Tan, R. Lee, G. Tong, W. Chen, B. Qi, K.-W. Huang, C.-H. Tan, Z. Jiang, Angew. Chem. Int. Ed. 
2012, 51, 10069. 
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Scheme 1.31 TADDOL catalyst and its application in hetero-Diels-Alder reaction 
 
In 2005, the nitroso aldol reaction between nitrosobenzene and enamines 
catalyzed by TADDOL catalyst was reported by Yamamoto and co-workers, 
TADDOL catalyst 1-124 gave N-Nitroso aldol product in 77-91% ee. Very 
interestingly, O-Nitroso aldol products could also be selectively formed when the 












































Scheme 1.32 Nitroso aldol reaction of enamine 
 
Guanidinium ions represent another important class of hydrogen bonding donor. 
                                                             
66 Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. 
67 N. Momiyama, H. Yamamoto, J. Am. Chem. Soc. 2005, 127, 1080. 
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In 1999, Corey first disclosed a C2-symmetric guanidine catalyst 1-134 and applied it 
in Strecker reaction of imine, and (S)-amino nitriles were obtained in high yields and 
with good nantioselectivities. In the proposed transitional state, a guanidinium 
cyanide salt was believed to provide hydrogen bonding interactions to activate the 
aldimine (Scheme 1.33).68 
 
 Scheme 1.33 Corey's chiral guanidine catalyst 
 
Guanidines derived from binaphthyl were also developed. In 2006, Terada and 
co-workers designed axially chiral guanidine 1-137, which was successfully applied 
to highly enantioselective Michael addition of 1,3-dicarbonyl compounds to 
nitroolefins. In the same year, the same group developed electrophilic amination 




68 E. J. Coery, M. Grogan, Org. Lett. 1999, 1, 157. 
69 a) M. Terada, H. Ube, Y. Yaguchi, J. Am. Chem. Soc. 2006, 128, 1454; b) M. Terada, M. Nakano, H. Ube, J. Am. 
Chem. Soc. 2006, 128, 16044. 
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Scheme 1.34 Binaphthyl derived guanidine catalysts 
 
Strong Brønsted acids are no doubt good hydrogen bonding donors, and chiral 
catalysts making use of strong Brønsted acids are certainly valuable. In 2004, Deng 
and co-worekers modified chichona alkaloid and prepared catalyst 1-143, which 
effectively promoted asymmetric Michael addition of malonate ester to nitroolefins 
(Scheme 1.35). Based on the observation that 6'-hydroxyquinoline derived catalysts 
gave significantly higher reaction rates and enantioselectivities when compared to the 
corresponding 6'-methoxyquinoline derivative, the authors suggested that the phenolic 









CO2MeMeO2C + R NO2
1-143 (10 mol%)






 Scheme 1.35 Cinchona alkaloid derivative mediated Michael addition 
 
                                                             
70 H. M. Li, Y. Wang, L. Tang, L. Deng, J. Am. Chem. Soc. 2004, 126, 9906. 
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In the same year, Akiyama and Terada independently reported that chiral 
phosphoric acids could mediate highly enantioselective Mannich reactions. The 
phosphoric acids were shown to be superior catalysts for Mannich reactions of 
aldimines with silyl enolates,71 and acetyl acetone to N-Boc-protected arylimines72 
(Scheme 1.36). These seminal contributions  demonstrated that modifications on the 
3,3’-bisaryl substituents of the catalysts could have immense effects on asymmetric 
induction, which had opened up a new avenue in catalyst design . 
Recently, our group developed the sulfonamide catalysts from the cinchona 
alkaloid, these catalysts were utilized to promote Michael addition of bicyclic 
-substituted -ketoesters to nitroolefins. The desired Michael adducts with 
all-carbon quaternary centers were constructed in high yields and with excellent 
enantioselectivities (Scheme 1.37).73 
 
 
Scheme 1.36 Chiral phosphoric acids mediated Mannich reaction 
 
                                                              
71 T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed. 2004, 43, 1566. 
72 D. Uraguchi, M. Terada, J. Am. Chem. Soc. 2004, 126, 5356. 
73 J. Luo, L.-W. Xu, R. A. S. Hay, Y. Lu, Org. Lett. 2009, 11, 437. 
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 Scheme 1.37 Cinchona alkaloid derived sulfonamide catalyst 
 
Catalyst 1-153 with the aminothiocarbamate moiety as hydrogen bonding donor 
and sulfur Lewis base was recently designed by Yeung and co-workers. This catalyst 
was utilized in the bromolactonization of unsaturated carboxylic acids, and  
-lactones were obtained in up to 99% yield and 93% ee. 74  Enantioselective 
bromoaminocyclization of unsaturated sulfonamides were also efficiently promoted 
by catalyst 1-156, and enantioenriched pyrrolidines were obtaind in very high yields 




















OH 1-153 (10 mol%), NsNH2 (50 mol%)




















Scheme 1.38 Aminothiocarbamate mediated bromocyclization reactions 
 
                                                             
74 L. Zhou, C. K. Tan, X. Jiang, F. Chen, Y.-Y. Yeung, J. Am. Chem. Soc. 2010, 132, 15474. 
75 L. Zhou, J. Chen, C. K. Tan, Y.-Y. Yeung, J. Am. Chem. Soc. 2011, 133, 9164. 
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1.3 Project Objectives 
The field of hydrogen bonding based organocatalysis has advanced rapidly in the 
past decade. Particularly, bifunctional and multifunctional organic molecules 
containing a tertiary amino group and a thiourea moiety are remarkably useful organic 
catalysts. A wide range of enantioselective transformations were discovered, which 
provide access to many useful synthetic building blocks. 
Natural amino acids are obviously ideal chiral building blocks for design of 
organocatalysts.76 Our group has keen interests in designing novel organocatalysts 
from natural amino acids. In particular, we have successfully uncovered primary 
amine catalysts and phosphine catalysts that are based on L-threonine, and 
demonstrated their effectiveness in a number of asymmetric reactions. Some of the 
catalysts developed by our group are shown in Figure 1.2.77 
 
 
Figure 1.2 Organocatalysts based on L-threonine developed by the Lu group 
 
As a further extension of our L-threonine based organocatalytic systems, the 
main aim of this project was to design and synthesize bifunctional or multifunctional 
                                                              
76 For related reviews, see: a) L.-W. Xu, J. Luo, Y. Lu, Chem. Commun. 2009, 1807; b) L.-W. Xu, Y. Lu, Org. Biomol. 
Chem. 2008, 6, 2047; c) F. Peng, Z. Shao, J. Mol. Catal. A 2008, 285, 1; d) E. A. C. Davie, S. M. Mennen, Y. Xu, S. 
J. Miller, Chem. Rev. 2007, 107, 5759. 
77 a) L.Cheng, X. Han, H. Huang, M. W. Wong, Y. Lu, Chem. Commun. 2007, 4143; b) L. Cheng, X. Wu, Y. Lu, Org. 
Biomol. Chem. 2007, 5, 1018; c) X. Wu, Z. Jiang, H.-M. Shen, Y. Lu, Adv. Synth. Catal. 2007, 349, 812; d) Q. Zhu, 
Y. Lu, Chem. Commun. 2010, 46, 2235; e) X. Han, Y. Wang, F. Zhong, Y. Lu, J. Am. Chem. Soc. 2011, 133, 1726; 
f) X. Han, F. Zhong, Y. Wang, Y. Lu, Angew. Chem. Int. Ed. 2012, 51, 767; g) F. Zhong, Y. Wang, X. Han, K.-W. 
Huang, Y. Lu, Org. Lett. 2011, 13, 1310; h) F. Zhong, X. Han, Y. Wang, Y. Lu, Angew. Chem. Int. Ed. 2011, 50, 
7873; i) F. Zhong, X. Han, Y. Wang, Y. Lu, Chem. Sci. 2012, 3, 1231; j) F. Zhong, J. Luo, G.-Y. Chen, X. Dou, Y. 
Lu, J. Am. Chem. Soc. 2012, 134, 10222; k) F. Zhong, X. Dou, X. Han, W. Yao, Q. Zhu, Y. Meng, Y. Lu, Angew. 
Chem. Int. Ed. 2013, 52, 943. 
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tertiary amine thiourea catalysts that are based on privileged L-threonine structure, 
and employ them in the enantioselective synthesis of biologically useful furan and 
oxindole derivatives. We will demonstrate in the following Chapters that different 
types of bifunctional or multifunctional L-threonine-based catalysts are superior to 
many tertiary amine thiourea catalysts reported in the literature, and our methods 
represent novel enantioselective preparations of chiral 3-2(H)-furanones, 
2,3-dihydrofurans, 3-spirocyclopropyl-2-oxindoles and different 
3-heteroatom-substituted oxindoles. 
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Chapter 2 From the Feist-Bénary Reaction to 
Organocatalytic Domino Michael-Alkylation Reactions: 
Asymmetric Synthesis of 3(2H)-Furanones 
 
2.1 Introduction 
3(2H)-Furanones are well known as basic structural motifs of many natural 
products and medicinally important agents (Figure 2.1).1 Over the past few decades, a 
number of approaches toward the synthesis of 3(2H)-furanones have been established, 
including: metal-mediated cyclizations of alkynyl substrates,2 transformations from 
furans, 3  cyclization of dienes or alkynes 4  and cycloisomerization of allenes. 5 
However, most of the above reactions required the employment of specific substrates, 
and the reaction conditions were often harsh. Moreover, to the best of our knowledge, 
an organocatalytic asymmetric synthesis of chiral furanone derivatives has not been 
reported to date. Thus, there clearly exists a need to devise an efficient and mild 
                                                              
1 a) For recent review: T. T. Haug, S. F. Kirsch, Targets in Heterocyclic Syntems, vol.13 (Ed.: O. A. Attanasi, D. 
Spinelli), Royal Society of Chemistry, London, 2009, p. 57; b) S. M. Kupchan, C. W. Sigel, M. J. Matz, C. J. Gilmore, 
R. F. Bryan, J. Am. Chem. Soc. 1976, 98, 2295; c) A. B. Smith, III, M. A. Guaciaro, S. R. Schow, P. M. Wovkulich, B. 
H. Toder, T. W. Hall, J. Am. Chem. Soc. 1981, 103, 219; d) P. K. Chowdhury, R. P. Sharma, G. Thyagarajan, J. Org. 
Chem. 1980, 45, 4993; e) R. A. Mack, W. I. Zazulak, L. A. Radov, J. E. Baer, J. D. Stewart, P. H. Elzer, C. R. 
Kinsolving, V. S. Gerrgiev, J. Med. Chem. 1988, 31, 1910; f) K. Takao, H. Ochiai, K. Yoshida, T. Hashizuka, H. 
Koshimura, K. Tadano, S. Ogawa, J. Org. Chem. 1995, 60, 8179; g) G. Comte. D. P. Allais, A. J. Chulia, Tetrahedron 
Lett. 1996, 37, 2995; h) R. J. M. Goss, J. Fuchser, D. O’Hagan, Chem. Commun. 1999, 2255; i) P. G. Steel, Chem. 
Commun. 1999, 2257; i) K. C. Nicolaou, D. Sarlah, D. M. Shaw, Angew. Chem. Int. Ed. 2007, 46, 4708. 
2 a) H. Saimoto, T. Hiyama, H. Nozaki, J. Am. Chem. Soc. 1981, 103, 4975; b) Y. Liu, M. Liu, S. Guo, H. Tu, Y. 
Zhou, H. G, Org. Lett. 2006, 8, 3445; c) S. F. Kirsch, J. T. Binder, C. Liébert, H. Menz, Angew. Chem. Int. Ed. 2006, 
45, 5878; d) B. Crone, S. F. Kirsch, J. Org. Chem. 2007, 72, 5435; e) M. Egi, K. Azechi, M. Saneto, K. Shimizu, S. 
Akai, J. Org. Chem. 2010, 75, 2123. 
3 a) D. W. Henry, R. M. Silverstein, J. Org. Chem. 1966, 31, 2391; b) R. Antonioletti, F. Bonadies, T. Prencipe, A. 
Scettri, J. Chem. Soc. Chem. Commun. 1988, 850. 
4 a) P. Langer, T. Krummel, Chem. Commun. 2000, 967; b) P. Langer, T. Krummel, Chem. Eur. J. 2001, 7, 1720; c) C. 
M. Marson, E. Edaan, J. M. Morrell, S. J. Coles, M. B. Hursthouse, D. T. Davies, Chem. Commun. 2007, 2494; e) B. 
A. Trofimov, O. A. Shemyakina, A. G. Mal'kina, I. A. Ushakov, O. N. Kazheva, G. G. Alexandrov, O. A. Dyachenko, 
Org. Lett. 2010, 12, 3200. 
5 M. Poonoth, N. Krause, J. Org. Chem. 2011, 76, 1934 
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Jatrophone: R = CH3








Figure 2.1 Natural products containing a 3(2H)-furanone motif 
 
The FeistBénary reaction is a base-catalyzed condensation between -halogen 
ketones and -dicarbonyl compounds for the preparation of substituted furans.6 The 
FeistBénary synthesis can also be viewed as a domino aldolalkylation reaction, in 
which the ketone electrophile plays a key role in the proton transfer, and the presence 
of halogen atom is crucial for the cyclization step. Except its application in furan 
synthesis, this name reaction was considerly less explored. We envisioned that a 
modified FeistBénary reaction employing other reaction partners may provide a new 
route for thesis of some interesting furan derivatives. Since furanones are furan 
derivatives, a modified FeistBénary reaction that can provide a straightforward 
method for the synthesis of furanones became our interest. By employing a 
γ-halogenated-β-dicarbonyl compound and a suitable electrophile, a modified 
                                                             
6 a) F. Feist, Chem. Ber. 1902, 35, 1537; b) E. Bénary, Chem. Ber. 1911, 44, 489. For recent selected examples, see: c) 
M. A. Calter, R. M. Phillips, C. Flaschenriem, J. Am. Chem. Soc. 2005, 127, 14566; d) E. Holtz, P. Langer, Synlett 
2004, 1805; e) G. Mross, E. Holtz, P. Langer, J. Org. Chem. 2006, 71, 8045. 
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FeistBénary reaction via a Michaelalkylation cascade sequence7 is anticipated to 
generate 3(2H)-furanones (Scheme 2.1).  
 
Scheme 2.1 Synthesis of furanones through a modified FeistBénary reaction 
 
2.2 Results and Discussion 
2.2.1 Catalyst Design and Synthesis 
Our group has been investigating amino acid-based asymmetric organocatalysis 
in the past few years, and asymmetric amino catalysis and asymmetric phosphine 
catalysis based on different amino acids have been established as powerful and 
versatile tools in asymmetric synthesis.8 In our previous studies, L-threonine based 
catalysts9 showed to be previliged among all the natural amino acids tested due to its 
unique stucuture. To further expand the L-threonine-based asymmetric 
organocatalysis system, we were interested in establishing novel bifunctional 
                                                              
7 For recent reviews on asymmetric domino reactions, see: a) D. J. Ramón, M. Yus, Angew. Chem. Int. Ed. 2005, 44, 
1602; b) D. Tejedor, D. G. Cruz, A. S. Expósito, J. J. M. Tellado, P. D. Armas, F. G. Tellado, Chem. Eur. J. 2005, 11, 
3502; c) H.-C. Guo, J.-A. Ma, Angew. Chem. Int. Ed. 2006, 45, 354; d) H. Pellissier, Tetrahedron 2006, 62, 2143; e) 
D. Enders, C. Grondal, M. R. M. Hüttl, Angew. Chem. Int. Ed. 2007, 46, 1570; f) G. Guillena, D. J. Ramón, M. Yus, 
Tetrahedron: Asymmetry 2007, 18, 693; g) C. J. Chapman, C. G. Frost, Synthesis 2007, 1, 1; h) X. Yu, W. Wang, Org. 
Biomol. Chem. 2008, 6, 2037; i) C. Grondal, M. Jeanty, D. Enders, Nature Chem. 2010, 2, 167. 
8 For reviews on asymmetric catalysis mediated by amino acids, see: a) L.-W. Xu, J. Luo, Y. Lu, Chem. Commun. 
2009, 1807; b) L.-W. Xu, Y. Lu, Org. Biomol. Chem. 2008, 6, 2047; c) E. A. C. Davie, S. M. Mennen, Y. Xu, S. J. 
Miller, Chem. Rev. 2007, 107, 5759.  
9 see Chapter 1, ref 77. 
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tertiaryamine thiourea catalysts based on L-threonine scaffold. We envisioned that 
novel bifunctional tertiaryamine thiourea catalysts can be easily derived from 
L-threonine, and the catalyst design is ilustrated in Figure 2.2. Simple transformations 
convert the acid group into a tertiary amine, and the thiourea site for the bifunctional 
catalysts can be easily derived from the amine moiety. Proper selection of protecting 
groups on the hydroxy moiety then provides steric tuning to the structures of the 
catalysts. Using L-threonine as starting chiral source, bifunctional tertiaryamine 







































Figure 2.3 Structures of bifunctional catalysts synthesized from L-threonine 
 
Synthetic route for bifunctional tertiaryamine thiourea 2-8a from L-threonine is 
illustrated in Scheme 2.2. Alcohol 2-8a110 was oxidized to aldehyde 2-8a2 via Swern 
oxidation. Subsequent reductive amination yielded tertiaryamine 2-8a3, which 
                                                             
10 K. Kawamura, H. Fukuzawa, M. Hayashi, Org. Lett. 2008, 10, 3509. 
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underwent subsequent deprotection and selective protection of hydroxy group to 
afford primary amine 2-8a4. Catalyst 2-8a was prepared upon reaction of 2-8a4 with 
the corresponding isothiocyanate.  
 
Scheme 2.2 Synthetic route for preparation of catalyst 2-8a 
 
2.2.2 Reaction Optimization 
To test the feasibility of our proposal for the synthesis of 3(2H)-furanones, we 
chose nitroolefins as potential electrophiles, since they are readily available and 
versatile electrophiles in the conjugate addition.11 For the selection of the catalysts, 
except the novel L-threonine-derived bifunctional catalysts, we also tested other 
bifunctional amino catalysts containing a Brønsted acid moiety;12 promotion of the 
modified FeistBénary reaction could be realized through the interactions of the 
                                                              
11 For selected examples of Michael reaction between β-dicarbonyl compound and nitroolefin, see: a) J. Ji, D. M. 
Barnes, J. Zhang, S. A. King, S. J. Steven, H. E. Morton, J. Am. Chem. Soc. 1999, 121, 10215; b) D. M. Barnes, J. Ji, 
M. G. Fickes, M. A. Fitzgerald, S. A. King, H. E. Morton, F. A. Fpagge, M. Preskill, S. H. Wagaw, S. J. Wittenberger, 
J. Zhang, J. Am. Chem. Soc. 2002, 124, 13097; c) T. Okino, Y. Hoashi, Y. Takemoto, J. Am. Chem. Soc. 2003, 125, 
12672; d) H. Li, Y. Wang, L. Tang, L. Deng, J. Am. Chem. Soc. 2004, 126, 9906; e) S. H. McCooey, S. J. Connon, 
Angew. Chem. Int. Ed. 2005, 44, 6367; f) T. Okino, Y. Hoashi, T. Furukawa, X. Xu, Y. Takemoto, J. Am. Chem. Soc. 
2005, 127, 119; g) D. A. Evans, D. Seidel, J. Am. Chem. Soc. 2005, 127, 9958; h) M. Terada, H. Ube, Y. Yaguchi, J. 
Am. Chem. Soc. 2006, 128, 1454; i) C.-J. Wang, Z.-H. Zhang, X.-Q. Dong, X.-J. Wu, Chem. Commun. 2008, 1431; j) 
H. Li, S. Zhang, C. Yu, X. Song, W. Wang, Chem. Commun. 2009, 2136; k) Z. Yu, X. Liu, L. Zhou, L. Lin, X. Feng, 
Angew. Chem. Int. Ed. 2009, 48, 5195; l) Q. Zhu, H. Huang, D. Shi, Z. Shen, C. Xia, Org. Lett. 2009, 11, 4536. 
12 For reviews, see: a) P. R. Schreiner, Chem. Soc. Rev. 2003, 32, 289; b) M. S. Taylor, E. N. Jacobsen, Angew. Chem. 
Int. Ed. 2006, 45, 1520; c) T. Akiyama, J. Itoh, K. Fuchibe, Adv. Synth. Catal. 2006, 348, 999; d) X. Yu, W. Wang, 
Chem. Asian J. 2008, 3, 516; f) S. J. Connon, Chem. Commun. 2008, 2499; g) A. G. Doyle, E. N. Jacobsen, Chem. 
Rev. 2007, 107, 5713. 
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catalysts with both substrates in a cooperative manner. The domino reaction between 
ethyl 4-bromoacetoacetate 2-1 and nitrostyrene 2-2a was selected as a model reaction, 
and the results are summarized in Table 2.1.  
When quinidine-derived tertiaryamine thiourea catalyst 2-4 was used, the 
reaction proceeded with very low conversion (entry 1). This result is not surprising, 
and it suggested that the catalyst was probably quenched by HBr generated during the 
reaction. To circumvent this problem, we next introduced a stoichiometric amount of 
base as an additive to capture HBr released. The inclusion of Et3N or K2CO3 into the 
reaction system proved to be beneficial, the desired products were obtained in very 
high yields, however,  the enantioselectivities were very poor (entries 23). 
Suspecting the above bases were strong enough to induce undesired background 
reactions, (NH4)2CO3 was then introduced as a HBr scavenger. Gratifyingly, the 
desired furanone 2-3a was obtained in good yield and with moderate 
enantioselectivity in the presence of (NH4)2CO3 (entry 4). To further improve the 
enantioselectivity of the reaction, we turned our attention to different types of tertiary 
amine thiourea catalysts with an amino acid structural scaffold, including our group 
recently developed tryptophan-derived tertiaryamine thiourea catalysts13 and amino 
acid-incorporating trifunctional catalysts. 14  While cinchonidine-derived 
multifunctional catalyst 2-5 and quinidine-derived sulfonamide15 2-6 gave moderate 
enantioselectivity (entries 56), tryptophan-based 2-7 turned out to be an excellent 
                                                             
13 a) X. Han, J. Kwiatkowski, F. Xue, K.-W. Huang, Y. Lu, Angew. Chem. Int. Ed. 2009, 48, 7604; b) J. Luo, H. Wang, 
X. Han, L.-W. Xu, J. Kwiatkowski, K.-W. Huang, Y. Lu, Angew. Chem. Int. Ed. 2011, 50, 1861. 
14 Q. Zhu, Y. Lu, Angew. Chem. Int. Ed. 2010, 49, 7753. 
15 J. Luo, L.-W. Xu, R. A. S. Hay, Y. Lu, Org. Lett. 2009, 11, 437. 
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catalyst, furnishing the desired product with very good enantioselectivity (entry 7). 
Gratifyingly, L-threonine-derived tertiaryamine thiourea catalysts 2-8 proved to be the 
most efficient catalysts, and the desired 3(2H)-furanones 2-3a was obtained in 
excellent yield and with very high enantioselectivity (entries 89). 
 
Table 2.1 Domino MichaelAlkylation Reaction for the Synthesis of 3(2H)-Furanone 2-3aa 
 
entry cat. additive t (h) yield (%)b ee (%)c 
1 2-4 none 24 <10 - 
2 2-4 Et3N 0.5 95 -10 
3 2-4 K2CO3 1 86 -16 
4 2-4 (NH4)2CO3 16 73 -65 
5 2-5 (NH4)2CO3 8 82 75 
6 2-6 (NH4)2CO3 24 60 -61 
7 2-7 (NH4)2CO3 24 84 95 
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8 2-8a (NH4)2CO3 24 90 90 
9 2-8b (NH4)2CO3 24 85 90 
a Reactions were performed with 2-1 (0.05 mmol), 2-2a (0.05 mmol), the additive (0.05 mmol) 
and the catalyst (0.01 mmol) in toluene (0.5 mL) at room temperature. b Isolated yield. c 
Determined by HPLC analysis on a chiral stationary phase.  
 
2.2.3 Substrate Scope 
The substrate scope for this novel domino Michaelalkylation reaction was 
subsequently examined (Table 2.2). Consistently high yields and excellent 
enantioselectivities were observed for a wide range of aryl nitroolefins (entries 110). 
Nitroolefins with different halide substitutions, substitution groups with different 
electronic properties and subsitution positions were all well tolerated (entries 28). 
Furyl and thienyl substituted nitroolefins could also be employed (entries 910). 
Moreover, alkyl nitroolefins were also suitable substrates, and high yields and ee 
values were attainable (entries 1113). The absolute configurations of the 
3(2H)-furanones were determined on the basis of the X-ray crystal structure of 2-3d.  
 


















entry product (R) t (h) yield (%)b ee (%)c 
1 2-3a (C6H5) 24 90 90 
2 2-3b (2-F-C6H4) 24 89 94 
3 2-3c (2-Cl-C6H4) 24 88 96 
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4 2-3d (2-Br-C6H4) 24 83 96 
5 2-3e (2-Me-C6H4) 30 85 94 
6 2-3f (3-NO2-C6H4) 24 86 88 
7 2-3g (4-Cl-C6H4) 24 78 91 
8 2-3h (4-CN-C6H4) 24 84 95 
9 2-3i (2-furyl) 24 85 91 
10 2-3j (2-thienyl) 30 75 90 
11 2-3k (cyclohexyl) 48 72 87 
12 2-3l (n-butyl) 48 81 91 
13 2-3m (iso-butyl) 48 78 93 
a Reaction were performed with 2-1 (0.05 mmol), 2-2 (0.05 mmol), (NH4)2CO3 (0.05 mmol) and 
2-8a (0.01 mmol ) in toluene (0.5 mL) at room temperature. b Isolated yield. c Determined by 
chiral phase HPLC analysis.  
 
Scheme 2.3 Synthesis of furanone employing bromodiketone 
 
In an attempt to broaden the substrate scope, bromodiketone 2-9 was examined, as 
illustrated in Scheme 2.3. Under the optimized reaction conditions established in our 
previous experiments, the desired furanone 2-10 was obtained in moderate yield and 
with only 50% ee. Meanwhile, furanone 2-11, resulted from the self-cyclization of 
2-9, was obtained in 30% yield. When 2-9 was treated with triethylamine alone (2 
eq.), product 2-11 was isolated in 89% yield, which clearly demonstrated the high 
tendency of such substrates to undergo rapid cyclization reaction. However, when 2-1 
was treated with triethylamine alone without adding nitroolefin 2-2, decomposition of 
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2-1 was observed, and only trace amount of the cyclization product was observed 
after 1h, and the vast majority of 2-1 remained unreacted. The same was observed 
under the optimal reaction conditions. 
 
2.2.4 Synthetic Manipulations of the 3(2H)-Furanone Product 
The 3(2H)-furanone products 2-3 are valuable molecules due to the importance of 
the furanone core in natural product and medicinal chemistry.1 Moreover, such 
structures are also valuable synthetic intermediates. As illustrated in Scheme 2.4, 
treatment with HCl readily elaborated furanone 2-3a to tetronic acid 2-3a-1,16 a core 
structural skeleton that has been found in many bioactive natural products. 17 
Furthermore, reducing the nitro group of the teronic acid resulted in spontaneous 
formation of -alkylidene-lactam 2-3a-2, an intriguing structural motif possessing a 


















2-3a 2-3a-1 2-3a-2  
Scheme 2.4 Preparation of tetronic acid and -lactam from furanone 2-3a 
 
2.2.5 Proposed Transition State 
                                                             
16 E. Wenkert, A. J. Marsaioli, P. D. R. Moeller, J. Chromatogr. 1988, 440, 449. 
17 a) Y. S. Rao, Chem. Rev. 1976, 76, 625; b) M. Sodeoka, R. Sampe, S. Kojima, Y. Baba, T. Usui, K. Ueda, H. Osada, 
J. Med. Chem. 2001, 44, 3216; c) H. Bühler, A. Bayer, F. Effenberger, Chem. Eur. J. 2000, 6, 2564; d) J. Wu, Q. Zhu, 
L. Wang, R. Fathi, Z. Yang, J. Org. Chem. 2003, 68, 670; e) D. T. Aragon, G. V. Lopez, F. G. Tellado, J. J. M. Tellado, 
P. D. Armas, D. Terrero, J. Org. Chem. 2003, 68, 3363; f) T. L. Trullinger, J. Qi, W. R. Roush, J. Org. Chem. 2006, 71, 
6915; g) D. Tejedor, A. S. Exposito, F. G. Tellado, Synthlett 2006, 10, 1607; h) R. K. Boeckman, Jr., P. Shao, S. T. 
Wrobleski, D. J. Boehmler, G. R. Heintzelman, A. J. Barbosa, J. Am. Chem. Soc. 2006, 128, 10572; i) K. C. Nicolaou, 
S. T. Harrison, J. Am. Chem. Soc. 2007, 129, 429; j) A. Mallinger, T. L. Gall, C. Mioskowski, Synthlett 2008, 3, 386. 
18 a) W. Xu, A. Kong, X. Lu, J. Org. Chem. 2006, 71, 3854; b) R. L. Vezouet, A. J. P. White, J. N. Burrows, A. G. M. 
Barrett, Tetrahedron 2006, 62, 12252; c) H. Wang, X. Han. X. Lu, Tetrahedron 2010, 66, 9129; d) Y.-C. Jeong, M. G. 
Mooney, J. Org. Chem. 2011, 76, 1342; e) S. Tekkam, M. A. Alam, S. C. Jonnalagadda, V. R. Mereddy, Chem. 
Commun. 2011, 47, 3219. 
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The detailed mechanism of the reaction is not investigated at this stage. A plausible 
transition state model is shown in Scheme 2.5. The tertiary amine group of the 
catalyst deprotonates the -ketoester to form an enolate, which engages in hydrogen 
bonding interactions with the thiourea moiety of the catalyst. The ionic interaction 
between positively charged ammonium with nitroolefin is believed to be important for 
the substrate binding. Such a proposal is consistent with the theoretical studies carried 
out in the literature for similar systems.19  
 
Scheme 2.5 A plausible transition state model 
 
2.3 Conclusions 
In summary, we have designed a modified FeistBénary reaction employing a 
domino Michaelalkylation sequence for the enantioselective preparation of 
3(2H)-furanones, synthetically useful structural motifs with significant biological 
importance. We have also prepared L-threonine-derived tertiaryamine thiourea 
catalysts for the first time; such catalysts promoted the designed domino 
Michaelalkylation reactions efficiently, affording 3(2H)-furanones in high yields and 
with excellent enantioselectivities. Further development of practical synthetic 
                                                              
19 A. Hamza, G. Schubert, T. Soós, I. Pápai, J. Am. Chem. Soc. 2006, 128, 13151. 
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methods based on the FeistBénary reaction to access biologically significant 
molecules is currently ongoing in our laboratory. 
 
2.4 Experimental section 
2.4.1 Material and General Methods 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. 1H and 13C NMR spectra were 
recorded on a Bruker ACF300 or AMX500 (500 MHz) spectrometer. Chemical 
shifts were reported in parts per million (ppm), and the residual solvent peak was 
used as an internal reference: proton (chloroform δ 7.26), carbon (chloroform δ 77.0). 
Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), dd (doublet of doublet), br (broad singlet). Coupling constants were 
reported in Hertz (Hz). Low resolution mass spectra were obtained on a 
Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT 95XL- T mass 
spectrometer in EI mode. All high resolution mass spectra were obtained on a 
Finnigan/MAT 95XL- T spectrometer. For thin layer chromatography (TLC), Merck 
pre- coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. Further visualization was achieved by staining with 
iodine, or ceric ammonium molybdate followed by heating on a hot plate. Flash 
chromatographic separations were performed on Merck 60 (0.040- 0.063 mm) mesh 
silica gel. The enantiomeric excesses of products were determined by chiral-phase 
HPLC analysis.  
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2.4.2 Catalysts Preparation 
Preparation of L-threonine-derived bifunctional catalyst 2-8a 
(4R,5R)-tert-Butyl-2,2,5-trimethyl-4-(piperidin-1-ylmethyl)oxazolidine- 
3-carboxylate 2-83a 
Alcohol 2-8a1 was oxidized to aldehyde 2-8a2 (0.5 mmol, 122 mg) via Swern 
oxidation, and the crude aldehyde was added directly to a stirred solution of 
piperidine (0.6 mmol, 51 mg) in methanol (5 mL). The resulting mixture was stirred 
at RT for 2 h, and then NaBH3CN (2 mmol, 160 mg) was added. The reaction mixture 
was further stirred for 6 h, during which acetic acid was added periodically to 
maintain the pH of the solution at 56. Ammonia solution was introduced, and white 
precipitate was formed. The mixture was concentrated under reduced pressure, and 
the residue was taken up in dichloromethane (20 mL), washed with brine and dried 
over Na2SO4. After filtration and concentration, the residue was purified by column 
chromatography (hexane/ethyl acetate = 5/1 to ethyl acetate) to afford 2-8a3 as a 
colorless oil (125 mg, 83%). 
1H NMR (300 MHz, CDCl3) δ 1.25 (d, J = 6.2 Hz, 3H), 1.37-1.51 (m, 21H), 2.23-2.42 
(m, 6H), 3.42-3.57 (m, 2H), 4.01-4.12 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 21.0, 
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21.4, 24.2, 25.8, 25.9, 26.9, 28.1, 28.2, 28.3, 55.3, 61.3, 77.2, 79.4, 93.6, 93.8, 151.7; 
HRMS (ESI) m/z calcd for C17H33N2O3 [M+H]+ = 313.2486, found = 313.2477. 
(2R,3R)-3-((tert-Butyldimethylsilyl)oxy)-1-(piperidin-1-yl)butan-2-amine 2-8a4 
To a stirred solution of TFA (0.3 mL) in CH2Cl2 (1.2 mL) was added 2-8a3 (123 mg, 
0.4 mmol), and the resulting solution was stirred overnight. The solvent was then 
removed under reduced pressure and the residue was further dried under vacuum. The 
residue was dissolved in anhydrous CH2Cl2 (1 mL), followed by addition of 
triethylamine (2 mmol, 202 mg) and DMAP (0.08 mmol, 10 mg). t-Butyldimethylsilyl 
chloride (0.4 mmol) in anhydrous CH2Cl2 (0.5 mL) was introduced to the reaction 
mixture dropwise. After stirring at room temperature for 24 h, the reaction mixture 
was concentrated and the residue was purified by flash column chromatography 
(CH2Cl2/MeOH = 50/1 to 5/1) to afford amine 2-8a4 as a yellow oil (105 mg, 93%). 
1H NMR (300 MHz, CDCl3) δ 0.05 (d, J = 2.6 Hz, 6H), 0.86 (s, 9H), 1.14 (d, J = 6.2 
Hz, 3H), 1.38-1.44 (m, 2H), 1.54-1.58 (m, 4H), 2.21-2.32 (m, 4H), 2.47 (d, J = 5.3 Hz, 
2H), 2.75-2.81 (m, 1H), 3.42 (br s, 2H), 3.68-3.76 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ -5.0, -4.3, 17.9, 20.6, 24.2, 25.7, 25.7, 53.5, 54.8, 62.6, 69.8; HRMS (ESI) 
m/z calcd for C15H35N2OSi [M+H]+ = 287.2513, found = 287.2506. 
1-(3,5-Bis(trifluoromethyl)phenyl)-3-((2R,3R)-3-((tert-butyldimethylsilyl)oxy)-1-(pip
eridin-1-yl)butan-2-yl)thiourea 2-8a 
Amine 2-8a4 (100 mg, 0.35 mmol) was dissolved in CH2Cl2 (3 mL), and 
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3,5-bis(trifluoromethy)-phenylisothiocyanate (95 mg, 0.35 mmol) was then added. 
After stirring for 4 h, the reaction mixture was concentrated and subjected to flash 
chromatographic separation (CH2Cl2 to CH2Cl2/MeOH = 10/1) to afford catalyst 2-8a 
as a yellow oil (185 mg, 95%). 
1H NMR (300 MHz, CDCl3) δ 0.09 (d, J = 4.3 Hz, 6H), 0.90 (s, 9H), 1.26 (d, J = 6.1 
Hz, 4H), 1.54 (d, J = 17.6 Hz, 6H), 2.45-2.72 (m, 6H), 3.60 (s, 1H), 3.92 (s, 1H), 6.68 
(s, 1H), 7.61 (s, 1H), 8.04 (s, 1H); 13C NMR (75 MHz, CDCl3) δ -5.0, -4.2, 17.8, 21.1, 
23.3, 25.5, 25.6, 55.1, 59.7, 65.3, 69.4, 117.9, 124.4, 131.3, 131.7, 141.8, 184.0; 
HRMS (ESI) m/z calcd for C24H38F6N3OSSi [M+H]+ = 558.2404, found = 558.2380.  
 




To a stirred solution of TFA (0.15 mL) in CH2Cl2 (0.6 mL) was added amine 2-8a3 
(62 mg, 0.2 mmol), and the resulting solution was stirred overnight. The solvent was 
then removed under reduced pressure and the residue was further dried under vacuum. 
The residue was dissolved in anhydrous CH2Cl2 (1 mL), followed by addition of 
triethylamine (1 mmol, 101 mg) and DMAP (0.04 mmol, 5 mg). t-Butyldiphenylsilyl 
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chloride (0.2 mmol) in anhydrous CH2Cl2 (0.25 ml) was introduced to the reaction 
mixture dropwise. After stirring at room temperature for 24 h, the reaction mixture 
was concentrated and further dried under vacuum. The residue was then dissolved in 
CH2Cl2 (2.5 mL), and 3,5-bis(trifluoromethy)-phenylisothiocyanate (54 mg, 0.2 mmol) 
was added. After stirring for 4 h, the reaction mixture was washed with water and 
concentrated under reduced pressure to afford the crude product, which was subjected 
to flash chromatographic separation (ethyl acetate/hexanes = 1/5 to 1/1) to afford 
catalyst 2-8b as a yellow oil (52 mg, 38% for 3 steps). 
1H NMR (500 MHz, CDCl3) δ 1.00-1.27 (m, 13H), 1.36-1.53 (m, 6H), 2.25-2.67 (m, 
6H), 3.51 (s, 1H), 3.90 (d, J = 6.9 Hz, 1H), 6.68 (s, 1H), 7.39-7.46 (m, 7H), 7.63-7.69 
(m, 5H), 8.02 (s, 1H); 13C NMR (125 MHz, CDCl3) 19.2, 20.6, 20.9, 23.4, 24.3, 25.5, 
26.0, 27.0, 52.9, 54.7, 59.1, 68.0, 118.1, 124.5, 127.7, 130.1, 132.8, 132.9, 135.9, 
184.1; HRMS (ESI) m/z calcd for C34H42F6N3OSSi [M+H]+ = 682.2717, found = 
682.2758. 















2-8a (20 mol %)
toluene, (NH4)2CO3
 
Ethyl 4-bromoacetoacetate 2-1 (10.5 mg, 0.05 mmol) was added to a mixture of 2-2a 
(7.5 mg, 0.05 mmol), (NH4)2CO3 (4.8 mg, 0.05 mmol) and 2-8a (5.6 mg, 0.01 mmol) 
in anhydrous toluene (0.5 mL) in a sample vial. The vial was then sealed and the 
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resulting mixture was stired at room temperature for 24 h. The reaction mixture was 
concentrated in vacuo, and the crude was purified by flash column chromatography 
(ethyl acetate/hexane = 1/5 to 1/1) to afford furanone 2-3a (12.5 mg, 90% yield). The 
enantiomeric excess of 2-3a was determined by chiral HPLC analysis.  
2.4.4 Derivatizations of the 3(2H)-Furanone Product 
 
Synthesis of 4-hydroxy-3-(2-nitro-1-phenylethyl)furan-2(5H)-one 2-3a-1 
5-Ethoxy-4-(2-nitro-1-phenylethyl)furan-3(2H)-one 2-3a (111 mg, 0.4 mmol) was 
dissolved in THF (4 mL), then 6 M HCl (4 mL) was added in to the solution, and the 
resulting mixture was stirred at room temperature for 2 h. The reaction mixture was 
concentrated in vacuo, the residue was extracted with ethyl acetate several times (5 
mL x 3), and the combined organic extracts were dried, filtered and concentrated. 
Purification by flash chromatography (ethyl acetate/hexane = 1/1 to 10/1) afforded 
tetronic acid 2-3a-1 as a yellow solid (95 mg, 95%). 
1H NMR (500 MHz, (CD3)2CO) δ 4.64-4.72 (m, 3H), 5.11 (dd, J = 7.0 Hz, 13.2Hz, 
1H), 5.29 (dd, J = 8.9 Hz, 13.3Hz, 1H), 7.26 (t, J = 7.0 Hz, 1H), 7.33 (t, J = 7.6 Hz, 
2H), 7.45 (d, J = 7.6 Hz, 2H), 11.05 (br s, 1H); 13C NMR (125 MHz, (CD3)2CO) δ 
38.3, 66.5, 76.2, 99.5, 127.5, 127.8, 128.7, 138.8, 173.4, 173.9; HRMS (ESI) m/z 
calcd for C12H11NNaO5 [M+Na]+ = 272.0529, found = 272.0539. 
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Synthesis of (E)-3-(1,2-dihydroxyethylidene)-4-phenylpyrrolidin-2-one 2-3a-2 
4-Hydroxy-3-(2-nitro-1-phenylethyl)furan-2(5H)-one 2-3a-1 (0.34 mmol, 85 mg) 
was dissolved in a mixture of THF (2 mL) and AcOH (1.5 mL), Zn dust ( 3.4 mmol, 
222mg) was then added, and the resulting mixture was stirred at room temperature for 
24 h. The reaction mixture was filtered through celite, and the filtrate was 
concentrated in vacuo. The residue was purified by flash chromatography  
(CH2Cl2/MeOH = 5/1 to CH2Cl2/MeOH/TEA=5/1/1) to afford γ-lactam 2-3a-2 as an 
orange solid (61 mg, 82%). 
1H NMR (500 MHz, CD3OD) δ 3.29 (dd, J = 4.4 Hz, 12.3Hz, 1H), 3.56 (dd, J = 7.6 
Hz, 12.3Hz, 1H), 4.00 (dd, J = 3.8 Hz, 7.6Hz, 1H), 4.40 (dd, J = 15.2 Hz, 19.6Hz, 2H), 
7.24 (t, J = 7.6 Hz, 1H),7.32-7.38 (m, 4H); 13C NMR (125 MHz, CD3OD) δ 38.8, 43.9, 
69.9, 91.0, 126.7, 127.6, 128.4, 140.5, 181.0, 189.8; HRMS (ESI) m/z calcd for 
C12H13NNaO3 [M+Na]+ = 242.0788, found = 242.0796. 
 
2.4.5 X-Ray Crystallographic Analysis and Determination of Configurations of 
the 3(2H)-Furanone Products 
The absolute configuration of the product 2-3d (S) was assigned based on the 
X-ray crystallographic analysis of a single crystal of 2-3d (Figure 2.4). The 
configurations of other 3(2H)-furanone products were assigned by analogy. 
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Figure 2.4 X-ray structure of 2-3d 
 
Table 2.3  Crystal Data and Structure Refinement for A435. 
Identification code  a435 
Empirical formula  C14 H14 Br N O5 
Formula weight  356.17 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 9.9607(14) Å = 90°. 
 b = 6.8788(9) Å = 94.974(3)°. 
 c = 10.6438(14) Å  = 90°. 
Volume 726.54(17) Å3 
Z 2 
Density (calculated) 1.628 Mg/m3 
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Absorption coefficient 2.850 mm-1 
F(000) 360 
Crystal size 0.60 x 0.26 x 0.14 mm3 
Theta range for data collection 1.92 to 27.49°. 
Index ranges -8<=h<=12, -8<=k<=8, -13<=l<=13 
Reflections collected 4995 
Independent reflections 3071 [R(int) = 0.0213] 
Completeness to theta = 27.49° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6911 and 0.2797 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3071 / 1 / 191 
Goodness-of-fit on F2 0.967 
Final R indices [I>2sigma(I)] R1 = 0.0256, wR2 = 0.0590 
R indices (all data) R1 = 0.0268, wR2 = 0.0594 
Absolute structure parameter 0.011(6) 
Largest diff. peak and hole 0.514 and -0.275 e.Å-3 
 
2.4.6 Analytical Data of the 3(2H)-Furanone Products 
(R)-5-Ethoxy-4-(2-nitro-1-phenylethyl)furan-3(2H)-one 2-3a 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.43 (t, J = 7.6 Hz, 3H), 4.41-4.49 
(m, 3H), 4.55 (dd, J = 16.4 Hz, 19.5 Hz, 2H), 4.86 (dd, J = 6.9 Hz, 12.6 Hz, 1H), 5.23 
(dd, J = 8.8 Hz, 12.9 Hz, 1H), 7.24-7.32 (m, 3H), 7.39 (d, J = 7.6 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 14.7, 37.9, 66.7, 74.9, 76.5, 92.4, 127.6, 127.7, 128.9, 139.2, 
181.2, 194.5; The ee value is 90%, tR (minor) = 27.83 min, tR (major) = 42.52 min 
(Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 
(ESI) m/z calcd for C14H15NNaO5 [M+Na]+ = 300.0842, found = 300.0836; [α]27D = 
-30.8 (c 0.80, CHCl3). 
(S)-5-Ethoxy-4-(1-(2-fluorophenyl)-2-nitroethyl) furan-3(2H)-one 2-3b 
 
A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.42 (t, J = 7.0 Hz, 3H), 4.20-4.49 
(m, 2H), 4.57 (dd, J = 15.8 Hz, 18.9 Hz , 2H), 4.79-4.85 (m, 2H), 5.22-5.28 (m, 1H), 
7.01-7.11 (m, 2H), 7.22-7.26 (m, 1H), 7.48-7.52 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 14.6, 30.7 (d, J = 3.6 Hz), 30.9, 66.8, 74.9, 75.1, 91.1, 115.6 (d, J = 22.8 
Hz), 124.5 (d, J = 3.6 Hz), 125.5 (d, J = 13.7 Hz), 129.3 (d, J = 8.2 Hz), 129.5 (d, J = 
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2.7 Hz), 160.0 (d, J = 246.0 Hz), 181.4, 194.6; The ee value is 94%, tR (minor) = 
26.56 min, tR (major) = 35.92 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C14H14FNNaO5 [M+Na]+ = 










A yellow oil; 1H NMR (300 MHz, CDCl3) δ 1.43 (t, J = 7.1 Hz, 3H), 4.42-4.58 (m, 
4H), 4.74-4.80 (m, 1H), 5.00 (dd, J = 5.8 Hz, 9.9 Hz, 1H), 5.24-5.32 (m, 1H), 
7.19-7.26 (m, 2H), 7.35-7.38 (m, 1H), 7.60 (d, J = 2.1 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 14.6, 34.3, 66.8, 74.9, 75.0, 91.0, 127.4, 128.8, 129.5, 129.8, 133.2, 136.1, 
181.6, 194.7; The ee value is 96%, tR (minor) = 26.46 min, tR (major) = 36.16 min 
(Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 
(ESI) m/z calcd for C14H14ClNNaO5 [M+Na]+ =334.0453, found = 334.0450; [α]27D = 
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A yellow solid; 1H NMR (300 MHz, CDCl3) δ 1.41 (t, J = 7.1 Hz, 3H), 4.40-4.50 (m, 
2H), 4.52-4.63 (m, 2H), 4.74 (dd, J = 5.6 Hz, 12.8 Hz, 1H), 4.97 (dd, J = 5.6 Hz, 10.1 
Hz, 1H), 5.23-5.31 (m, 1H), 7.08-7.13 (m, 1H), 7.24-7.30 (m, 1H), 7.54 (d, J = 8.1 Hz, 
1H), 7.60 (d, J = 1.3 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 14.5, 37.0, 66.7, 74.9, 
74.9, 91.0, 123.7, 127.9, 129.0, 129.6, 133.1, 137.7, 181.6, 194.6; The ee value is 
96%, tR (minor) = 27.71 min, tR (major) = 37.04 min (Chiralcel IC, λ = 254 nm, 30% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C14H1479BrNNaO5 [M+Na]+ = 377.9948, found = 377.9932; [α]27D = -33.3 (c 0.15, 
CHCl3). 
(R)-5-Ethoxy-4-(2-nitro-1-(o-tolyl)ethyl)furan-3(2H)-one 2-3e  
 
A yellow oil; 1H NMR (300 MHz, CDCl3) δ 1.42 (t, J = 7.1 Hz, 3H), 2.46 (s, 3H), 
4.41-4.55 (m, 4H), 4.69-4.82 (m, 2H), 5.20-5.29 (m, 1H), 7.13-7.18 (m, 3H), 
7.51-7.54 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 14.6, 19.5, 33.2, 66.6, 74.9, 75.9, 
92.4, 126.5, 127.3, 127.4, 130.6, 135.4, 137.4, 181.3, 194.7; The ee value is 90%, tR 
(minor) = 17.19 min, tR (major) = 19.18 min (Chiralcel AD-H, λ = 254 nm, 8% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C15H17NNaO5 
[M+Na]+ = 314.0999, found = 314.0991; [α]27D = -20.2 (c 0.80, CHCl3). 
(R)-5-Ethoxy-4-(2-nitro-1-(3-nitrophenyl)ethyl)furan-3(2H)-one 2-3f  
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An orange oil; 1H NMR (500 MHz, CDCl3) δ 1.47 (t, J = 6.9 Hz, 3H), 4.49-4.60 (m, 
5H), 4.99 (dd, J = 7.6 Hz, 13.3 Hz, 1H), 5.15 (dd, J = 8.2 Hz, 13.3 Hz, 1H), 7.50 (t, J 
= 8.2 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H), 8.12 (d, J = 8.2 Hz, 1H), 8.24 (t, J = 1.9 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 14.7, 37.4, 67.2, 75.1, 75.9, 91.4, 122.7, 129.9, 
134.0, 141.1, 148.5, 152.5, 181.2, 194.2; The ee value is 88%, tR (minor) = 36.78 min, 
tR (major) = 53.55 min (Chiralcel IC, λ = 254 nm, 40% iPrOH/hexanes, flow rate = 
1.0 mL/min); HRMS (ESI) m/z calcd for C14H14N2NaO7 [M+Na]+ = 345.0693, found 
= 345.0683; [α]27D = -12.4 (c 0.45, CHCl3). 








A yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.42 (t, J = 7.6 Hz, 3H), 4.37-4.58 (m, 
5H), 4.87 (dd, J = 6.9 Hz, 12.6 Hz, 1H), 5.13-5.175 (dd, J = 8.8 Hz, 12.6 Hz, 1H), 
7.27 (t, J = 8.2 Hz, 1H), 7.33 (d, J = 8.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.7, 
37.3, 66.9, 75.0, 76.3, 92.1, 129.1, 133.5, 137.7, 153.5, 181.2, 194.4; The ee value is 
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91%, tR (minor) = 24.00 min, tR (major) = 34.58 min (Chiralcel IC, λ = 254 nm, 30% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C14H14ClNNaO5 
[M+Na]+ =334.0453, found = 334.045; [α]27D = -30.8 (c 0.50, CHCl3). 
(R)-4-(1-(2-Ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-2-nitroethyl)benzonitrile 2-3h 
 
An orange oil; 1H NMR (300 MHz, CDCl3) δ 1.42 (t, J = 7.1 Hz, 3H), 4.42-4.62 (m, 
5H), 4.96 (dd, J = 7.7 Hz, 13.1 Hz, 1H), 5.13 (dd, J = 8.2 Hz, 13.0 Hz, 1H), 7.49-7.52 
(m, 2H), 7.57-7.60 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 14.6, 37.7, 67.0, 75.0, 75.6, 
91.3, 111.5, 118.4, 128.5, 132.6, 144.3, 181.1, 194.2; The ee value is 95%, tR (major) 
= 62.83 min, tR (minor) = 69.27 min (Chiralcel AD-H, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min);HRMS (ESI) m/z calcd for C15H14N2NaO5 
[M+Na]+ = 325.0795, found = 325.0785; [α]27D = -22.7 (c 0.60, CHCl3). 
(R)-5-Ethoxy-4-(1-(furan-2-yl)-2-nitroethyl)furan-3(2H)-one 2-3i  
 
A red oil; 1H NMR (500 MHz, CDCl3) δ 1.42 (t, J = 7.0 Hz, 3H), 4.45-4.49 (m, 2H), 
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4.58-4.64 (m, 3H), 4.89 (dd, J = 7.0 Hz, 13.3 Hz, 1H), 5.03 (dd, J = 8.8 Hz, 12.6 Hz, 
1H), 6.16 (d, J = 3.2 Hz, 1H), 6.28 (dd, J = 1.9 Hz, 3.1 Hz, 1H), 7.32 (d, J = 1.3 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 14.7, 31.3, 66.8, 74.6, 75.0, 89.8, 106.9, 110.5, 
142.0, 150.8, 181.4, 194.1; The ee value is 91%, tR (minor) = 17.27 min, tR (major) = 
19.66 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); HRMS (ESI) m/z calcd for C12H13NNaO6 [M+Na]+ = 290.0635, found = 










A red oil; 1H NMR (300 MHz, CDCl3) δ 1.44 (t, J = 7.1 Hz, 3H), 4.45-4.60 (m, 4H), 
4.76 (dd, J = 6.9 Hz, 8.7 Hz, 1H), 4.86 (dd, J = 6.7 Hz, 12.5 Hz, 1H), 5.11-5.29 (m, 
1H), 6.90-6.93 (m, 1H), 7.00-7.02 (m, 1H), 7.15-7.17 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δ 14.6, 32.5, 66.8, 74.9, 76.5, 92.1, 124.6, 125.4, 127.0, 141.0, 180.9, 193.8; 
The ee value is 90%, tR (minor) = 32.93 min, tR (major) = 42.36 min (Chiralcel IC, λ 
= 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C12H13NNaO5S [M+Na]+ = 306.0407, found = 306.0396; [α]27D = -25.5 (c 0.40, 
CHCl3). 
(R)-4-(1-Cyclohexyl-2-nitroethyl)-5-ethoxyfuran-3(2H)-one 2-3k  
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A colorless oil; 1H NMR (300 MHz, CDCl3) δ 0.89-1.25 (m, 5H), 1.42 (t, J = 7.1 Hz, 
3H), 1.64-1.74 (m, 6H), 2.96-3.04 (m, 1H), 4.40-4.47 (m, 2H), 4.54-4.62 (m, 3H), 
4.89 (dd, J = 10.5 Hz, 11.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.6, 25.9, 26.0, 
26.1, 30.4, 31.0, 38.0, 38.7, 66.3, 74.6, 75.4, 90.9, 181.9, 195.1; The ee value is 87%, 
tR (minor) = 34.95 min, tR (major) = 43.60 min (Chiralcel IC, λ = 254 nm, 30% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C14H21NNaO5 
[M+Na]+ = 306.1312, found = 306.1302; [α]27D = 11.7 (c 0.10, CHCl3). 
(R)-5-Ethoxy-4-(1-nitrohexan-2-yl)furan-3(2H)-one 2-3l  
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.87 (t, J = 7.0 Hz, 3H), 1.22-1.32 (m, 
4H), 1.41-1.53 (m, 4H), 1.64-1.74 (m, 1H), 3.15-3.21 (m, 1H), 4.42-4.54 (m, 5H), 
4.71 (dd, J = 8.8 Hz, 12.0 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 13.9, 14.7, 22.3, 
29.3, 29.7, 32.2, 66.4, 74.7, 91.4, 181.7, 195.0; The ee value is 91%, tR (major) = 
34.70 min, tR (minor) = 36.47 min (Chiralcel IC, λ = 254 nm, 20% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C12H19NNaO5 [M+Na]+ = 
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A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.88-0.90 (m, 6H), 1.18-1.25 (m, 1H), 
1.40-1.48 (m, 4H), 1.67-1.77 (m, 1H), 3.25-3.30 (m, 1H), 4.42-4.56 (m, 5H), 4.69 (dd, 
J = 8.9 Hz, 11.4Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 14.7, 21.4, 23.2, 25.7, 30.3, 
38.6, 66.4, 74.7, 77.5, 91.3, 181.7, 195.0; The ee value is 93%, tR (major) = 53.09 min, 
tR (minor) = 56.30 min (Chiralcel IC, λ = 254 nm, 15% iPrOH/hexanes, flow rate = 
1.0 mL/min); HRMS (ESI) m/z calcd for C12H19NNaO5 [M+Na]+ = 280.1155, found = 








A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 4.64-4.69 (m, 3H), 4.84 (dd, J = 5.7 
Hz, 12.9Hz, 1H), 5.52 (dd, J = 9.5 Hz, 12.9Hz, 1H), 7.29-7.37 (m, 3H), 7.42 (d, J = 
2.6 Hz, 2H), 7.49-7.59 (m, 3H), 7.62 (d, J = 7.6 Hz, 2H); 13C NMR (125 MHz, CDCl3) 
δ 40.5, 74.1, 76.6, 113.2, 127.9, 128.0, 129.0, 129.2, 129.3, 132.3, 138.6, 185.5, 202.4; 
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The ee value is 50%, tR (major) = 53.09 min, tR (minor) = 56.30 min (Chiralcel IC, λ 
= 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min) 
5-Phenylfuran-3(2H)-one 2-11 
 
A light yellow solid; 1H NMR (500 MHz, CDCl3) δ 4.64-4.69 (m, 3H), 4.84 (dd, J = 
5.7 Hz, 12.9Hz, 1H), 5.52 (dd, J = 9.5 Hz, 12.9Hz, 1H), 7.29-7.37 (m, 3H), 7.42 (d, J 
= 2.6 Hz, 2H), 7.49-7.59 (m, 3H), 7.62 (d, J = 7.6 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 75.4, 101.5, 127.1, 128.8, 128.9, 132.8, 187.0, 202.2. MS (ESI) m/z calcd 
for C10H7O2 [M-H]- = 159.1, found = 159.1 
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Chapter 3 A Highly Enantioslective Synthesis of 




2,3-Dihydrofurans distribute widely in many natural products, and also serve as 
useful synthetic intermediates. 1  In particular, enantiomerically enriched 
2,3-dihydrofurans have attracted much attention as they are important precursors for 
the asymmetric synthesis of tetrahydrofurans, 2  and many synthetic strategies 
employing chiral auxiliaries and precursors3 or metal-containing catalysts4 have been 
devised toward this end. On the other hand, organocatalytic approaches to access 
chiral 2,3-dihydrofurans are very limited.5 Recently, Rueping5c and Xie5e reported the 
synthesis of 2,3-dihydrofurans from cyclic diketones. A practical and general strategy 
employing acyclic -ketoester for the asymmetric preparation of 2,3-dihydrofurans is 
still lacking, thus it is our goal to develop an efficient asymmetric synthetic method to 
access chiral 2,3-dihydrofurans. 
                                                             
1 a) O. R. Gottlied, New Natural Products and Plant Drugs with Pharmacological, Biological, or Therapeutical 
Activity; Springer-Verlag: Berlin-Heidelberg, Germany, 1987; p 227; b) B. M. Fraga, Nat. Prod. Rep., 1992, 9, 217; 
c) A. T. Merrit, S. B. Ley, Nat. Prod. Rep., 1992, 9, 243. 
2 a) B. H. Lipshutz, Chem. Rev., 1986, 86, 795; b) M. M. Faul, B. E. Huff, Chem. Rev., 2000, 100, 2407. 
3 a) H. J. Gais, L. R. Reddy, G. S. Babu, G. Raabe, J. Am. Chem. Soc., 2004, 126, 4859; b) F. Garzino, A. Méou, P. 
Brun, Eur. J. Org. Chem., 2003, 1410; c) W. Xia, C. Yang, B. O. Patrick, J. R. Scheffer, C. Scott, J. Am. Chem. Soc., 
2005, 127, 2725; d) R. K. Bowman, J. S. Jonhson, Org. Lett., 2006, 8, 573; e) J.-C. Zheng, C.-Y. Zhu, X.-L. Sun, Y. 
Tang, L.-X. Dai, J. Org. Chem., 2008, 73, 6909. 
4 a) D. A. Evans, Z. K. Sweeney, T. Rovis, J. S. Tedrow, J. Am. Chem. Soc., 2001, 123, 12095; b) S. Son, G. C. Fu, J. 
Am. Chem. Soc., 2007, 129, 1046; c) H. M. L. Davies, G. Ahmed, R. L. Calvo, M. R. Churchill, D. G. Churchill, J. 
Org. Chem., 1998, 63, 2641; d) F. Ozawa, A. Kubo, Y. Matsumoto, T. Hayashi, Organometallics, 1993, 12, 4188; e) 
P. Müller, G. Bernardinelli, Y. F. Allenbach, M. Ferri, S. Grass, Synlett, 2005, 9, 1397. 
5 a) F. Silva, M. Sawicki, V. Gouverneur, Org. Lett., 2006, 8, 5417; b) L. Albrecht, L. K. Ransborg, B. Gschwend, K. 
A. Jørgensen, J. Am. Chem. Soc., 2010, 132, 17886; c) M. Rueping, A. Parra, U. Uria, F. Besselièvre, E. Merino, Org. 
Lett., 2010, 12, 5680; d) M. Rueping, M.-Y. Lin, Chem. Eur. J., 2010, 16, 4169; e) L.-P. Fan, P. Li, X.-S. Li, D.-C. Xu, 
M.-M. Ge, W.-D. Zhu, J.-W. Xie, J. Org. Chem., 2010, 75, 8716; f) T. G. Kilroy, T. P. O’Sullivan, P. J. Guiry,  Eur. J. 
Org. Chem., 2005, 4929; g) Z. Chen, J. Zhang, Chem. Asian J., 2010, 5, 1542. 
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The FeistBénary reaction is a base catalyzed reaction between 
-halogenated ketones and 1,3-dicarbonyl compounds for the synthesis of 
substituted furans. Synthetic methods based on the FeistBénary reaction could 
lead to effective formation of various furan derivatives.6 In Chapter 2, we have 
shown that a modified FeistBénary reaction could be utilized for a convenient 
synthesis of chiral 3(2H)-furanone derivatives. After that, we tried to employ the 
modified FeistBénary reaction to prepare other useful furan derivatives. Herein, 
we describe a modified FeistBénary reaction for an enantioselective synthesis of 
functionalized 2,3-dihydrofurans. 
 
Scheme 3.1 Modified FeistBénary reaction for synthesis of functionalized 2,3-dihydrofurans 
 
The FeistBénary synthesis can be regarded as a domino aldolalkylation 
reaction, in which the -halogenated ketones are used as a dielectrophile and 
1,3-dicarbonyl compounds as a dinucleophile. By employing halogen-substituted 
electron-deficient olefins and -ketoesters as a dielectrophile and a dinucleophile, 
respectively, we reasoned that such modified FeistBénary reaction could be utilized 
                                                              
6 See Chapter 2, ref. 6. 
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for the asymmetric synthesis of  highly functionalized 2,3-dihydrofuran products 
(Scheme 3.1). 
 
3.2 Results and Discussion 
3.2.1 Reaction Optimization 
The domino Michaelalkylation reaction between -ketoesters 3-4 and 
(E)-β,β-bromonitrostyrene7 3-5a was chosen as a model reaction (Table 3.1). For the 
selection of the catalysts, we still focused on the amino catalysts containing a 
Brønsted acid moiety; it is anticipated that high stereoselectivity could be achieved 
via cooperative interactions between the catalysts and the substrates. Since HBr would 
be generated during the reaction, (NH4)2CO3 was thus introduced as a HBr scavenger, 
and this strategy was proven to be effective in our previous 3(2H)-furanone synthesis 
system in Chapter 2. In the presence of quinine-derived bifunctional tertiaryamine 
thiourea catalyst 3-1a, the desired product was obtained with moderate 
enantioselectiviy (entry 1). Our recently developed multifunctional catalyst 3-1b8 
gave similar results (entry 2). Quinidine-derived sulfonamide 3-2 also led to moderate 
enantioselectivity (entry 3). To our delight, threonine structural motif proved to be 
privileged again. L-Threonine-derived tertiaryamine thiourea catalysts 3-3 were found 
to be effective, diastereomerically pure products 3-6 were obtained in good yields and 
with high enantioselectivities, and the ester moiety had little influence on the reaction 
(entries 45). Performing reaction with excess ketoester under dilute reaction 
                                                             
7 W. E. Parham, J. L. Bleasdale, J. Am. Chem. Soc., 1951, 73, 4664. 
8 a) Q. Zhu, Y. Lu, Angew. Chem. Int. Ed. 2010, 49, 7753; b) X. Dou, Y. Lu, Chem. Eur. J. 2012, 18, 8315; c) J. Luo, 
H. Wang, F. Zhong, J. Kwiatkowski, L.-W. Xu, Y. Lu, Chem. Commun. 2012, 48, 4707; d) F. Zhong, J. Luo, G.-Y. 
Chen, X. Dou, Y. Lu, J. Am. Chem. Soc. 2012, 134, 10222. 
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conditions resulted in further improvement (entries 67). By lowering the temperature, 
2,3-dihydrofuran 3-6 was obtained in high yield and with excellent enantioselectivity 
(entry 8). It should be highlighted that threonine-based bifunctional catalysts are not 
only effective in asymmetric induction, but also structurally highly tunable; fine 
tuning was achieved in the above study by simply utilizing TBDPS instead of TBS as 
a protective group (entry 9).  
 
Figure 3.1 Organic catalysts examined 
 
Table 3.1 Domino MichaelAlkylation Reaction between β-Ketoester and Bromonitroolefina 
 
entry cat. R t (h) yield (%)b ee(%)c 
1 3-1a Et 18 71 63 
2 3-1b Et 18 75 65 
3 3-2 Et 18 62 52 
4 3-3a Et 18 65 84 
5 3-3a Bn 18 72 84 
6d 3-3a Et 18 87 88 
7d 3-3a Bn 18 91 86 
8d,e 3-3a Et 36 82 92 
9d,e 3-3b Et 36 86 94 
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a Reactions were performed with 3-4 (0.04 mmol), 3-5a (0.04 mmol), (NH4)2CO3 (0.04 mmol) and 
the catalyst (20 mol %) in toluene (0.4 mL) at room temperature. b Yield of the isolated product. c 
Determined by HPLC analysis on a chiral stationary phase. d 0.8 mL toluene and 0.2 mmol 3-4 
were used.e The reaction was performed at -20 oC. 
 
3.2.2 Substrate Scope 
With the optimized reaction conditions in hand, the substrate scope of 
1,2-dihydrofuran synthesis was then investigated. This domino reaction is applicable 
to various aryl-substituted bromonitroolefins, high yields and excellent 
enantioselectivities were attainable (Table 3.2, entries 110). A large scale synthesis 
of 3-6a was achieved in 67% yield and with 90% ee (Table 3.2, entry 1, 3 mmol scale). 
In addition, the reaction also tolerated well with bromonitroolefin with an alkyl group, 
which is a difficult substrate and was not reported before (entry 11).  
 
Table 3.2 Substrate Scope of the Asymmetric Synthesis of 2,3-Dihydrofurans via a 
















entry R (3-6) t (h) yield (%)b ee (%)d 





2 2-F-C6H4 (3-6b) 20 82 91 
3 2-Me-C6H4 (3-6c) 72 70 96 
4 3-Br-C6H4 (3-6d) 36 83 88 
5 4-F-C6H4 (3-6e) 36 77 91 
6 4-Br-C6H4 (3-6f) 36 74 91 
7 4-Me-C6H4 (3-6g) 72 78 92 
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8 4-OMe-C6H4 (3-6h) 96 68 99 
9 2-thienyl (3-6i) 96 73 95 
10 1-naphthyl (3-6j) 96 75 91 
11d n-butyl (3-6k) 96 59 91 
a Reactions were performed with 3-4a (2.5 mmol), 3-5 (0.5 mmol), (NH4)2CO3 (0.5 mmol) and the 
catalyst (0.1 mmol) in toluene (10 mL) at -20 oC. b Isolated yield c Determined by HPLC analysis 
on a chiral stationary phase. d Benzyl acetoacetate was used and reaction was performed at room 
temperature. e Reaction was performed on a 3.0 mmol scale. 
 
Scheme 3.2 Versatile domino Michael-alkylation reaction 
 
Our reaction system was also suitable for other -ketoester substrates. Interestingly, 
when 4-chloro ethyl acetoacetate 3-7 was used in the reaction, 2,3-dihydrofuran 3-8 
was obtained in 94% yield and with 95% ee, and no competing 3(2H)-furanone 
product was observed. Employment of coumarin 3-9 led to tricyclic coumarin 3-10 in 
96% yield and with 91% ee (Scheme 3.2). The absolute configurations of 
2,3-dihydrofuran products were assigned on the basis of the absolute configuration of 
3-10.[5e] 
Complete trans-diastereoselectivity was observed for all the examples examined in 
this study. The observed diastereoselectivity may be a result from a stereospecific 
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protonation of the nitronate anion, following the initial Michael addition of keto 
enolate to nitroolefin. Alternatively, the abromo nitro intermediates may readily 
epimerize with only one of the epimers being converted to the diastereomerically pure 
products. We cannot draw a definite conclusion at the moment. However, a 
stereospecific protonation seems unlikely under the reaction conditions, and based on 




In conclusion, we have employed acyclic -ketoesters in a modified 
FeistBénary reaction for the enantioselective preparation of 2,3-dihydrofurans, 
which are synthetically useful molecules. We have also prepared L-threonine-derived 
tertiary amine thiourea bifunctional catalysts; such catalysts promoted the designed 
domino Michaelalkylation reactions efficiently, affording highly functionalized  
2,3-dihydrofurans in good yields and with excellent enantioselectivities. Further 
development of practical synthetic methods based on the FeistBénary reaction to 
access biologically significant heterocyclic compounds is currently ongoing in our 
laboratory. 
 
3.4 Experimental Section 
3.4.1 Material and General Methods 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. 1H and 13C NMR spectra were 
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recorded on a Bruker ACF300 or AMX500 (500 MHz) spectrometer. Chemical shifts 
were reported in parts per million (ppm), and the residual solvent peak was used as an 
internal reference: proton (chloroform δ 7.26), carbon (chloroform δ 77.0). 
Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), dd (doublet of doublet), br (broad singlet). Coupling constants were 
reported in Hertz (Hz). Low resolution mass spectra were obtained on a 
Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT 95XL- T mass 
spectrometer in FAB mode. All high resolution mass spectra were obtained on a 
Finnigan/MAT 95XL- T spectrometer. For thin layer chromatography (TLC), Merck 
pre- coated TLC plates (Merck 60 F254) were used, and compounds were visualized 
with a UV light at 254 nm. Further visualization was achieved by staining with iodine, 
or ceric ammonium molybdate followed by heating on a hot plate. Flash 
chromatographic separations were performed on Merck 60 (0.040- 0.063 mm) mesh 
silica gel. The enantiomeric excesses of products were determined by chiral-phase 
HPLC analysis. 
 
3.4.2 Representative Procedure 
 
Ethyl acetoacetate 3-4a (316 l, 2.5 mmol) was added to a mixture of 3-5a (114 
mg, 0.5 mmol) and (NH4)2CO3 (48 mg, 0.5 mmol) in anhydrous toluene (9.4 mL) in a 
25 mL RBF under N2. The reaction mixture was cooled down to -20 oC and a 0.29 M 
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solution of 3-3b in anhydrous toluene (345 l, 0.1 mmol) was then added to the 
reaction mixture. The resulting mixture was stirred at -20 oC until the TLC analysis 
showed complete consumption of 3-5a. The reaction mixture was then filtered and the 
filtrate was concentrated in vacuo, the crude was purified by flash column 
chromatography (ethyl acetate/hexane = 1/8) to afford the desired adduct 3-6. The 
enantiomeric excess of 3-6 was determined by chiral HPLC analysis. Catalyst 3-3b 
was washed out the column and recovered by changing the eluent to 
dichloromethane/MeOH = 5/1. 
 
3.4.3 Analytical Data of the 2,3-Dihydrofuran Products 





A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.11 (t, J = 7.3 Hz, 3H), 2.51 (d, J = 
1.9 Hz, 3H), 4.01-4.11 (m, 2H), 4.60 (s, 1H), 5.78 (d, J = 1.9 Hz, 1H), 7.22 (t, J = 6.9 
Hz, 2H), 7.31-7.38 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 13.7, 14.0, 55.8, 60.3, 
107.8, 109.6, 127.1, 128.3, 129.1, 138.0, 163.4, 167.0; The ee value is 93% (0.5 mmol 
scale), 90% (3 mmol scale), tR (major) = 31.48 min, tR (minor) = 24.89 min (Chiralcel 
IC, λ = 254 nm, 0.8% iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z calcd 
for C14H15O3 [M-NO2] = 231.1021, found = 231.1020; [α]27D = -17.6 (c 0.85, CHCl3). 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.11 (t, J = 7.3 Hz, 3H), 2.50 (d, J = 
1.3 Hz, 1H), 4.01-4.11 (m, 2H), 4.89 (s, 1H), 5.85 (d, J = 1.9 Hz, 1H), 7.08-7.15 (m, 
3H), 7.29-7.34 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 13.7, 13.9, 49.3(d, J = 2.7 
Hz), 60.3, 106.4, 108.8, 116.0 (d, J = 21.9 Hz), 124.5(d, J = 3.6 Hz), 124.8 (d, J = 
13.7 Hz), 128.7 (d, J = 3.7 Hz), 130.1(d, J = 8.2 Hz), 160.4 (d, J = 246.9 Hz), 163.2, 
167.6; The ee value is 91%, tR (major) = 36.31 min, tR (minor) = 31.82 min (Chiralcel 
IC, λ = 254 nm, 0.6 % iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z 
calcd for C14H14O3F [M-NO2] = 249.0927, found = 249.0926; [α]27D = -25.1 (c 0.80, 
CHCl3). 
(4R,5R)-Ethyl 2-methyl-5-nitro-4-(o-tolyl)-4,5-dihydrofuran-3-carboxylate 3-6c 
 
A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.10 (t, J = 7.0 Hz, 3H), 2.53 (d, 
6H), 4.04 (dd, J = 7.0 Hz, 14.5 Hz, 2H), 4.86 (d, J = 1.9 Hz, 1H), 5.71 (d, J = 0.8 Hz, 
1H), 6.94 (d, J = 7.4 Hz, 1H), 7.16-7.24 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 13.7, 
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13.9, 51.6, 60.2, 108.3, 109.5, 125.7, 126.7, 128.1, 130.9, 135.9, 136.2, 163.3, 167.0; 
The ee value is 96%, tR (major) = 14.81 min, tR (minor) = 13.28 min (Chiralcel IC, λ 
= 254 nm, 0.8% iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z calcd for 








A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.17 (t, J = 7.3 Hz, 3H), 2.54 (d, J = 
1.3 Hz, 3H), 4.05-4.16 (m, 2H), 4.58 (s, 1H), 5.79 (d, J = 1.9 Hz, 1H), 7.19 (d, J = 7.6 
Hz, 1H), 7.28 (t, J = 3.8 Hz, 1H), 7.38 (d, J = 1.9 Hz, 1H), 7.49 (d, J = 4.4 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 13.8, 14.0, 55.3, 60.4, 107.4, 109.0, 123.1, 125.9, 
130.1, 130.7, 131.5, 140.1, 163.1, 167.5; The ee value is 88%, tR (major) = 88.43 min, 
tR (minor) = 72.60 min (Chiralcel IC, λ = 254 nm, 0.2 % iPrOH/hexanes, flow rate = 
0.5 mL/min); HRMS (EI) m/z calcd for C14H14O3 81Br [M-NO2] = 311.0106, found = 
311.0096; [α]27D = -17.3 (c 1.00, CHCl3). 
(4R,5R)-Ethyl 4-(4-fluorophenyl)-2-methyl-5-nitro-4,5-dihydrofuran- 
3-carboxylate 3-6e 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.12 (t, J = 7.3 Hz, 3H), 2.50 (d, J = 
1.3 Hz, 3H), 4.03-4.10 (m, 2H), 4.58 (s, 1H), 5.74 (d, J = 1.3 Hz, 1H), 7.04-7.07 (m, 
2H), 7.18-7.21 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 13.8, 14.0, 55.1, 60.4, 107.8, 
109.4, 116.1 (d, J = 21.9 Hz), 128.7(d, J = 8.2 Hz), 133.7 (d, J = 3.7 Hz) , 162.6 (d, J 
= 246.0 Hz), 163.2, 167.1; The ee value is 91%, tR (major) = 26.70 min, tR (minor) = 
21.85 min (Chiralcel IA, λ = 254 nm, 0.8 % iPrOH/hexanes, flow rate = 0.5 mL/min); 
HRMS (EI) m/z calcd for C14H14O3F [M-NO2] = 249.0927, found = 249.0926; [α]27D 




A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.13 (t, J = 7.3 Hz, 3H), 2.50 (d, J = 
1.9 Hz, 3H), 4.04-4.09 (m, 2H), 4.56 (s, 1H), 5.73 (d, J = 1.9 Hz, 1H), 7.10 (dd, J = 
2.2 Hz, 6.6Hz, 2H), 7.49 (dd, J = 1.9 Hz, 7.0Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 
13.8, 14.0, 55.2, 60.4, 107.5, 109.1, 122.3, 128.8, 132.3, 136.9, 163.2, 167.3; The ee 
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value is 91%, tR (major) = 35.21 min, tR (minor) = 43.44 min (Chiralcel IC, λ = 254 
nm, 1.0 % iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z calcd for 
C14H14O381Br [M-NO2] = 311.0106, found = 311.0096; [α]27D = -15.8 (c 0.80, CHCl3). 






A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.13 (t, J = 6.9 Hz, 3H), 2.35 (s, 
3H), 2.50 (d, J = 1.9 Hz, 3H), 4.06 (dd, J = 7.0 Hz, 14.5 Hz, 2H), 4.56 (s, 1H), 5.76 (d, 
J = 1.9 Hz, 1H), 7.10 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.2 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 13.7, 14.0, 21.1, 55.5, 60.2, 107.9, 109.7, 126.9, 129.7, 134.9, 138.0, 
163.4, 166.8; The ee value is 92%, tR (major) = 24.96 min, tR (minor) = 21.87 min 
(Chiralcel IC, λ = 254 nm, 0.8 % iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.13 (t, J = 7.0 Hz, 3H), 2.50 (d, J = 
1.3 Hz, 3H), 3.80 (s, 3H), 4.02-4.11 (m, 2H), 4.55 (s, 1H), 5.75 (d, J = 1.9 Hz, 1H), 
6.88 (d, J = 8.2 Hz, 2H), 7.49 (d, J = 8.2 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
13.7, 14.0, 55.2, 55.3, 60.2, 108.0, 109.8, 114.5, 128.1, 130.0, 159.6, 163.4, 166.7; 
The ee value is 99%, tR (major) = 30.11 min, tR (minor) = 26.69 min (Chiralcel IA, λ 
= 254 nm, 1.2 % iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z calcd for 




An orange oil; 1H NMR (500 MHz, CDCl3) δ 1.17 (t, J = 6.9 Hz, 3H), 2.49 (d, J = 1.3 
Hz, 3H), 4.07-4.17 (m, 2H), 4.91 (s, 1H), 5.83 (d, J = 1.3 Hz, 1H), 6.99-7.00 (m, 2H), 
7.27 (d, J = 5.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.8, 14.0, 50.9, 60.4, 107.8, 
109.2, 125.5, 127.4, 140.9, 163.1, 167.3; The ee value is 95%, tR (major) = 18.42 min, 
tR (minor) = 16.76 min (Chiralcel IC, λ = 254 nm, 0.8 % iPrOH/hexanes, flow rate = 
0.5 mL/min); HRMS (EI) m/z calcd for C12H13O3S [M-NO2] = 237.0585, found = 
237.0585; [α]27D = -22.0 (c 0.80, CHCl3). 
(4R,5R)-Ethyl 2-methyl-4-(naphthalen-1-yl)-5-nitro-4,5-dihydrofuran- 
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A brown oil; 1H NMR (500 MHz, CDCl3) δ 1.03 (t, J = 7.3 Hz, 3H), 2.60 (d, J = 1.9 
Hz, 3H), 4.02-4.06 (m, 2H), 5.46 (s, 1H), 5.77 (s, 1H), 7.21 (d, J = 7.0 Hz, 1H), 7.43 
(t, J = 7.9 Hz, 1H), 7.59 (t, J = 7.6 Hz, 1H), 7.68 (t, J = 8.2 Hz, 1H), 7.85 (d, J = 8.2 
Hz, 1H), 7.93 (d, J = 8.2 Hz, 1H), 8.45 (d, J = 7.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 13.9, 14.0, 60.3, 107.1, 109.3, 123.1, 125.3, 126.2, 127.1, 129.1, 129.2, 
131.1, 132.8, 134.2, 163.5, 167.9; The ee value is 91%, tR (major) = 18.75 min, tR 
(minor) = 16.69 min (Chiralcel IC, λ = 254 nm, 1.0 % iPrOH/hexanes, flow rate = 0.5 
mL/min); HRMS (EI) m/z calcd for C18H17O3 [M-NO2] = 281.1636, found = 
281.1632; [α]27D = -11.3 (c 1.00, CHCl3). 






A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.83-0.93 (m, 3H), 1.24-1.36 (m, 6H), 
2.37(d, J = 1.3 Hz, 3H), 3.41-3.44 (m, 1H), 5.13 (d, J = 12.6 Hz, 1H), 5.22 (d, J = 
12.6 Hz, 1H), 5.68 (d, J = 1.9 Hz, 1H), 7.33-7.39 (m, 5H); 13C NMR (125 MHz, 
CDCl3) δ 13.8, 13.9, 22.2, 28.1, 31.5, 50.7, 66.1, 107.2, 107.9, 128.2, 128.3, 128.6, 
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135.8, 163.6, 166.7; The ee value is 93%, tR (major) = 43.54 min, tR (minor) = 53.51 
min (Chiralcel OJ, λ = 254 nm, 0.8 % iPrOH/hexanes, flow rate = 0.5 mL/min); 
HRMS (EI) m/z calcd for C17H21O3 [M-NO2] = 273.1482, found = 273.1480; [α]27D = 




A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.15 (t, J = 7.3 Hz, 3H), 4.11 (dd, J 
= 7.2 Hz, 14.2 Hz, 2H), 4.61 (t, J = 5.4 Hz, 2H), 4.90 (d, J = 12.0 Hz, 1H), 5.83 (d, J 
= 1.9 Hz, 1H), 7.10-7.13 (m, 2H), 7.51-7.54 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 
13.9, 34.5, 55.2, 61.2, 108.7, 110.6, 122.8, 128.7, 132.5, 135.8, 161.8, 162.8; The ee 
value is 95%, tR (major) =55.66 min, tR (minor) = 50.53 min (Chiralcel AD-H, λ = 
254 nm, 0.6 % iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (EI) m/z calcd for 
C14H13ClO381Br [M-NO2] = 345.4554, found = 345.4551; [α]27D = -23.7 (c 1.00, 
CHCl3). 
(2R,3R)-3-(4-Bromophenyl)-2-nitro-2H-furo[3,2-c]chromen-4(3H)-one 3-10 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 4.92 (d, J = 1.9 Hz, 1H), 6.21 (d, J = 2.5 
Hz, 1H), 7.16 (d, J = 8.2 Hz, 2H), 7.42-7.48 (m, 2H), 7.53 (d, J = 8.2 Hz, 2H), 
7.69-7.73 (m, 1H), 7.87 (dd, J = 1.3 Hz, 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
53.1, 104.3, 110.9, 111.0, 117.3, 123.1, 123.2, 124.8, 128.8, 132.7, 134.0, 134.5, 155.6, 
157.9, 165.8; The ee value is 91%, tR (major) =37.16 min, tR (minor) = 22.23 min 
(Chiralcel IC, λ = 254 nm, 20 % iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 
(ESI) m/z calcd for C17H10NO5BrNa [M+Na] = 409.9638, found = 409.9635; [α]27D = 
-11.6 (c 0.80, CHCl3). 
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Chapter 4 Diastereodivergent Synthesis of 3-Spirocyclo 
-propyl-2-oxindoles through Direct Enantioselective 
Cyclopropanation of Oxindoles 
 
4.1 Introduction 
Oxindoles are structural motifs that are widely present in natural products and 
medicinally important agents. 1  In particular, spirocyclic oxindoles bearing a 
quaternary stereogenic center at the 3-position possess significant biological profiles.2 
In this context, syntheses of 3-spirocyclic oxindoles bearing a five3 or six-membered4 
ring system have been intensively investigated due to the biological importance of 
these molecules. Spiro cyclopropyl oxindoles have shown remarkable biological 
activities (Figure 4.1),5 moreover, they are also molecules of high synthetic values.6 
                                                              
1 For selected reviews, see: a) C. Marti, E. M. Carreira, Eur. J. Org. Chem. 2003, 2209; b) A. B. Dounay, L. E. 
Overman, Chem. Rev. 2003, 103, 2945; c) C. V. Galliford, K. A. Scheidt, Angew. Chem. Int. Ed. 2007, 46, 8748; d) B. 
M. Trost, M. K. Brennan, Synthesis, 2009, 18, 3003. 
2 G. S. Singh, Z. Y. Desta, Chem. Rev. 2012, 112, 6104; (b) R. Dalpozzo, G. Bartoli, G. Bencivenni, Chem. Soc. Rev. 
2012, 41, 7247; (c) N. R. Ball-Jones, J. J. Badillo, A. K. Franz, Org. Biomol. Chem. 2012, 10, 5165; (d) L. Hong, R. 
Wang, Adv. Synth. Catal. 2013, 355, 1023. 
3 For representative examples, see: a) S. Edmondson, S. J. Danishefsky, S.-L. Laura, N. Rosen, J. Am. Chem. Soc. 
1999, 121, 2147; b) P. R. Sebahar, R. M. Williams, J. Am. Chem. Soc. 2000, 122, 5666; c) C. Marti, E. M. Carreira, J. 
Am. Chem. Soc. 2005, 127, 11505; d) K. Ding, Y. Lu, N.-C. Zaneta, S. Qiu, Y. Ding, W. Gao, J. Stuckey, K. 
Krajewski, P. P. Roller, Y. Tomita, D. A. Parrish, J. R. Deschamps, S. Wang, J. Am. Chem. Soc. 2005, 127, 10130; e) 
A. K. Franz, P. D. Dreyfuss, S. L. Schreiber, J. Am. Chem. Soc. 2007, 129, 1020; f) B. M. Trost, N. Cramer, S. M. 
Silverman, J. Am. Chem. Soc. 2007, 129, 12396; g) B. M. Trost, N. Cramer, H. Bernsmann, J. Am. Chem. Soc. 2007, 
129, 3086; h) X.-H. Chen,W. Wei, S.-W. Luo, H. Xiao, L.-Z. Gong, J. Am. Chem. Soc. 2009, 131, 13819. 
4 a) H. Lin, S. J. Danishefsky, Angew. Chem. Int. Ed. 2003, 42, 36; b) G. Bencivenni, L.-Y. Wu, A. Mazzanti, B. 
Giannichi, F. Pesciaioli, M.-P. Song, G. Bartoli, P. Melchiorre, Angew. Chem. Int. Ed. 2009, 48, 7200; c) Q. Wei, L.-Z. 
Gong, Org. Lett. 2010, 12, 1008; d) W.-B. Chen, Z.-J. Wu, Q.-L. Pei, L.-F. Cun, X.-M. Zhang, W.-C. Yuan, Org. Lett. 
2010, 12, 3132; e) K. Jiang, K.; Z.-J. Jia, X. Yin, L. Wu, Y.-C. Chen, Org. Lett. 2010, 12, 2766; f) Z.-J. Jia, H. Jiang, 
J.-L. Li, B. Gschwend, Q.-Z. Li, X. Yin, J. Grouleff, Y.-C. Chen, K. A. Jørgensen, J. Am. Chem. Soc. 2011, 133, 
5053. 
5 a) J. R. Bagley, S. A. Thomas, F.G. Rudo, H. K. Spencer, B. M. Doorley, M. H. Ossipov, T. P. Jerussi, M. J. 
Benvenga, T. Spaulding, J. Med. Chem. 1991, 34, 827; b) D. W. Robertson, J. H. Krushinski, G. D. Pollock, H. 
Wilson, R. F. Dauffman, J. S. Hayes, J. Med. Chem. 1987, 30, 824; c) T. Jiang, K. L. Kuhen, K. Wolff, H. Yin, K. 
Bieza, J. Caldwell, B. Bursulaya, T. Y.-H. Wu, Y. He, Bioorg. Med. Chem. Lett. 2006, 16, 2105; d) T. Jiang, K. L. 
Kuhen, K. Wolff, H. Yin, K. Bieza, J. Caldwell, B. Bursulaya, T. Tuntland, K. Zhang, D. Karanewsky, Y. He, Bioorg. 
Med. Chem. Lett. 2006, 16, 2109. 
6 a) J. L. Wood, A. A. Holubec, B. M. Stoltz, M. M. Weiss, J. A. Dixon, B. D. Doan, M. F. Shamji, J. M. Chen, T. P. 
Heffron, J. Am. Chem. Soc. 1999, 121, 6326; b) P. B. Alper, C. Meyers, A. Lerchner, D. R. Siegel, E. M. Carreira, 
Angew. Chem. Int. Ed. 1999, 38, 3186; c) A. Lerchner, E. M. Carreira, J. Am. Chem. Soc. 2002, 124, 14826; d) C. 
Meyers, E. M. Carreira, Angew. Chem. Int. Ed. 2003, 42, 694; e) A. Lerchner, E. M. Carreira, Chem. Eur. J. 2006, 12, 
8208; f) V. Helan, A. Mills, D. Drewry, D. Grant, J. Org. Chem. 2010, 75, 6693. 
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Surprisingly, methods for the preparation of  3-spirocyclopropane-2-oxindoles are 
very limited. 7  To the best of our knowledge, only one example describing 
enantioselective construction of cyclopropyl spirooxindoles was reported recently;  
Bartoli and Bencivenni utilized a Michaelalkylation cascade to realize 
enantioselective nitrocyclopropanation of 3-alkylidene oxindoles.8 As part of our 
ongoing efforts towards efficient creation of quaternary stereogenic centers and chiral 
spirooxindole derivatives,9 we became interested in developing an enantioselective 





















Figure 4.1 Bioactive molecules containing a spiro cyclopropyl oxindole/indoline motif 
 
The asymmetric cyclopropanation reactions have fascinated organic chemists for 
decades as the cyclopropane motif is both synthetically useful and biologically 
important. 10  The well-established synthetic strategies for asymmetric 
                                                             
7 For the preparation of non-chiral spiro cyclopropyl oxindoles, see: a) M. K. Eberle, G. G. Kahle, M. J. Shapiro, J. 
Org. Chem. 1982, 47, 2210; b) P. Shanmugam, V. Caithiyanathan, B. Viswambharan, Tetrahedron 2006, 62, 4342; c) 
S. R. Yong, A. T. Ung, S. G. Pyne, B. W. Skelton, A. H. White, Tetrahedron 2007, 63, 1191; d) S. Muthusamy, D. 
Azhagan, B. Gnanaprakasam, E. Suresh, Tetrahedron Lett. 2010, 51, 5662; e) H. Yu, Y. Liu, H. Zhang, J. Chen, H. 
Deng, M. Shao, Z. Ren, W. Cao, Tetrahedron 2010, 66, 2598; f) S. Jaegli, J.-P. Vors, L. Neuville, J. Zhu, Tetrahedron 
2010, 63, 8911. 
8 F. Pesciaioli, P. Righi, A. Mazzanti, G. Bartoli, G. Bencivenni, Chem. Eur. J. 2011, 17, 2842. 
9 a) X. Han, Y. Wang, F. Zhong, Y. Lu, J. Am. Chem. Soc. 2011, 133, 1726; (b) F. Zhong, X. Han, Y. Wang, Y. Lu, 
Angew. Chem. Int. Ed. 2011, 50, 7837; c) Q. Zhu, Y. Lu, Angew. Chem. Int. Ed. 2010, 49, 7753; d) X. Han, J. 
Kwiatkowski, F. Xue, K.-W. Huang, Y. Lu, Angew. Chem. Int. Ed. 2009, 48, 7604; e) Q. Zhu, Y. Lu, Chem. Commun. 
2010, 46, 2235; f) Z. Jiang, Y. Lu, Tetrahedron Lett. 2010, 51, 1884; g) J. Luo, L.-W. Xu, R. A. S. Hay, Y. Lu, Org. 
Lett. 2009, 11, 437; h) X. Han, J. Luo, C. Liu, Y. Lu, Chem. Commun. 2009, 2044; i) X. Han, F. Zhong, Y. Lu, Adv. 
Synth. Catal. 2010, 352, 2778; j) F. Zhong, G.-Y. Chen, Y. Lu, Org. Lett. 2011, 13, 82. 
10 For selected reviews, see: a) M.-N. Roy, V. N. G. Lindsay, A. B. Charette, Science of Synthesis, Stereoselective 
synthesis 2011, 1, 731; b) A. B. Charette, A. Beauchemin, Org. React. 2001, 58, 1; c) H. Lebel, J.-F. Marcoud, C. 
Molinaro, A. B. Charette, Chem. Rev. 2003, 103, 977; d) H. Pellissier, Tetrahedron 2008, 64, 7041; e) C. A. Carson, 
M. A. Kerr, Chem. Soc. Rev. 2009, 38, 3051; f) M. J. Campbell, J. S. Johnson, A. T. Parsons, P. D. Pohlhaus, S. D. 
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cyclopropanation include SimmonsSmith reaction, 11  transition metal-catalyzed 
decomposition of diazoalkanes,12  Michael-initiated ring closure reactions,13  and 
others.14 In the past few years, organocatalytic cyclopropanations have emerged as a 
powerful approach for the construction of chiral cyclopropanes.15 However, a direct 
cyclopropanation method to access spiro cyclopropyl oxindoles has yet to be 
developed. In the reported organocatalytic cyclopropanation approaches, 
-halogenated carbonyl compounds are commonly utilized as a C1 synthon, which 
contains a nucleophilic/electrophilic center for the construction of cyclopropanes. 
From a practical viewpoint, it would be ideal if simple oxindoles can be used directly 
as a C1 synthon for the synthesis of cyclopropyl spirooxindoles. We envisioned that 
employment of oxindoles containing a dinucleophilic center as a C1 synthon, in 
combination with a suitable dielectrophilic C2 synthon (e.g. halogenated 
                                                                                                                                                                                  
Sanders, J. Org. Chem. 2010, 75, 6317. 
11 a) H. E. Simmons, R. D. Smith, J. Am. Chem. Soc. 1959, 81, 4256. For recent examples, see: b) M.-C. Lecasse, C. 
Poulard, A. B. Charette, J. Am. Chem. Soc. 2005, 127, 12440; c) H. Shitama, T. Katsuki, Angew. Chem. Int. Ed. 2008, 
47, 2450.; d) L. E. Zimmer, A. B. Charette, J. Am. Chem. Soc. 2009, 131, 15624; e) S. R. Goudreau, A. B. Charette, 
J. Am. Chem. Soc. 2009, 131, 15633; f) J. A. Bull, A. B. Charette, J. Am. Chem. Soc. 2010, 132, 1895. 
12 For recent selected examples, see: a) S. Zhu, J. V. Ruppel, H. Lu, L. Wojtas, X. P. Zhang, J. Am. Chem. Soc. 2008, 
130, 5042; b) D. Marcoux, A. B. Charette, Angew. Chem. Int. Ed. 2008, 47, 10155; c) S. Zhu, J. A. Perman, X. P. 
Zhang, Angew. Chem. Int. Ed. 2008, 47, 8460; d) D. Marcoux, S. Azzi, A. B. Charette, J. Am. Chem. Soc. 2009, 131, 
6970; e) V. N. G. Lindsay, W. Lin, A. B. Charette, J. Am. Chem. Soc. 2009, 131, 16383; f) M. Ichinose, H. Suematsu, 
T. Katsuki, Angew. Chem. Int. Ed. 2009, 48, 3121; g) S. Zhu, X. Xu, J. A. Perman, X. P. Zhang, J. Am. Chem. Soc. 
2010, 132, 12796; h) T. Nishimura, Y. Maeda, T. Hayashi, Angew. Chem. Int. Ed. 2010, 49, 7324; i) V. N. G. Lindsay, 
C.  Nicolas, A. B. Charette, A. B. J. Am. Chem. Soc. 2011, 133, 8972. 
13 a) W.-W. Liao, K. Li, Y. Tang, J. Am. Chem. Soc. 2003, 125, 13030; b) J.-C. Zheng, W.-W. Liao, Y. Tang, L.-X. 
Dai, J. Am. Chem. Soc. 2005, 127, 12222; c) X.-M. Deng, P. Cai, S. Ye, X.-L. Sun, W.-W. Liao, K. Li, Y. Tang, Y.-D. 
Wu, L.-X. Dai, J. Am. Chem. Soc. 2006, 128, 9730. 
14 a) B. Moreau, A. B. Charette, J. Am. Chem. Soc. 2005, 127, 18014; b) R. Shintani, S. Park, T. Hayashi, T. J. Am. 
Chem. Soc. 2007, 129, 14866; c) W. Liu, D. Chen, X.-Z. Zhu, X.-L. Wan, X.-L. Hou, J. Am. Chem. Soc. 2009, 131, 
8734; d) H. Y. Kim, L. Salvi, P. J. Carroll, P. J. Walsh, J. Am. Chem. Soc. 2010, 132, 402. 
15 a) C. D. Papageorgiou, S. V. Ley, M. J. Gaunt, Angew. Chem. Int. Ed. 2003, 42, 828; b) C. D. Papageorgiou, M. A. 
C. Dios, S. V. Ley, M. J. Gaunt, Angew. Chem. Int. Ed. 2004, 43, 4641; c) N. Bremeyer, S. C. Smith, S. V. Ley, M. J. 
Gaunt, Angew. Chem. Int. Ed. 2004, 43, 2681; d) R. K. Kunz, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 
3240; e) C. C. C. Johansson, N. Bremeyer, S. V. Ley, D. R. Owen, S. C. Smith, M. J. Gaunt, Angew. Chem. Int. Ed. 
2006, 45, 6024; f) S. H. McCooey, T. McCabe, S. J. Connon, J. Org. Chem. 2006, 71, 7494; g) H. Xie, L. Zu, H. Li, 
J. Wang, W. Wang, J. Am. Chem. Soc. 2007, 129, 10886; h) R. Rios, H. Sundén, J. Vesely, G.-L. Zhao, P. Dziedzic, A. 
Córdova, Adv. Synth. Catal. 2007, 349, 1028; i) I. Ibrahem, G.-L. Zhao, R. Rios, J. Vesely, H. Sundén, P. Dziedzic, A. 
Córdova,  Chem. Eur. J. 2008, 14, 7867; j) Y. Xuan, S. Nie, L. Dong, J. Zhang, M. Yan, Org. Lett. 2009, 11, 1583; k) 
V. Terrasson, A. Lee, R. M. Figueiredo, J. M. Campagne, Chem. Eur. J. 2010, 16, 7875; l) Y. Cheng, J. An, L.-Q. Lu, 
L. Luo, Z.-Y. Wang, J.-R. Chen, W.-J. Xiao, J. Org. Chem. 2011, 76, 281. 
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nitroolefines), may provide a straightforward cyclopropanation strategy. In the 
presence of a suitable catalyst, oxindole can readily add to nitroolefin. Followed by 
intramolecular proton transfer, an SN2 substitution is expected to generate the 
cyclopropane core. Apparently, the O-alkylation product may also be formed, in 
addition to the desired C-alkylation product (Scheme 4.1). It is noteworthy that 
utilization of a dinucleophilic C1 synthon in asymmetric organocatalytic 
cyclopropanation is unknown, and the use of halogenated nitroolefins in asymmetric 
cyclopropanation has also not been disclosed. Notably, Connon and co-workers 
described a stereoselective synthesis of functioanlized nitrocyclopropanes employing 
nitroolefins as a reaction component. However, their attempt of utilizing halogenated 
nitroolefin in the asymmetric cyclopropanantion led to disappointing results.15f Herein, 
we describe the first direct highly diastereoselective and enantioselective 
cyclopropanation of oxindoles by employing oxindoles as readily available C1 
synthon and (E)-β,β-bromo nitroolefins as a convenient C2 synthon.  
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Scheme 4.1 Organocatalytic approaches to access cyclopropanes and cyclopropyl 
spirooxindoles 
 
4.2 Results and Discussion 
4.2.1 Reaction Optimization 
We initiated our study by examining the reaction between N-Boc-protected 
oxindole 4-1a and (E)-β,β-bromo nitrostyrene 4-2a (Table 4.1). Tertiary 
amine thiourea catalysts were selected to promote the projected reaction. As HBr 
would be generated during the reaction process, thus a stoichiometric amount of 
(NH4)2CO3 was used as HBr scavenger, since (NH4)2CO3 could capture the released 
HBr and not induce undesired background reaction. Cinchona alkaloid-derived 4-5 
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and 4-6 promoted the reaction efficiently, furnishing three diastereomers 4-3a, 4-3a'16 
and 4-4a in high yields and with excellent enantioselectivities, but with very poor 
diastereoselectivities (Table 4.1, entries 12). To further improve the results, we chose 
to employ our recently developed amino acid-incorporating multifunctional catalysts. 
All the multifunctional catalysts could efficiently promote the reaction, affording the 
desired C-alkylation products 4-3a, 4-3a' and 4-4a in high yields. Fine tuning the side 
chain of the amino acid moiety of the catalysts led to formation of 4-3a and 4-4a with 
excellent enantioselectivity and diastereoselectivity. However, the selectivity between 
4-3a and 4-4a remained poor (Table 4.1, entries 39). 
 






















4-5 R = H; 4-6 R = OMe
4-7a: R = H, R' = 3-methyl-1H-indolyl
4-7b: R = H, R' = iPr
4-7c: R = H, R' = -CH(OTBS)CH3
4-7d: R = H, R' = -CH(OTDS)CH3
4-7e: R = H, R' = -CH(OTBDPS)CH3
4-7f: R = H, R' = tBu







































4-3a 4-3a' 4-4a 
1 4-5 95 28:58:14 90 93 n.d. 
2 4-6 97 44:44:12 88 93 n.d. 
3 4-7a 82 46:12:42 57 n.d. 80 
                                                             
16 3a' is a known compound reported in reference 8. 
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4 4-7b 85 43:14:43 75 n.d. 87 
5 4-7c 95 45:6:49 72 n.d. 85 
6 4-7d 95 45:5:50 78 n.d. 86 
7 4-7e 97 39:4:57 85 n.d. 86 
8 4-f 98 52:6:42 96 n.d. 92 
9 4-g 98 53:5:42 97 n.d. 92 
a Reactions were performed with 4-1a (0.05 mmol), 4-2a (0.06 mmol) , (NH4)2CO3 (0.05 mmol) 
and the catalyst ( 0.005 mmol, 10 mol %) in toluene (1.0 mL) at room temperature for 3h. 
Products 4-3a, 4-3a' was obtained as a mixture and 4-4a were easily separated by column 
chromatography. b Combined isolated yield of three stereoisomers. c Determined by 1H NMR 
analysis of the crude products. d Determined by HPLC analysis on a chiral stationary phase. (n.d.: 
not determined) 
 













1 Hexane 95 43:7:50 n.d. 
2 Xylene 97 51:4:45 92 
3 THF 93 28:58:14 n.d. 
4 Et2O 88 50:6:44 n.d. 
5 CHCl3 98 57:11:32 96 
6 CH2Cl2 98 61:11:28 93 
7 DCE 97 53:18:29 n.d. 
a Reactions were performed with 4-1a (0.05 mmol), 4-2a (0.06 mmol) , (NH4)2CO3 (0.05 mmol) 
and 4-7g ( 0.005 mmol, 10 mol %) in solvent (1.0 mL) at room temperature for 3h. b Combined 
isolated yield of three stereoisomers. c Determined by 1H NMR analysis of the crude products. d ee 
values of 4-3a, determined by HPLC analysis on a chiral stationary phase. (n.d.: not determined; 
DCE: Dichloroethane) 
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Table 4.3 Survey of Additives, Temperature and Catalyst Loading Effects on 4-7g Catalyzed 









































1 CHCl3 4 Å MS, rt 98 63:13:24 95 
2 CH2Cl2 4 Å MS, rt 97 65:13:22 92 
3 CHCl3 3 Å MS, rt 98 66:10:24 95 
4 CHCl3 5 Å MS, rt 98 67:9:24 97 
5 CHCl3 5 Å MS, -20oC 87 64:11:25 95 
6 CHCl3 5 mol % cat, rt 95 53:13:34 94 
a Reactions were performed with 4-1a (0.05 mmol), 4-2a (0.06 mmol) , (NH4)2CO3 (0.05 mmol) 
and 4-7g ( 0.005 mmol, 10 mol %) in solvent (1.0 mL) at room temperature for 3h. b Combined 
isolated yield of three stereoisomers. c Determined by 1H NMR analysis of the crude products. d ee 
values of 4-3a, determined by HPLC analysis on a chiral stationary phase. (n.d.: not determined) 
 
Solvent studies showed that CH2Cl2 and CHCl3 were superior to other for 4-3a 
synthesis (Table 4.2). Gratifyingly, further extensive additive studies resulted in 
promising results; when the reaction was performed in chloroform in the presence of 
5 Å molecular sieves, cyclopropyl spirooxindole 4-3a was obtained in good yield and 
excellent ee value (Table 4.3, entry 4). Further optimization did not help to improve 
the results, lower the reaction temperature or catalyst loading led to decline of 
selectivities (Table 4.3, entries 56). 
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Scheme 4.2 Conversion of 4-3a to 4-4a via nucleophilic catalyst-initiated cyclopropane ring 
openingclosing process 
 
Having stereoselectively obtained spirocyclopropanes 4-3a, our next task was to 
devise a diastereodivergent approach to selectively access cyclopropanes 4-4a. It is 
well-established that the activated cyclopropanes can be readily opened by 
nucleophiles,17 we therefore considered the possibility of converting 4-3a to 4-4a via 
cyclopropane openingclosing process. We reasoned that the employment of a 
suitable nucleophile may lead to the opening of the cyclopropane ring 4-3a, highly 
stabilized oxindole enolate makes the opening at the -position of the nitro group 
favorable, and the subsequent ring closure may yield 4-4a (Scheme 4.2). 
 















17 For selected examples on nucleophilic openings of activated nitrocyclopropanes: a) R. K. Dieter, S. Pounds, J. 
Org. Chem. 1982, 47, 3174; b) R. P. Wurz, A. B. Charette, Org. Lett. 2005, 7, 2313; c) E. M. Budynina, O. A. 
Ivanova, E. B. Averina, T. S. Kuznetsova, N. S. Zefirov, Tetrahedron Lett. 2006, 47, 647; d) O. Lifchits, A. B. 
Charette, Org. Lett. 2008, 10, 2809; e) O. Lifchits, D. Alberico, I. Zakharian, A. B. Charette, J. Org. Chem. 2008, 73, 
6838. 
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1 DIPEA 12 trace - - 
2 Et3N 6 42 >20:1 94 
3 DMAP 24 47 >20:1 95 
4 DABCO 6 73 >20:1 95 
5 PPh3 24 - - - 
6 Quinine 6 22 >20:1 86 
a Reactions were performed with 4-3a (0.05 mmol), base (0.05 mmol) in THF (0.5 mL) at room 
temperature. b Isolated yield. c Determined by 1H NMR analysis. d ee values of 4-4a, determined 
by HPLC analysis on a chiral stationary phase. 
 
The feasibility of converting 4-3a to 4-4a in the presence of a number of Lewis 
bases was studied (Table 4.4). When diisopropylethylamine (DIPEA) was used, only 
trace amount of 4-4a was observed, suggesting the importance of the nucleophilicity 
of the promoting base (entry 1). Both triethylamine and dimethylaminopyridine 
(DMAP) could promote conversion of 4-3a to 4-4a without affecting the ee values, 
however, yields were unsatisfactory (entries 23). DABCO was found to be the most 
effective promoter, leading to the formation of 4-4a in good yield, and the 
enantiomeric excess of the product was maintained (entry 4). Triphenylphosphine, 
however, was found to be completely ineffective (entry 5). A chiral base quinine was 
also introduced to the epimerization process, however, low conversion and lower ee 
value were observed (entry 6). It is noteworthy that 4-3a' remained unchanged in the 
epimerization process of 3a. We believe that the conversion of 4-3a to 4-4a was 
initiated by the nucleophilic attack of the nucleophilic amine on the cyclopropane ring, 
as the ammonium enolate intermediate18 (Scheme 4.2, A: Nu = DABCO) was 
                                                             
18 HRMS (ESI) m/z calcd for C27H33N4O5 [M+H]+= 493.2445, found 493.2450, see the experimental section for the 
MS spectrum. For an excellent review on the uses of ammonium enolate, see: M. J. Gaunt, C. C. C. Johansson, 
Chem. Rev. 2007, 107, 5596. 
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observed in mass spectroscopy during the reaction process. 
 
 
Scheme 4.3 Reaction sequence for the synthesis of cyclopropyl spirooxindoles 4-4a 
 
With the effective method for the creation of 4-4a from 4-3a in hand, we then 
proceeded to directly prepare cyclopropanes 4-4a from oxindoles 4-1a and 
bromonitroolefins 4-2a (Scheme 4.3). Following the reaction conditions we had 
established (Table 4.1, entry 9), 4-3a and 4-3a' were separated from the reaction 
system and obtained as a mixture (4-3a:4-3a' = 53:3, 3a 97% ee) while 4-4a was 
obtained in 92% ee. DABCO was then introduced to effect the conversion of 4-3a to 
4-4a. The epimerization from 4-3a lead to the formation of 4-4a in high yield and the 
enantiomeric excess of the product was maintained. The final products 4-4a were 
derived from two sources; via direct cyclopropanation reaction and epimerization 
from 4-3a, and it was obtained in 82% overall yield and 95% ee. 
 
4.2.2 Substrate Scope 
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With the optimized reaction condition in hand, the generality of 4-7g catalyzed 
asymmetric cyclopropanation of oxindoles was then investigated. The substrate scope 
for preparation of spirocyclopropyl oxindoles 4-3 was first investigated (Table 4.5). 
Both oxindoles and bromonitroolefins could be varied, and cyclopropyl spiroxindoles 
4-3 were obtained in good diastereomeric ratios and excellent enantioselectivities 
(entries 110). When alkyl bromonitroolefin 4-2q was employed, product with high 
ee was attainable, although only with moderate yield and poor diastereoselectivity 
(entry 11). When the reaction was performed at a larger scale, similar results were 
obtained (entry 12). 
 


























entry R/R' t (h) 4-3 dr (4-3:4-3')b yield (%)c ee (%)d 
1e H/C6H5 12 4-3a 87:13 72 97 
2e H/3-Br-C6H4 12 4-3c 81:19 81 90 
3e H/4-Br-C6H4 24 4-3d 81:19 75f 95 
4e H/2-F-C6H4 72 4-3g 86:14 63f 96 
5 H/4-F-C6H4 36 4-3h 82:18 76f 97 
6 H/4-Cl-C6H4 24 4-3f 82:18 68f 98 
7 H/2-Me-C6H4 36 4-3i >20:1 60 97 
8 H/4-Me-C6H4 36 4-3j 88:12 72f 98 
9e 6-Cl/C6H5 12 4-3s 88:12 68 93 
10 6-Cl/2-BrC6H4 12 4-3o 92:8 45 99 
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11 H/phenethyl 36 4-3q 57:43 46 93 
12e,g H/C6H5 12 4-3a 85:15 68 95 
a Reactions were performed with 4-1 (0.05 mmol), 4-2 (0.06 mmol), (NH4)2CO3 (0.05 mmol) and 
4-7g (0.005 mmol, 10 mol %) in CHCl3 (1.0 mL) at room temperature. b Determined by 1H NMR 
analysis of the crude products. c Isolated yield of 4-3 and 4-3'. d ee values of 4-3, determined by 
HPLC analysis on a chiral stationary phase. e Molecular sieve (5 Å, 10 mg) was added. f Two 
diastereoisomers could be separated by silica gel column chromatography. g Reaction was 
performed with 0.5 mmol oxindole 4-1. 
Following the same procedure as preparation of 4-4a, the substrate scope of 
synthesis of cyclopropyl spirooxindoles 4-4 was then investigated (Table 4.6). 
Consistently high chemical yields, excellent diastereoselectivities and 
enantioselectivities were attainable for a wide range of aryl bromonitroolefins (entries 
113). Variation of the substitutions on the oxindole rings was also tolerated (entries 
1415). Alkyl bromonitroolefins were suitable for the reaction, high ee values, 
chemical yields, and moderate diastereoselectivities were attainable (entries 1617). 
The reaction repeated well at a larger scale (entry 18). The products 4-4 were derived 
from two sources; via direct cyclopropanation reaction and epimerization from 4-3. 
Thus the ee values in Table 4.6 differed slightly from those shown in Table 4.5. 
 
Table 4.6 The Substrate Scope of the Direct Cyclopropanation Reaction for Preparation of 
Spirooxindoles 4-4a 
 
entry R/R' 4-3 drb yield (%)c ee (%)d 
1 H/C6H5 4-4a >20:1 82 95 
2 H/2-Br-C6H4 4-4b >20:1 92 94 
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3 H/3-Br-C6H4 4-4c >20:1 84 95 
4 H/4-Br-C6H4 4-4d >20:1 80 96 
5 H/2-Cl-C6H4 4-4e >20:1 85 95 
6 H/4-Cl-C6H4 4-4f >20:1 81 94 
7 H/2-F-C6H4 4-4g >20:1 88 94 
8 H/4-F-C6H4 4-4h >20:1 71 96 
9 H/2-Me-C6H4 4-4i >20:1 90 90 
10 H/4-Me-C6H4 4-4j >20:1 72 95 
11 H/1-naphthyl 4-4k >20:1 77 97 
12 H/2-naphthyl 4-4l >20:1 74 96 
13 H/2,4-Cl-C6H3 4-4m >20:1 86 94 
14 5-Cl/2-Br-C6H4 4-4n >20:1 91 98 
15 6-Cl/2-Br-C6H4 4-4o >20:1 95 97 
16e H/iso-butyl 4-4p 4:1 69 92 
17e H/phenethyl 4-4q 3:1 82 92 
18f 6-Cl/2-Br-C6H4 4-4o >20:1 93 96 
a Reactions were performed with 4-1 (0.05 mmol), 4-2 (0.06 mmol) , (NH4)2CO3 (0.05 mmol) and 
4-7g ( 0.005 mmol, 10 mol %) in toluene (1.0 mL) at room temperature for 6 h; in the subsequent 
step, crude 4-3 was separated and treated with DABCO (0.05 mmol) in THF (0.5 mL) at room 
temperature for 3 h. 4-4 was obtained as a sum of the 4-4 obtained in the first step and 4-4 
obtained after epimerization b Determined by 1H NMR analysis. c Isolated combined yield. d 
Determined by HPLC analysis on a chiral stationary phase, ee value of the final combined product. 
e Reaction time was 18 h. f Reaction was performed with 0.5 mmol oxindole 4-1. 
 
4.3 Conclusions 
In summary, we have developed the first direct asymmetric cyclopropanation 
reaction of oxindoles. In our novel cyclopropanation strategy, we employed oxindoles 
with a dinucleophilic center as a C1 synthon, and we also used bromonitroolefins 
containing a dielectrophilic center as a unique C2 synthon. We believed the 
cyclopropanation strategy reported herein will find wide applications in synthetic 
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organic chemistry. By engaging DABCO as a nucleophilic catalyst, a 
stereochemically retentative conversion of different diastereomers of cyclopropyl 
spirooxindoles was discovered. We achieved highly diastereodivergent and 
enatioselective synthesis of 3-spirocyclopropyl-2-oxindoles, which are classes of 
compounds of great biological significance. Currently we are extending such novel 
cyclopropanation approach to prepare other cyclopropanes, and the biological 
evaluation of the prepared cyclopropyl spirooxindoles is underway. 
 
4.4 Experimental Section 
4.4.1 Material and General Methods 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. THF and diethyl ether were dried 
and distilled from sodium benzophenone ketyl prior to use. CHCl3 and CH2Cl2 were 
distilled from CaH2 prior to use. 1H and 13C NMR spectra were recorded on a Bruker 
ACF300 or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts 
per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as 
follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), br (broad singlet). Coupling constants were reported in Hertz (Hz). Low 
resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL- T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL- T spectrometer. For 
thin layer chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) 
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were used, and compounds were visualized with a UV light at 254 nm. Further 
visualization was achieved by staining with iodine, or ceric ammonium molybdate 
followed by heating on a hot plate. Flash chromatographic separations were 
performed on Merck 60 (0.040-0.063 mm) mesh silica gel. The enantiomeric excesses 
of products were determined by chiral-phase HPLC analysis. 
The catalysts 4-7a4-7b, 4-7c4-7f were prepared following the literature 
procedure.19 
 






































4-7a R = H, R' = 3-methyl-1H-indolyl
4-7b R = H, R' = iPr
4-7c R = H, R' = -CH(OTBS)CH3
4-7d R = H, R' = -CH(OTDS)CH3
4-7e R = H, R' = -CH(OTBDPS)CH3
4-7f R = H, R' = tBu








To a stirred solution of acid (181 mg, 0.5 mmol) in anhydrous tetrahydrofuran (8 
                                                             
19 Q. Zhu, Y. Lu, Angew. Chem. Int. Ed. 2010, 49, 7753. 
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mL) and triethylamine (174 μL, 1.25 mmol) was added ethylchloroformate (60 mg, 
0.22 mmol) under N2 at 0 oC. After stirring for 1 h, (S)-quinolin-4-yl((2S) 
-8-vinylquinuclidin-2-yl) methanamine(epi-cinchonidine-NH2, 147 mg, 0.2 mmol) 
was added. The reaction mixture was warmed to room temperature and stirred for 2 h. 
After concentration, water (15 mL) was added to the residue, and the resulting 
mixture was extracted with dichloromethane (15 mL x 2). The combined organic 
layers were dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash column chromatography (ethyl acetate 
/hexanes = 1:2 to ethyl acetate to ethyl acetate/methanol = 20:1) to afford 4-7d’ (250 
mg, 80% yield) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 0.07 (s, 3H), 0.15 (s, 3H), 0.86 (s, 3H), 0.87 (s, 3H), 
0.92 (d, J = 5.7 Hz, 6H), 1.11 (d, J = 6.3 Hz, 3H), 1.37 (m, 12H), 1.56-1.63 (m, 4H), 
2.26 (s, 1H), 2.63-2.71 (m, 2H), 3.07 (br, 2H), 3.18-3.23 (m, 1H), 4.04 (s, 1H), 4.20 (s, 
1H), 4.91-4.96 (m, 2H), 5.43 (br, 2H), 5.66-5.73 (m, 1H), 7.36 (s, 1H), 7.60 (br, 1H), 
7.68-7.71 (m, 1H), 8.04 (br, 1H), 8.1 (d, J = 8.2 Hz, 1H), 8.38 (br, 1H), 8.86 (d, J = 4.4 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ -3.0, -2.7, 14.2, 17.9, 18.6, 18.7, 20.1, 20.2, 
24.9, 26.1, 27.5, 27.9, 28.3, 34.1, 39.6, 40.8, 56.1, 59.0, 68.4, 77.3, 79.4, 114.4, 123.2, 
126.7, 129.0, 130.5, 141.4, 150.0, 155.4, 170.1; HRMS (ESI) m/z calcd for 
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To a stirred solution of 4-7d’ (64 mg, 0.10 mmol) in dichloromethane (4.0 mL) 
was added trifluoroacetic acid (0.4 mL). After stirring at room temperature for 12 h, 
aqueous NaHCO3 (15 mL) was added. The resulting mixture was then extracted with 
dichloromethane (10 mL x 3), and the organic extracts were combined, dried over 
Na2SO4, filtered and concentrated. The crude product was used directly dissolved in 
dichloromethane (5.0 mL) at room temperature and was treated with 
1-isothiocyanato-3,5-bis(trifluoromethyl)benzene (27 mg, 0.10 mmol). After stirring 
for 2 h, the reaction mixture was concentrated under reduced pressure to afford the 
crude product, which was subjected to flash chromatographic separation (ethyl acetate 
/hexanes = 1:2 to ethyl acetate) to afford product 4-7d (69.8 mg, 86% for two steps) 
as a white solid. 
1H NMR (500 MHz, CDCl3) δ 0.24 (s, 3H), 0.27 (s, 3H), 0.95 (m, 13H), 1.19 (d, J = 5.7 
Hz, 3H), 1.32-1.37 (m, 1H), 1.58-1.72 (m, 4H), 2.28 (s, 1H), 2.66-2.74 (m, 2H), 3.08 
(br, 2H), 3.20-3.25 (m, 1H), 4.45 (s, 1H), 4.95-5.02 (m, 3H), 5.52 (br, 1H), 5.67-5.74 (m, 
1H), 7.28 (d, J = 4.4 Hz, 1H), 7.47-7.62 (m, 6H), 7.99 (d, J = 8.2 Hz, 1H), 8.22 (d, J = 
7.6 Hz, 1H), 8.34 (br, 2H), 8.76 (s, 1H); 13C NMR (125 MHz, CDCl3) δ -2.6, -2.3, 17.7, 
18.6, 18.7, 20.2, 20.3, 25.0, 26.0, 27.4, 27.9, 34.1, 39.5, 40.1, 56.0, 62.1, 68.1, 114.6, 
118.6, 121.8, 122.7, 123.5, 124.0, 126.7, 129.2, 130.6, 131.9, 132.2, 139.3, 141.2, 
150.0, 170.4; HRMS (ESI) m/z calcd for C40H51F6N5O2SSi [M+H]+ = 808.3510, found 
= 808.3510. 
Catalysts 4-7e & 4-7g were prepared following the same procedures described for the 
preparation of 4-7d 
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A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.02 (d, J = 6.3 Hz, 3H), 1.05 (s, 9H), 
1.36 (m, 12H), 1.64 (m, 3H), 2.04 (br, 1H), 2.25 (m, 1H), 2.72-2.78 (m, 1H), 3.12-3.14 
(m, 3H), 4.23-4.27 (m, 2H), 4.91-4.94 (m, 2H), 5.33 (m, 1H), 5.65-5.67 (m, 1H), 
7.32-7.46 (m, 6H), 7.62 (br, 1H), 7.71-7.72 (m, 6H), 8.13-8.15 (m, 2H), 8.43 (br, 1H), 
8.86 (d, J = 4.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 18.1, 19.2, 27.0, 27.5, 27.9, 
28.2, 39.5, 40.9, 55.9, 59.2, 70.2, 79.4, 114.4, 123.2, 126.7, 127.5, 127.7, 129.1, 129.7, 
129.9, 130.5, 132.5, 134.0, 135.8, 136.1, 141.4, 150.1, 155.2, 170.0; HRMS (ESI) m/z 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.14 (d, J = 6.3 Hz, 3H), 1.22 (s, 9H), 
1.27 (m, 2H), 1.54-1.60 (m, 3H), 2.25 (s, 1H), 2.49-2.52 (m, 1H), 2.74 (m, 1H), 3.03 (br, 
2H), 3.08-3.13 (m, 1H), 4.29-4.31 (m, 1H), 4.91-4.95 (m, 2H), 5.44 (br, 2H), 5.62-5.69 
(m, 1H), 7.20 (br, 1H), 7.27 (s, 1H), 7.38 (s, 2H), 7.43-7.53 (m, 9H), 7.57 (m, 1H), 
7.79-7.81 (m, 4H), 7.87 (d, J = 8.2 Hz, 1H), 8.15 (d, J = 8.6 Hz, 1H), 8.47 (br, 1H), 8.67 
(d, J = 3.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 17.8, 19.2, 27.2, 27.3, 27.8, 39.3, 
40.9, 56.5, 61.8, 69.9, 114.6, 118.2, 121.8, 122.2, 122.2, 122.3, 122.4, 123.3, 124.0, 
126.6, 127.7, 127.9, 129.1, 130.0, 130.3, 130.5, 131.3, 131.6, 132.0, 133.6, 135.9, 
136.3, 139.3, 141.1, 149.9, 171.2, 181.1. HRMS (ESI) m/z calcd for C48H51F6N5O2SSi 
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[M+H]+ = 904.3510, found = 904.3498. 
tert-Butyl-((S)-1-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate 4-7g’ 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.83-1.04 (m, 12H), 1.22-1.42 (m, 12H), 
1.58 (s, 2H), 1.65 (s, 1H), 2.27 (s, 1H), 2.68 (s, 2H), 2.99 (br, 1H), 3.13-3.21 (m, 2H), 
3.80 (s, 1H), 3.94 (s, 3H), 4.94 (m, 2H), 5.07 (br, 1H), 5.36 (br, 1H), 5.70 (br, 1H), 7.05 
(br, 1H), 7.32 (s, 2H), 7.56 (br, 1H), 7.98 (d, J = 8.9 Hz, 1H), 8.66 (d, J = 3.8 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 14.2, 21.0, 23.4, 25.9, 26.5, 27.4, 28.2, 34.3, 39.5, 41.0, 
42.0, 50.4, 55.6, 55.8, 60.4, 60.6, 62.4, 76.8, 79.5, 101.7, 114.7, 118.5, 121.6, 128.4, 
128.5, 131.7, 131.9, 132.0, 141.2, 144.6, 145.3, 147.5, 155.8, 157.9, 170.7;HRMS 
(ESI) m/z calcd for C31H45N4O4 [M+H]+ = 537.3435, found = 537.3418. 
(S)-2-(3-(3,5-Bis(trifluoromethyl)phenyl)thioureido)-N-((S)-(6-methoxyquinolin-4-yl)
((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)-3,3-dimethylbutanamide 4-7g 
A white solid; 1H NMR (500 MHz, CDCl3) δ 0.80-1.05 (m, 15H), 1.23-1.25 (m, 
2H), 1.60-1.68 (m, 4H), 2.28 (s, 1H), 2.71 (m, 2H), 2.90-3.12 (m, 2H), 3.20-3.24 (m, 
2H), 3.79 (s, 1H), 3.93 (s, 3H), 4.84-4.91 (m, 3H), 5.26 (br, 1H), 5.67 (br, 1H), 
7.24-7.50 (m, 7H), 7.72-7.79 (m, 2H), 8.16 (br, 1H); 13C NMR (125 MHz, CDCl3) δ 
25.4, 26.7, 27.1, 27.3, 27.7, 27.8, 29.7, 34.4, 35.4, 39.8, 41.2, 55.5, 55.8, 56.0, 60.8, 
61.3, 65.5, 100.6, 101.6, 114.9, 118.4, 119.7, 121.5, 121.9, 123.1, 124.1, 125.2, 125.6, 
126.3, 127.9, 128.7, 130.4, 130.7, 131.0, 131.2, 131.7, 131.9, 132.0, 139.0, 141.0, 
144.0, 144.7, 146.6, 147.6, 157.3, 157.9, 172.2, 172.8, 181.8, 182.5; HRMS (ESI) m/z 
calcd for C35H40F6N5O2S [M+H]+ = 708.2801, found = 708.2808. 
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4.4.3 Representative Procedure 
Asymmetric Synthesis of Spiro Cyclopropyl Oxindole 4-3 
 
Oxindole 4-1 (0.05 mmol) was added to a mixture of nitrostyrene 4-2 (0.06 
mmol), (NH4)2CO3 (4.8 mg, 0.05 mmol), catalyst 4-7g (3.5 mg, 0.005 mmol) and 5 Å 
molecular sieves (10 mg) in CHCl3 (1.0 mL) in a sample vial, and the resulting 
mixture was sealed and stirred at room temperature for the time specified in Table 4.5. 
At the end of the reaction, the reaction mixture was filtered and concentrated in vacuo 
to yield the crude product, which was purified by flash column chromatography (ethyl 
acetate/hexane = 1:7) to afford the desired adducts as a mixture (if not separatable by 
column chromatography) of 4-3 and 4-3' (46%-81% yield). The enantiomeric 
excessess of 4-3 were determined by chiral HPLC analysis. 
 
Lewis Base-initiated Conversion of 4-3a to 4-4a 
 
Enantioenriched 4-3a (95% ee, 0.05 mmol, 19 mg) was dissolved in THF (0.5 
mL), the Lewis base (0.05 mmol) was added and the resulting solution was stirred at 
room temperature for the time specified (624 h). The reaction mixture was 
concentrated in vacuo to yield the crude product, which was purified by flash column 
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chromatography (ethyl acetate/hexane = 1:5) to afford the desired adduct 4-4a. 
 




















Oxindole 4-1 (0.05 mmol) was added to a mixture of nitrostyrene 4-2 (0.06 
mmol), (NH4)2CO3 (4.8 mg, 0.05 mmol) and catalyst 4-7g (3.5 mg, 0.005 mmol) in 
toluene (1.0 mL) in a sealed sample vial and the resulting mixture was stirred at room 
temperature. After 6 h, the reaction mixture was concentrated in vacuo to yield the 
crude product, which was purified by flash column chromatography (ethyl 
acetate/hexane = 1:7) to afford the adducts 4-3 and 4-4. DABCO (0.05 mmol) was 
added to the THF solution (0.5 mL) of 4-3 and the resulting solution was stirred at 
room temperature for 3 h. The reaction solution was concentrated and then purified by 
flash column chromatography (ethyl acetate/hexane = 1:7) to afford the adduct 4-4, 
which was combined with adduct 4-4 from the first step to give the final product 
(69%-95% yield). The enantiomeric excess of 4-4 was determined by chiral HPLC 
analysis. 
 
4.4.4 MS Spectrum of Ammonium Enolate Intermediate 
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4.4.5 X-Ray Crystallographic Analysis and Determination of Configurations of 
the Spirooxindole Products 
X-Ray Crystallographic Analysis of 4-3o 
The absolute configuration of the product 3o was assigned based on the X-ray 
crystallographic analysis of a single crystal of de-Boc 3o (Figure S1). The 
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4-3o de-Boc 4-3o93%  
4-3o (49.2 mg, 0.1 mmol) in CH2Cl2 (1.6 mL) was added TFA (0.4 mL) at 0 oC, 
the resulting solution was then stirred at 0 oC to room temperature for 6 h. The 
reaction was then diluted with CH2Cl2 (5 mL) and washed with aqueous saturated 
NaHCO3 solution (5 mL) and brine (5 mL). The organic phase was then dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo to yield the crude product, 
which was purified by flash column chromatography (ethyl acetate/hexane = 1:2) to 
afford the deprotected pruduct de-Boc 4-3o as a light yellow solid (36.5 mg, 93% 
yield). 
1H NMR (500 MHz, CDCl3) δ 3.64 (d, J = 8.9 Hz, 1H), 5.26 (d, J = 8.2 Hz, 1H), 6.76 
(d, J = 8.2 Hz, 1H), 6.92-6.94 (m, 1H), 7.07-7.09 (m, 2H), 7.27-7.33 (m, 2H), 
7.63-7.65 (m, 1H), 8.97 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 36.8, 39.9, 70.3, 
111.1, 118.7, 122.7, 125.9, 127.2, 127.8, 128.3, 130.1, 131.2, 133.2, 135.3, 143.0, 
174.2; HRMS (ESI) m/z calcd for C16H9N2O379BrCl [M-H]- = 390.9491, found = 
390.9481; calcd for C16H9N2O381BrCl [M-H]- = 392.9470, found = 392.9473. 
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Figure 4.2 X-ray structure of de-Boc 4-3o 
Table 4.7 Crystal Data and Structure Refinement for B559. 
Identification code  b559 
Empirical formula  C16 H10 Br Cl N2 O3 
Formula weight  393.62 
Temperature  223(2) K 
Wavelength  0.71073 Å 
Crystal system  Tetragonal 
Space group  P4(3)2(1)2 
Unit cell dimensions a = 8.3189(4) Å = 90°. 
 b = 8.3189(4) Å = 90°. 
 c = 43.947(4) Å  = 90°. 
Volume 3041.3(3) Å3 
Z 8 
Density (calculated) 1.719 Mg/m3 
Absorption coefficient 2.895 mm-1 
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F(000) 1568 
Crystal size 0.60 x 0.54 x 0.10 mm3 
Theta range for data collection 1.85 to 27.50°. 
Index ranges -10<=h<=10, -10<=k<=10, -47<=l<=57 
Reflections collected 21393 
Independent reflections 3486 [R(int) = 0.0511] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7606 and 0.2755 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3486 / 1 / 212 
Goodness-of-fit on F2 1.030 
Final R indices [I>2sigma(I)] R1 = 0.0457, wR2 = 0.1034 
R indices (all data) R1 = 0.0611, wR2 = 0.1096 
Absolute structure parameter 0.022(12) 
Largest diff. peak and hole 0.675 and -0.500 e.Å-3 
 
X-Ray Crystallographic Analysis of 4-4b 
The absolute configuration of the product 4-4b was assigned based on the X-ray 
crystallographic analysis of a single crystal of 4-4b (Figure 4.3). The configurations 
of other products 4-4 were assigned by analogy.  
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Figure 4.3 X-ray structure of de-Boc 4-4b 
Table 4.8 Crystal Data and Structure Refinement for b350. 
Identification code  b350 
Empirical formula  C21 H19 Br N2 O5 
Formula weight  459.29 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 13.3854(19) Å = 90°. 
 b = 10.8817(16) Å = 91.611(4)°. 
 c = 14.380(2) Å  = 90°. 
Volume 2093.6(5) Å3 
Z 4 
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Density (calculated) 1.457 Mg/m3 
Absorption coefficient 1.997 mm-1 
F(000) 936 
Crystal size 0.66 x 0.28 x 0.24 mm3 
Theta range for data collection 2.05 to 27.49°. 
Index ranges -16<=h<=17, -13<=k<=14, -18<=l<=14 
Reflections collected 14931 
Independent reflections 8928 [R(int) = 0.0277] 
Completeness to theta = 27.49° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6457 and 0.3523 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8928 / 140 / 569 
Goodness-of-fit on F2 0.973 
Final R indices [I>2sigma(I)] R1 = 0.0382, wR2 = 0.0805 
R indices (all data) R1 = 0.0451, wR2 = 0.0826 
Absolute structure parameter 0.009(5) 
Largest diff. peak and hole 0.792 and -0.346 e.Å-3 
 
4.4.6 Analytical Data of the Spirooxindole Products 
(1S,2R,3R)-tert-Butyl-2-nitro-2'-oxo-3-phenylspiro[cyclopropane-1,3'-indoline]-1'-c
arboxylate 4-3a 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.69 (s, 9H), 3.81 (d, J = 8.9 Hz, 
1H), 5.14 (d, J = 8.2 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H), 7.00-7.05 (m, 3H), 7.32-7.39 
(m, 4H), 8.00 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 36.7, 39.6, 
70.6, 85.4, 114.9, 118.8, 124.0, 127.1, 127.4, 128.4, 128.6, 129.2, 130.0, 141.0, 148.6, 
171.5; The ee value was 97%, tR (minor) = 20.25 min and 35.81 min, tR (major) = 
20.08 min and 29.68 min (Chiralcel AD-H + IA, λ = 254 nm, 2% iPrOH/hexanes, 
flow rate = 0.8 mL/min); HRMS (ESI) m/z calcd for C21H20N2O5Na [M+Na]+ = 




A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.74 (d, J = 8.9 Hz, 
1H), 5.11 (d, J = 8.2 Hz, 1H), 6.77-6.79 (m, 1H), 6.99 (d, J = 6.9 Hz, 1H), 7.05 (dd, J 
= 6.9 Hz, 11.7 Hz, 1H), 7.19-7.26 (m, 2H), 7.34-7.51 (m, 2H), 8.01 (d, J = 8.2 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 35.6, 39.3, 70.2, 85.5, 115.1, 118.4, 122.4, 
124.1, 126.8, 128.8, 129.5, 129.7, 130.1, 131.6, 133.1, 141.1, 148.5, 171.2; The ee 
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value is 90%, tR (minor) = 12.73 min and 14.34 min, tR (major) = 12.07 min and 23.63 
min (Chiralcel IC + AD-H, λ = 254 nm, 15% iPrOH/hexanes, flow rate = 1.0 mL/min); 
HRMS (ESI) m/z calcd for C21H19N2O5Na79Br [M+Na]+ = 481.0370, found = 481.0383; 










A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.70 (d, J = 8.9 Hz, 
1H), 5.12 (d, J = 8.9 Hz, 1H), 6.73 (d, J = 8.2 Hz, 1H), 6.92 (d, J = 8.8 Hz, 2H), 
7.03-7.06 (m, 1H), 7.34-7.46 (m, 1H), 7.47-7.49 (m, 2H), 8.01 (d, J = 8.2 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 28.1, 35.9, 39.3, 70.3, 85.4, 115.1, 118.5, 122.7, 124.1, 
126.8, 129.4, 130.6, 131.7, 131.9, 141.0, 148.5, 171.2; The ee value is 95%, tR (minor) 
= 19.51 min and 25.99 min, tR (major) = 22.29 min and 30.42 min (Chiralcel IB + IA, 
λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C21H19N2O5Na79Br [M+Na]+ = 481.0370, found = 481.0383; calcd for 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.69 (s, 9H), 3.63 (d, J = 8.2 Hz, 
1H), 5.17 (d, J = 8.2 Hz, 1H), 6.80 (d, J = 7.6 Hz, 1H), 6.94 (t, J = 7.6 Hz, 1H), 7.02 
(t, J = 8.2 Hz, 1H), 7.10 (dd, J = 10.8 Hz, 17.6 Hz, 2H), 7.26-7.40 (m, 2H), 8.00 (d, J 
= 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 31.5, 38.8, 70.1, 85.5, 115.1, 
115.2, 115.3, 115.8, 115.9, 118.8, 123.9, 124.0, 124.1, 126.3, 129.4, 130.5, 131.7, 
141.1, 148.5, 171.2; The ee value is 96%, tR (minor) = 26.89 min, tR (major) = 18.34 
min (Chiralcel AD-H, λ = 254 nm, 2% iPrOH/hexanes, flow rate = 0.5 mL/min); 










A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.73 (d, J = 8.2 Hz, 
1H), 5.12 (d, J = 8.9 Hz, 1H), 6.74 (d, J = 8.9 Hz, 1H), 7.01-7.05 (m, 5H), 7.35-7.41 
(m, 1H), 8.00 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 35.9, 39.5, 
70.5, 85.4, 115.1, 115.7, 115.9, 118.6, 124.0, 126.8, 129.3, 131.9 (d, J = 8.2 Hz), 
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141.0, 148.5, 162.6 (d, J = 246.9 Hz), 171.3; The ee value is 97%, tR (minor) = 10.12 
min and 14.11 min, tR (major) = 12.57 min and 20.45 min (Chiralcel IB, λ = 254 nm, 
3% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 










A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.72 (d, J = 8.2 Hz, 
1H), 5.12 (d, J = 8.8 Hz, 1H), 6.75 (d, J = 8.2 Hz, 1H), 6.98 (d, J = 8.2 Hz, 2H), 7.04 
(t, J = 7.6 Hz, 1H), 7.30-7.40 (m, 3H), 8.00 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 28.1, 35.9, 39.4, 70.3, 85.5, 115.1, 118.5, 124.1, 125.9, 126.8, 128.9, 129.4, 
131.4, 134.6, 141.0, 148.5, 171.2; The ee value is 98%, tR (minor) = 17.60 min and 
22.06 min, tR (major) = 20.24 min and 26.16 min (Chiralcel IB+IA, λ = 254 nm, 5% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C21H19N2O5ClNa 
[M+Na]+ = 437.0875, found = 437.0883. 
(1S,2R,3R)-tert-Butyl-2-nitro-2'-oxo-3-(o-tolyl)spiro[cyclopropane-1,3'-indoline]-1'-
carboxylate 4-3i 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.69 (s, 9H), 2.02 (s, 3H), 3.66 (d, J 
= 8.8 Hz, 1H), 5.18 (d, J = 8.9 Hz, 1H), 6.78 (d, J = 7.6 Hz, 1H), 6.96 (d, J = 7.6 Hz, 
1H), 7.01 (t, J = 7.6 Hz, 1H), 7.13 (t, J = 8.2 Hz, 1H), 7.20 (d, J = 6.9 Hz , 1H), 7.29 
(d, J = 7.6 Hz , 1H), 7.35-7.39 (m, 1H), 7.99 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 19.4, 28.1, 36.2, 39.6, 70.9, 85.4, 115.0, 119.2, 124.1, 125.8, 126.2, 126.3, 
128.6, 129.2, 129.6, 130.6, 138.3, 140.8, 148.6, 171.5; The ee value was 97%, tR 
(minor) = 12.70 min and 16.88 min, tR (major) = 8.77 min and 14.98 min (Chiralcel 
IC, λ = 254 nm, 3% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = -91.5 (c 0.81, 





A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 2.36 (s, 3H), 3.76 (d, J 
= 8.8 Hz, 1H), 5.12 (d, J = 8.9 Hz, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.91 (d, J = 7.6 Hz, 
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2H), 7.02 (t, J = 7.0 Hz, 1H), 7.13 (d, J = 8.2 Hz, 2H), 7.37 (t, J = 7.6 Hz, 1H), 7.99 
(d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.2, 28.1, 36.6, 39.6, 70.7, 85.3, 
118.9, 123.9, 124.2, 127.2, 128.8, 129.1, 129.3, 129.8, 138.3, 140.9, 148.6, 171.5; The 
ee value was 98%, tR (minor) = 17.46 min and 23.29 min, tR (major) = 16.59 min and 
18.88 min (Chiralcel IB+IA, λ = 254 nm, 3% iPrOH/hexanes, flow rate = 1.0 









A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.80 (d, J = 8.9 Hz, 
1H), 5.14 (d, J = 8.2 Hz, 1H), 6.67 (d, J = 8.8 Hz, 1H), 6.99-7.02 (m, 3H), 7.28-7.39 
(m, 3H), 8.08 (d, J = 1.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.0, 36.8, 39.4, 
70.5, 85.9, 115.7, 117.2, 124.1, 127.1, 128.0, 128.6, 128.8, 129.9, 135.4, 141.8, 148.3, 
171.1; The ee value was 93%, tR (minor) = 10.34 min and 10.93 min, tR (major) = 
8.87 min and 23.01 min (Chiralcel IC, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 
1.0 mL/min); HRMS (ESI) m/z calcd for C21H19N2O5ClNa [M+Na]+ = 437.0875, 
found = 437.0883. 
(1S,2S,3R)-tert-Butyl-2-(2-bromophenyl)-6'-chloro-3-nitro-2'-oxospiro[cyclopropan
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H), 3.63 (d, J = 8.2 Hz, 
1H), 5.20 (d, J = 8.2 Hz, 1H), 6.68 (d, J = 8.2 Hz, 1H), 6.99-7.03 (m, 2H), 7.25-7.29 
(m, 2H), 7.60 (d, J = 7.0 Hz, 1H), 8.08 (d, J = 1.9 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 28.0, 37.4, 39.8, 70.8, 85.9, 115.9, 117.4, 124.3, 126.0, 126.8, 127.2, 127.9, 
130.2, 131.2, 133.2, 135.6, 141.9, 148.3, 170.7; The ee value is 99%, tR (minor) = 
5.90 min and 9.14 min, tR (major) = 7.44 min and 8.18 min (Chiralcel IA, λ = 254 nm, 
2% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C21H18N2O5Na79BrCl [M+Na]+ = 514.9980, found = 515.0000; calcd for 




A light yellow oil. 1H NMR (mixture of two diastereoisomers, 500 MHz, CDCl3) δ 
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1.65 (s, 9H), 2.28-2.38 (m, 1H), 2.55-2.80 (m, 3H), 2.91-2.97 (m, 1H), 4.73-4.86 (1H, 
4.73-4.75 (major, d, J = 6.3 Hz), 4.85-4.86 (minor, d, J = 7.6 Hz)), 6.98-7.10 (m, 2H), 
7.13-7.24 (m, 3H), 7.28-7.38 (m, 3H), 7.82-7.92 (1H, 7.82-7.84 (major, d, J = 8.2 Hz), 
7.90-7.92 (minor, d, J = 8.2 Hz)); 13C NMR (125 MHz, CDCl3) δ 22.9, 24.1, 28.1, 
31.1, 34.8, 34.9, 35.3, 37.2, 37.8, 39.8, 60.7, 69.7, 73.7, 84.8, 85.0, 115.1, 115.4, 
120.1, 121.4, 123.6, 124.4, 124.6, 126.2, 126.3, 126.6, 128.2, 128.3, 128.6, 128.7, 
128.8, 128.9, 139.4, 139.5, 140.2, 140.7, 148.5, 169.4, 171.7; The ee value is 93%, tR 
(minor) = 28.15 min and 41.17 min, tR (major) = 17.20 min and 23.92 min (Chiralcel 
OD-H, λ = 254 nm, 2.5% iPrOH/hexanes, flow rate = 0.8 mL/min); HRMS (ESI) m/z 








A white solid; 1H NMR (500 MHz, CDCl3) δ 1.66 (s, 9H), 4.45 (d, J = 6.3 Hz, 1H), 
5.09 (d, J = 6.3 Hz, 1H), 5.97 (d, J = 7.6 Hz, 1H), 6.85 (t, J = 7.6 Hz, 1H), 7.19 (t, J = 
3.2 Hz, 2H), 7.27 (d, J = 8.2 Hz, 1H), 7.33 (dd, J = 2.6 Hz, 16.4 Hz, 3H), 7.96 (d, J = 
8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.8, 40.4, 71.5, 85.1, 115.4, 121.1, 
122.1, 124.0, 128.8, 129.0, 129.1, 129.3, 129.4, 140.4, 148.9, 168.4; The ee value is 
95%, tR (minor) = 13.06 min, tR (major) = 17.21 min (Chiralcel IC, λ = 254 nm, 30% 
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iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +144.5 (c 0.80, CHCl3); HRMS 




A colorless crystal; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.33 (d, J = 7.0 Hz, 
1H), 5.12 (d, J = 6.3 Hz, 1H), 5.89 (d, J = 8.2 Hz, 1H), 6.82 (t, J = 7.6 Hz, 1H), 
7.25-7.31 (m, 2H), 7.40 (d, J = 4.4 Hz, 2H), 7.50 (d, J = 7.6 Hz, 1H), 7.95 (d, J = 8.2 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 40.0, 41.3, 71.4, 85.1, 115.4, 119.9, 
121.9, 124.0, 126.4, 127.8, 129.1, 129.7, 130.2, 130.5, 133.4, 140.5, 148.9, 168.0; The 
ee value is 94%, tR (minor) = 10.86 min, tR (major) = 9.12 min (Chiralcel IC, λ = 254 
nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +102.6 (c 0.91, CHCl3); 
HRMS (ESI) m/z calcd for C21H19N2O5Na79Br [M+Na]+ = 481.0370, found = 481.0383; 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.66 (s, 9H), 4.40 (d, J = 7.0 Hz, 1H), 
5.06 (d, J = 6.3 Hz, 1H), 6.01 (d, J = 7.6 Hz, 1H), 6.92 (t, J = 7.6 Hz, 1H), 7.09 (d, J = 
7.6 Hz, 1H), 7.22 (t, J = 7.6 Hz, 1H), 7.32 (t, J = 8.2 Hz, 1H), 7.39 (s, 1H), 7.50 (d, J 
= 8.2 Hz, 1H), 7.98 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.5, 
39.6, 71.1, 85.3, 115.6, 121.1, 121.5, 123.1, 124.3, 128.1, 129.3, 130.6, 131.5, 132.1, 
132.3, 140.4, 148.8, 168.2; The ee value is 95%, tR (minor) = 20.69 min, tR (major) = 
10.91 min (Chiralcel IB, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); 
[α]24D = +114.1 (c 0.85, CHCl3); HRMS (ESI) m/z calcd for C21H19N2O5Na79Br 
[M+Na]+ = 481.0370, found = 481.0383; calcd for C21H19N2O5Na81Br [M+Na]+ = 










A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.36 (d, J = 6.9 Hz, 1H), 
5.04 (d, J = 6.3 Hz, 1H), 5.99 (d, J = 7.6 Hz, 1H), 6.91 (t, J = 7.6 Hz, 1H), 7.07 (d, J = 
8.2 Hz, 2H), 7.30-7.33 (m, 1H), 7.49 (d, J = 8.2 Hz, 2H), 7.97 (d, J = 8.2 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 28.1, 39.5, 39.6, 71.2, 85.3, 115.5, 121.1, 121.6, 123.1, 
124.3, 128.3, 129.2, 131.0, 132.3, 140.4, 148.8, 168.2; The ee value is 96%, tR (minor) 
= 11.96 min, tR (major) = 15.07 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, 
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flow rate = 1.0 mL/min); [α]24D = +84.8 (c 0.78, CHCl3); HRMS (ESI) m/z calcd for 
C21H19N2O5Na79Br [M+Na]+ = 481.0370, found = 481.0383; calcd for 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.35 (d, J = 6.3 Hz, 1H), 
5.12 (d, J = 6.3 Hz, 1H), 5.90 (d, J = 7.6 Hz, 1H), 6.82 (t, J = 7.6 Hz, 1H), 7.27-7.40 
(m, 5H), 7.95 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.1, 39.7, 
71.1, 85.1, 115.4, 119.9, 121.9, 124.0, 127.2, 127.9, 129.1, 130.0, 130.1, 130.4, 136.2, 
140.4, 148.9, 168.1; The ee value is 95%, tR (minor) = 8.89 min, tR (major) = 10.57 
min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D 
= +140.5 (c 0.74, CHCl3); HRMS (ESI) m/z calcd for C21H19N2O5ClNa [M+Na]+ = 
437.0875, found = 437.0883. 
(1S,2R,3S)-tert-Butyl-2-(4-chlorophenyl)-3-nitro-2'-oxospiro[cyclopropane-1,3'-indo
line]-1'-carboxylate 4-4f 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.38 (d, J = 6.3 Hz, 1H), 
5.05 (d, J = 6.3 Hz, 1H), 5.99 (d, J = 7.6 Hz, 1H), 6.90 (t, J = 7.6 Hz, 1H), 7.13 (d, J = 
8.2 Hz, 2H), 7.30-7.34 (m, 3H), 7.97 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 28.1, 39.6, 71.3, 85.3, 115.5, 121.1, 121.7, 124.2, 127.8, 129.2, 129.4, 130.8, 135.0, 
140.4, 148.8, 168.3; The ee value is 94%, tR (minor) = 11.58 min, tR (major) = 14.26 
min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D 
= +132.8 (c 0.69, CHCl3); HRMS (ESI) m/z calcd for C21H19N2O5ClNa [M+Na]+ = 










A white solid; 1H NMR (500 MHz, CDCl3) δ 1.66 (s, 9H), 4.31 (d, J = 7.0 Hz, 1H), 
5.12 (d, J = 6.3 Hz, 1H), 6.01 (d, J = 7.6 Hz, 1H), 6.87 (t, J = 7.6 Hz, 1H), 7.03 (t, J = 
8.8 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 7.24-7.38 (m, 4H), 7.97 (d, J = 8.2 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 28.1, 35.2, 39.2, 70.8, 85.1, 115.5, 116.2 (d, J = 21.0 Hz), 
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117.1 (d, J = 13.7 Hz), 120.2, 122.0, 124.1, 124.6 (d, J = 3.7 Hz), 129.1, 130.6 (d, J = 
2.7 Hz), 131.0 (d, J = 8.2 Hz), 140.4, 148.9, 161.7 (d, J = 248.7 Hz), 168.1; The ee 
value is 94%, tR (minor) = 12.97 min, tR (major) = 8.07 min (Chiralcel IB, λ = 254 nm, 
10% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +151.0 (c 0.73, CHCl3); 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.39 (d, J = 6.3 Hz, 1H), 
5.06 (d, J = 7.0 Hz, 1H), 5.97 (d, J = 7.6 Hz, 1H), 6.910 (t, J = 7.6 Hz, 1H), 7.02-7.07 
(m, 2H), 7.17 (dd, J = 5.1 Hz, 7.9 Hz, 2H), 7.30 (t, J = 8.2 Hz, 1H), 7.96 (d, J = 8.2 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.6, 39.7, 71.5, 85.3, 115.5, 116.3 (d, 
J = 21.8 Hz), 121.1, 121.8, 124.2, 125.1 (d, J = 2.7 Hz), 129.2, 131.2 (d, J = 8.2 Hz), 
140.4, 148.8, 162.8 (d, J = 247.8 Hz), 168.3; The ee value is 96%, tR (minor) = 11.72 
min, tR (major) = 13.96 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate 
= 1.0 mL/min); [α]24D = +130.8 (c 1.11, CHCl3); HRMS (ESI) m/z calcd for 
C21H19N2O5FNa [M+Na]+ = 421.1170, found = 421.1184. 
(1S,2S,3R)-tert-Butyl-2-nitro-2'-oxo-3-(o-tolyl)spiro[cyclopropane-1,3'-indoline]-1'-
carboxylate 4-4i 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.66 (s, 9H), 1.89 (s, 3H), 4.30 (d, J = 
6.3 Hz, 1H), 5.13 (d, J = 7.0 Hz, 1H), 5.91 (d, J = 7.6 Hz, 1H), 6.83 (t, J = 7.6 Hz, 
1H), 7.11 (d, J = 7.6 Hz, 1H), 7.27-7.33 (m, 4H), 7.95 (d, J = 8.2 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 19.3, 28.1, 39.6, 71.6, 85.2, 115.3, 120.3, 122.1, 124.2, 126.4, 
127.9, 128.3, 129.0, 129.1, 130.8, 138.7, 140.0, 148.9, 168.3; The ee value is 90%, tR 
(minor) = 10.71 min, tR (major) = 11.47 min (Chiralcel IC, λ = 254 nm, 30% 
iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +148.6 (c 0.74, CHCl3); HRMS 










A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 2.35 (s, 3H), 4.41 (d, J = 
7.0 Hz, 1H), 5.07 (d, J = 6.3 Hz, 1H), 6.01 (d, J = 7.6 Hz, 1H), 6.87 (t, J = 7.6 Hz, 
1H), 7.06 (d, J = 7.6 Hz, 2H), 7.14 (d, J = 7.6 Hz, 2H), 7.28 (d, J = 8.2 Hz, 1H), 7.95 
(d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.2, 28.1, 39.7, 40.3, 71.6, 85.1, 
Chapter 4 Asymmetric Cyclopropanation of Oxindoles 
- 124 - 
 
115.3, 121.2, 122.2, 124.1, 126.1, 128.9, 129.2, 129.8, 138.8, 140.2, 148.9, 168.5; The 
ee value is 95%, tR (minor) = 12.36 min, tR (major) = 20.13 min (Chiralcel IC, λ = 254 
nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +161.2 (c 1.10, CHCl3); 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.69 (s, 9H), 4.73 (d, J = 7.0 Hz, 1H), 
5.26 (d, J = 7.0 Hz, 1H), 5.93 (d, J = 7.6 Hz, 1H), 6.68 (t, J = 7.6 Hz, 1H), 7.17 (t, J = 
7.9 Hz, 1H), 7.40-7.50 (m, 4H), 7.69 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 
7.89 (t, J = 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 38.8, 40.0, 71.8, 85.3, 
115.3, 120.4, 122.2, 123.0, 124.1, 124.9, 125.6, 126.5, 126.8, 127.3, 128.8, 129.0, 
129.8, 132.2, 133.7, 140.1, 148.9, 168.5; The ee value is 97%, tR (minor) = 13.30 min, 
tR (major) = 11.14 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 
1.0 mL/min); [α]24D = +49.5 (c 0.68, CHCl3); HRMS (ESI) m/z calcd for 
C25H22N2O5Na [M+Na]+ = 453.1421, found = 453.1433. 
(1S,2R,3S)-tert-Butyl-2-(naphthalen-2-yl)-3-nitro-2'-oxospiro[cyclopropane-1,3'-ind
oline]-1'-carboxylate 4-4l 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.67 (s, 9H), 4.59 (d, J = 7.0 Hz, 1H), 
5.22 (d, J = 7.0 Hz, 1H), 5.86 (d, J = 8.2 Hz, 1H), 6.74 (dd, J = 1.9 Hz, 8.2 Hz, 1H), 
7.17 (dd, J = 1.9 Hz, 8.2 Hz, 1H), 7.54-7.55 (m, 2H), 7.75 (s, 1H), 7.80-7.82 (m, 4H), 
8.05 (d, J = 1.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.5, 40.7, 71.4, 85.7, 
116.2, 120.4, 121.8, 124.3, 126.4, 126.5, 127.0 127.1, 127.8, 127.9, 128.4, 129.3, 
133.1, 133.2, 135.1, 141.1, 148.7, 168.1; The ee value is 96%, tR (minor) = 14.13 min, 
tR (major) = 22.39 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 
1.0 mL/min); [α]24D = +235.4 (c 0.65, CHCl3); HRMS (ESI) m/z calcd for 











A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.27 (d, J = 6.9 Hz, 1H), 
5.10 (dd, J = 2.5 Hz, 6.6 Hz, 1H), 5.94 (d, J = 7.6 Hz, 1H), 6.88 (t, J = 7.6 Hz, 1H), 
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7.30-7.35 (m, 4H), 7.95 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 38.4, 
39.6, 70.9, 85.2, 115.6, 119.9, 121.6, 124.2, 126.6, 127.6, 129.3, 130.1, 130.9, 135.8, 
136.9, 140.4, 148.8, 168.0; The ee value is 94%, tR (minor) = 9.99 min, tR (major) = 
7.61 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); 
[α]24D = +109.1 (c 0.87, CHCl3); HRMS (ESI) m/z calcd for C21H18N2O5Cl2Na 




A white solid; 1H NMR (500 MHz, CDCl3) δ 1.64 (s, 9H), 4.33 (d, J = 6.3 Hz, 1H), 
5.13 (d, J = 6.3 Hz, 1H), 5.81 (d, J = 2.5 Hz, 1H), 7.24-7.31 (m, 2H), 7.41-7.46 (m, 
2H), 7.54 (d, J = 8.2 Hz, 1H), 7.91 (d, J = 8.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 28.1, 39.5, 41.6, 71.3, 85.5, 116.6, 120.2, 123.7, 126.4, 128.0, 129.0, 129.1, 129.5, 
130.1, 130.8, 133.5, 139.0, 148.7, 167.5; The ee value is 98%, tR (minor) = 9.95 min, 
tR (major) = 6.50 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 
mL/min); [α]24D = +93.4 (c 1.10, CHCl3); HRMS (ESI) m/z calcd for 
C21H18N2O5Na79BrCl [M+Na]+ = 514.9980, found = 515.0000; calcd for 
C21H18N2O5Na81BrCl [M+Na]+ = 516.9959, found = 516.9977. 
(1S,2S,3S)-tert-Butyl-2-(2-bromophenyl)-6'-chloro-3-nitro-2'-oxospiro[cyclopropane
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.65 (s, 9H), 4.31 (d, J = 6.9 Hz, 1H), 
5.13 (d, J = 7.0 Hz, 1H), 5.79 (d, J = 8.2 Hz, 1H), 6.81 (dd, J = 1.9 Hz, 8.2 Hz, 1H), 
7.28 (t, J = 4.1 Hz, 1H), 7.40-7.42 (m, 2H), 7.52 (d, J = 8.2 Hz, 1H), 8.02 (d, J = 1.9 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.1, 39.6, 41.5, 71.2, 85.7, 116.3, 120.3, 
120.6, 124.1, 126.4, 127.9, 129.4, 130.1, 130.7, 133.5, 135.2, 141.2, 148.7, 167.7; The 
ee value is 97%, tR (minor) = 10.86 min, tR (major) = 6.65 min (Chiralcel IC, λ = 254 
nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); [α]24D = +146.3 (c 1.13, CHCl3); 
HRMS (ESI) m/z calcd for C21H18N2O5Na79BrCl [M+Na]+ = 514.9980, found = 








A colorless oil; 1H NMR (500 MHz, CDCl3) δ 0.82 (d, J = 7.0 Hz, 1H), 0.90-0.93 (m, 
5H), 1.67 (s, 9H), 3.04-3.09 (m, 1H), 4.60 (d, J = 7.0 Hz, 1H), 6.94 (d, J = 7.6 Hz, 
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1H), 7.17-7.20 (m, 1H), 7.37-7.41 (m, 1H), 8.00 (d, J = 8.2 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 14.1, 22.0, 22.2, 27.9, 28.1, 33.3, 36.6, 36.8, 37.1, 38.4, 69.8, 72.6, 
84.4, 85.0, 115.1, 115.3, 115.7, 118.0, 120.9, 122.9, 123.2, 124.2, 124.6, 128.1, 128.7, 
128.9, 140.4, 141.0, 148.9, 149.2, 169.1, 173.2; The ee value is 92%, tR (minor) = 
6.39 min and 7.02 min, tR (major) = 7.71 min and 15.96 min (Chiralcel IC, λ = 254 
nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 








A white solid; 1H NMR (500 MHz, CDCl3) δ 1.63 (s, 9H), 1.88-1.96 (m, 1H), 
2.14-2.21 (m, 1H), 2.59-2.69 (m, 1H), 2.75-2.79 (m, 1H), 3.04-3.08 (m, 1H), 4.50 (d, 
J = 6.9 Hz, 1H), 6.86 (d, J = 7.6 Hz, 1H), 7.02-7.07 (m, 2H), 7.12-7.17 (m, 4H), 7.35 
(t, J = 4.1 Hz, 1H), 7.92 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 22.5, 
26.0, 28.1, 34.5, 35.4, 37.4, 37.6, 38.3, 69.6, 71.8, 84.6, 84.9, 115.3, 115.7, 120.7, 
122.5, 124.1, 124.4, 128.3, 128.5, 128.6, 128.9, 139.4, 139.6, 139.7, 140.3, 148.8, 
168.8; The ee value is 91%, tR (minor) = 7.98 min and 14.03 min, tR (major) = 11.98 
min and 15.29 min (Chiralcel IC, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 
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Chapter 5 A Facile and Versatile Approach for the 
Asymmetric Synthesis of Oxindoles with a 3-Heteroatom 
-substituted Quaternary Stereocenter 
 
5.1 Introduction 
3,3-Disubstituted oxindoles are widely present in natural products and 
biologically significant molecules. 1  In particular, oxindoles  bearing a 
3-heteroatom-substituted quaternary stereogenic center are extremely important in 
medicinal chemistry (Figure 5.1),2 and thus their asymmetric synthesis has attracted 




1 For reviews, see: a) C. V. Galliford, K. A. Scheidt, Angew. Chem., Int. Ed. 2007, 46, 8748; b) A. B. Dounay,L. E. 
Overman, Chem. Rev. 2003, 103, 2945; c) G. S. Singh, Z. Y. Desta, Chem. Rev. 2012, 112, 6104; d) R. Dalpozzo, G. 
Bartoli, G. Bencivenni, Chem. Soc. Rev. 2012, 41, 7247; e) K. Shen, X. Liu, L. Lin, X. Feng, Chem. Sci. 2012, 3, 327; 
f) F. Zhou, Y.-L. Liu, J. Zhou, Adv. Synth. Catal. 2010, 352, 1381; g) B. M. Trost, M. K. Brennan, Synthesis 2009, 18, 
3003; h) C. Marti, E. M. Carreira, Eur. J. Org. Chem. 2003, 2209. 
2 For selected examples, see: (a) A. Abourriche, Y. Abboud, S. Maoufoud, H. Mohou, T. Seffaj, M. Charrouf, N. 
Chaib, A. Benamara, N. Bontemps, C. Francisco, Farmaco 2003, 58, 1351;. b) V. K. Gribkoff, D. J. Post-Munson, S. 
W. Yeola, C. G. Boissard, P. Hewawasam, PCT Int. Appl. WO 2002/030868, 2002; c) K. Bernard,S. Bogliolo, 
J.Ehrenfeld, Br. J. Pharmacol. 2005, 144, 1037; d) G. Gilles, S. L. Claudine, Stress 2003, 6, 199; e) N. Shibata, T. 
Ishimaru, E. Suzuki, K. L. Kirk, J. Org. Chem. 2003, 68, 2494; f) M. Kitajima, I. Mori, K. Arai, N. Kogure, H. 
Takayama, Tetrahedron Lett. 2006, 47, 3199; g) J. J. Badillo, N. V. Hanhan, A. K. Franz, Curr. Opin. Drug Discovery 
Dev. 2010, 13, 758; h) P. Gross, G. Sperl, R. Pamukcu, K. Brendel, PCT Int. Appl. WO 96/03987, 1996. 
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Figure 5.1 Biologically important oxindoles/indoline with a 3-heteroatom-substituted 
quaternary center 
 
A range of synthetic methods have been developed for catalytic asymmetric 
synthesis of 3-substituted-3-heteroatom oxindoles such as 3-aminooxindoles, 3 
3-hydroxyoxindoles,4 3-fluorooxindoles,5  3-sulfenyloxindoles,6  3-chlorooxindoles7 
and 3-selenooxindoles.8 The vast majority of the above examples relied on the 
employment of common 3-aryl or alkyl-substituted oxindoles, which were then 
subjected to different heteroatom-inducing catalytic processes. Asymmetric 
introduction of a specific heteroatom to the oxindole core is not trivial, which highly 
depends on the nature of the incoming heteroatom. Therefore, a diverse set of reaction 
conditions and catalytic systems are apparently required.  Moreover, the 3-alkyl or 
                                                             
3 For amination of pro-chiral oxindoles, see: a) S. Mouri, Z. Chen, H. Mitsunuma, M. Furutachi, S. Matsunaga, M. 
Shibasaki, J. Am. Chem. Soc. 2010, 132, 1255; b) T. Bui, M. Borregan, C. F. Barbas III, J. Org. Chem. 2009, 74, 8935; 
c) L. Cheng, L. Liu, D. Wang, Y.-J. Chen, Org. Lett. 2009, 11, 3874; d) Z.-Q. Qian, F. Zhou, T.-P. Du, B.-L. Wang, M. 
Ding, X.-L. Zhao, J. Zhou, Chem. Commun. 2009, 6753. For addition to isatin-derived ketimines, see: e) J. Feng, W. 
Yan, D. Wang, P. Li, Q. Sun, R. Wang, Chem. Commun. 20012, 48, 8003; f) N. Hara, S. Nakamura, M. Sano, R. 
Tamura, Y. Funahashi, N. Shibata, Chem. Eur. J. 2012, 18, 9726. 
4 For examples using isatins as the electrophile, see: a) Y.-L. Liu, J. Zhou, Chem. Commun. 2012, 48, 1919; b) J. 
Guang, Q. Guo, J. C.-G. Zhao, Org. Lett. 2012, 14, 3174; c) L. Liu, S. Zhang, F. Xue, G. Lou, H. Zhang, S. Ma, S.; W. 
Duan, W. Wang, Chem. Eur. J. 2011, 17, 7791; d) Y.-L. Liu, B.-L. Wang, J.-J. Cao, L. Chen, Y.-X. Zhang, C. Wang, J. 
Zhou, J. Am. Chem. Soc. 2010, 132, 15176; e) J. Itoh, S. B. Han, M. J. Krische, Angew. Chem. Int. Ed. 2009, 48, 6313; 
f) D. Tomita, K. Yamatsugu, M. Kanai, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 6946; g) T. Itoh, H. Ishikawa, Y. 
Hayashi, Org. Lett. 2009, 11, 3854; h) R. Shintani, M. Inoue, T. Hayashi, Angew. Chem. Int. Ed. 2006, 45, 3353. For 
hydroxylation of benzoyloxylation of pro-chiral oxindoles, see: i) Y.-H. Liao, Z.-J. Wu, W.-Y. Han, X.-M. Zhang, 
W.-C. Yuan, Chem. Eur. J. 2012, 18, 8916; j) Z. Zhang, W. Zheng, J. C. Antilla, Angew. Chem. Int. Ed. 2011, 50, 1135; 
k) T. Bui, N. R. Candeias, C. F. Barbas III, J. Am. Chem. Soc. 2010, 132, 5574; l) T. Ishimaru, N. Shibata, J. Nagai, S. 
Nakamura, T. Toru, S. Kanemasa, J. Am. Chem. Soc. 2006, 128, 16488. For examples employing 3-OH-oxindoles, 
see: m) G. Bergonzini, P. Melchiorre, Angew. Chem. Int. Ed. 2012, 51, 971; n) M. Retini, G. Bergonzini, P. 
Melchiorre, Chem. Commun. 20012, 48, 3336. 
5 a) L. Wu, L. Falivene, E. Drinkel, S. Grant, A. Linden, L. Cavallo, R. Dorta, Angew. Chem. Int. Ed. 2012, 51, 2870; 
b) Y. Li, Y. Cai, W. Chen, X. Liu, L. Lin, X. Feng, J. Org. Chem. 2012, 77, 9148; c) Q.-H. Deng, H. Wadepohl, L. H. 
Gade, Chem. Eur. J. 2011, 17, 14922; d) T. Ishimaru, N. Shibata, T. Horikawa, N. Yasuda, S. Nakamura, T. Toru, M. 
Shiro, Angew. Chem. Int. Ed. 2008, 47, 4157; e) Y. Hamashima, T. Suzuki, H. Takano, Y. Shimura, M. Sodeoka, J. 
Am. Chem. Soc. 2005, 127, 10164; f) N. Shibata, J. Kohno, K. Takai, T. Ishimaru, S. Nakamura, T. Toru, S. 
Kanemasa, Angew. Chem. Int. Ed. 2005, 44, 4204; g) L. Zoute, C. Audouard, J.-C. Plaquevent, D. Cahard, Org. 
Biomol. Chem. 2003, 1, 1833; h) N. Shibata, E. Suzuki, T. Asahi, M. Shiro, J. Am. Chem. Soc. 2001, 123, 7001. 
6 a) C. Wang, X. Yang, C. C. J. Loh, G. Raabe, D. Enders, Chem. Eur. J. 2012, 18, 11531; b) X. Li, C. Liu, X.-S. Xue, 
J.-P. Cheng, Org. Lett. 2012, 14, 4374; c) Z. Han, W. Chen, S. Dong, C. Yang, H. Liu, Y. Pan, L. Yan, Z. Jiang, Org. 
Lett. 2012, 14, 4670; d) Y. Cai, J. Li, W. Chen, M. Xie, X. Liu, L. Lin, X. Feng, Org. Lett. 2012, 14, 2726. 
7 a) W. Zheng, Z. Zhang, M. J. Kaplan, J. C. Antilla, J. Am. Chem. Soc. 2011, 133, 3339; b) D. Wang, J.-J. Jiang, R. 
Zhang, M. Shi, Tetrahedron: Asymmetry 2011, 22, 1133; c) M.-X. Zhao, Z.-W. Zhang, M.-X. Chen, W.-H. Tang, M. 
Shi, Eur. J. Org. Chem. 2011, 3001. Also see ref. 5f. 
8 V. Marcos, J. Alemán,J. L. G. Ruano, F. Marini, M. Tiecco, Org. Lett. 2011, 13, 3052. 
Chapter 5 3-Heteroatom-substituted Oxindoles 
- 132 - 
 
aryl-substituted prochiral oxindoles are commonly prepared from isatins. Such a 
preparation suffers from several key drawbacks, 9  including: employment of 
expensive isatins, poor functional group tolerance under Grignard conditions, as well 































R = aryl or alkyl
 
Scheme 5.1 Common methods for the synthesis of 3-heteroatom-substituted oxindoles  
 
Our group has been actively investigating asymmetric synthesis of chiral 
oxindole derivatives, particularly those bearing a quaternary stereogenic center. Given 
the biological significance of oxindoles containing a 3-heteroatom-substituted 
quaternary carbons, we became very interested in developing an efficient and   
versatile synthetic strategy to access a variety of these heteroatom containing chiral 
oxindoles. To make our method practical and synthetically useful, employment of 
cheap and readily available starting materials would be desirable. Moreover, 
asymmetry-inducing processes should ideally be promoted by similar catalytic 
systems.  
                                                              
9 For a representative preparation of 3-alkyl/aryl-substituted oxindoles from isatins, see the Supporting Information 
of ref. 5e. 
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Scheme 5.2 Our approach to access 3-heteroatom-3-substituted oxindoles 
 
With the above designing principles in mind, we turned our attention to 
3-chlorooxindoles as a key intermediate. Various 3-chlorooxindoles could be readily 
derived from nitroolefins,10 a method was reported more than 30 years ago, but did 
not draw much attention from the synthetic community. Ready availability and 
inexpensive nature of nitroolefins make the derivatization of the corresponding 
3-chlorinated oxindoles highly economical. We hypothesize their reactions with 
nucleophiles would install different heteroatoms at the 3-position of oxindoles. 
Alternatively, reactions of 3-chlorooxindoles with electrophiles, followed by reductive 
de-chlorination would also allow for the incorporation of the heteroatoms at the 
3-position. The reactions of different 3-heteroatom substituted oxindoles with carbon 
electrophiles then create the desired quaternary chiral centers in the oxindole 
structures. Presumably, when a given electrophilic reaction partner is employed, the 
projected carbon carbon bond forming reactions of different 3-heteroatom-substituted 
                                                             
10 a) P. Demerseman, J. Guillaumel, J.-M. Clavel, R. Royer, Tetrahedron Lett. 1978, 23, 2011; b) J. Guillaumel, P. 
Demerseman, J.-M. Clavel, R. Royer, Tetrahedron 1980, 36, 2459; c) J. Guillaumel, P. Demerseman, J.-M. Clavel, R. 
Royer, J. Heterocyclic Chem. 1980, 17, 1531. 
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oxindoles may be promoted by similar catalytic systems (Scheme 5.2), which will 
make this approach highly versatile. Herein, we describe preparation of various 
3-heteroatom-substituted (including Cl, O, S, F, N) oxindoles, and their catalytic 
reactions with nitroolefins11 for the facile asymmetric synthesis of oxindoles bearing 
a heteroatom-containing quaternary stereogenic center. 
 
5.2 Results and Discussion 
5.2.1 Reaction Optimization for the Synthesis of Chiral 3-Chlorooxindoles 
We first examined the conjugate addition of unprotected 3-chlorooxindole 5-1a 
to nitroolefin 5-2a in the presence of different bifunctional catalysts, and the results 
are summarized in Table 5.1. For the selection of organic catalysts, we firstly tested 
the bifunctional tertiary amine thiourea catalyst. When quinine-derived tertiary 
amine thiourea catalyst 5-4 was used, the reaction was fast, however, both 
diastereoselectivity and enantioselectivity were modest (entry 1). To further improve 
the results, we chose to employ our recently developed amino acid incorporating 
multifunctional catalysts. 12  Gratifyingly, all the multifunctional catalysts could 
efficiently promote the reaction, affording the desired products in high yields and with 
very high diastereoselectivities. Incorporation of silylated L-threonine backbone to the 
catalyst structure resulted in a series of multifunctional catalysts, essential for further 
                                                              
11 For examples of conjugate addition of 3-alkyl or aryl-substituted oxindoles to nitroolefins, see: a) M. Ding, F. 
Zhou, Y.-L. Liu, C.-H. Wang, X.-L. Zhao, J. Zhou, Chem. Sci. 2011, 2, 2035; b) Y.-Y. Han, Z.-J. Wu, W.-B. Chen, 
X.-L. Du, X.-M. Zhang, W.-C. Yuan, Org. Lett. 2011, 13, 5064; c) X. Li, B. Zhang, Z.-G. Xi, S. Luo, J.-P. Cheng, Adv. 
Synth. Catal. 2010, 352, 416; d) M. Ding, F. Zhou, Z.-Q. Qian, J. Zhou, Org. Biomol. Chem. 2010, 8, 2912; e) T. Bui, 
S. Syed, C. F. Barbas III, J. Am. Chem. Soc. 2009, 131, 8758; f) Y. Kato, M. Furutachi, Z. Chen, H. Mitsunuma, S. 
Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2009, 131, 9168; g) R. He, S. Shirakawa, K. Maruoka, J. Am. Chem. 
Soc. 2009, 131, 16620. 
12 a) Q. Zhu, Y. Lu, Angew. Chem. Int. Ed. 2010, 49, 7753; b) X. Dou, Y. Lu, Chem. Eur. J. 2012, 18, 8315; c) F. 
Zhong, J. Luo, G.-Y. Chen, X. Dou,Y. Lu, J. Am. Chem. Soc. 2012, 134, 10222; d) J. Luo, H. Wang, F. Zhong, J. 
Kwiatkowski, L.-W. Xu, Y. Lu, Chem. Commun. 2012, 48, 4707. 
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improvement of the enantioselectivity. It should be noted that the multifunctional 
catalysts utilized are structurally highly tunable, which is crucial for achieving the 
optimal interactions with different substrates during the reaction. Catalyst 5-9 which 
contains an O-TBDPS-L-threonine moiety turned out to be the best catalyst, affording 
5-3a in quantitative yield, excellent diastereoselectivity and enantioselectivity (entry 
6). When the reaction was performed at 0 oC in the presence of 5 mol% 5-9 under the 
optimized reaction conditions, adduct 5-3a was obtained in 98% yield, with >20:1 dr 
and 97% ee (entry 8).   
 
Table 5.1 Conjugate Addition of 3-Chlorooxindole 5-1a to Nitroolefin 5-2a Catalyzed by 






























5-6: R/R' = H/TBS
5-7: R/R' = H/TDS
5-8: R/R' = H/TBDPS






















entry cat. t (h) yield (%)b drc ee (%)d 
1 5-4 2 94 4:1 68 
2 5-5 1 90 19:1 74 
3 5-6 2 85 >20:1 84 
4 5-7 2.5 91 20:1 75 
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5 5-8 1 97 >20:1 94 
6 5-9 1 99 >20:1 95 
7e 5-9 5 98 >20:1 95 
8e,f 5-9 8 98 >20:1 97 
a Reactions were performed with 5-1a (0.1 mmol), 5-2a (0.12 mmol) and the catalyst (0.01 mmol) 
in toluene (1.0 mL) at room temperature. b Isolated yield. c Determined by 1H NMR analysis of the 
crude products. d The ee values of the major isomer, determined by HPLC analysis on a chiral 
stationary phase. e 5 mol % 5-9 was used. f Reaction was performed at 0 oC. 
 
5.2.2 Substrate Scope for the Synthesis of Chiral 3-Chlorooxindoles 
With the optimized reaction conditions in hand, the substrate scope was next 
examined (Table 5.2). Different aryl nitroolefins could be employed, including 
aromatic rings with different halogen substitutions, substituents with different 
electronic nature, as well as different substitution patterns (entries 112). Moreover, 
aryls other than phenyls could also be employed in the nitroolefin structures (entries 
1316). The reaction was also applicable to 3-chlorooxindoles containing different 
aromatic moieties (entries 1719). Alkyl nitroolefin could also be employed, the 
desired product was obtained with excellent diastereoselectivity and enantioselectivity, 
although the reaction was substantially slower and the yield was moderate (entry 20). 
In all the examples examined, nearly perfect diastereoselectivities and 
enantioselectivities were attainable.  In addition, synthesis of 5-3a was scaled up to 2 
mmol, and the yield, diastereo- and enantio- selectivities of the reaction were 
maintained (entry 1a). The absolute configurations of 3-chloro-3-substituted oxindole 
products were determined on the basis of the X-ray crystal structure of 5-3b.  
 
Table 5.2 Substrate Scope of the Conjugate Addition of 3-Chlorooxindoles to Nitroolefinsa 
PHD DISSERTATION 2013                                DOU XIAOWEI 






















entry R/R', 5-3 t (h) yield/%b drc ee/%d 
1 H/C6H5, 5-3a 8 98 >20:1 97 
1ae H/C6H5, 5-3a 12 96 >20:1 95 
2 H/2-Br-C6H4, 5-3b 8 99 >20:1 96 
3 H/3-Br-C6H4, 5-3c 12 94 >20:1 96 
4 H/4-Br-C6H4, 5-3d 10 98 >20:1 93 
5 H/2-Cl-C6H4, 5-3e 10 95 >20:1 94 
6 H/3-Cl-C6H4, 5-3f 16 91 >20:1 98 
7 H/4-Cl-C6H4, 5-3g 10 99 >20:1 98 
8 H/4-F-C6H4, 5-3h 12 99 >20:1 94 
9 H/2-Me-C6H4, 5-3i 22 98 >20:1 98 
10 H/4-Me-C6H4, 5-3j 12 98 >20:1 99 
11 H/3,4-OMeC6H3, 5-3k 24 99 >20:1 97 
12 H/4-CN-C6H4, 5-3l 8 99 >20:1 98 
13 H/1-naphthyl, 5-3m 20 98 >20:1 99 
14 H/2-naphthyl, 5-3n 18 99 >20:1 96 
15 H/2-furyl, 5-3o 18 95 >20:1 99 
16 H/2-thienyl, 5-3p 18 99 >20:1 97 
17 4-Cl/C6H5, 5-3q 24 95 12:1 99 
18 5-Cl/ C6H5, 5-3r 12 97 >20:1 99 
19 5-Cl/2-Br-C6H4, 5-3s 12 99 >20:1 98 
20f H/phenethyl, 5-3t 48 53 13:1 99 
a Reactions were performed with 5-1 (0.1 mmol), 5-2 (0.12 mmol) and the catalyst 5-9 (0.005 
mmol) in toluene (1.0 mL) at 0 oC. b Isolated yield. c Determined by 1H NMR analysis of the crude 
products. d Determined by HPLC analysis on a chiral stationary phase, ee value of the major 
isomer. e Reaction was performed on a 2.0 mmol scale. f 10 mol % 5-9 was used and reaction was 
performed at room temperature. 
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5.2.3 Facile Synthesis of Various 3-Heteroatom-substituted Oxindoles 
Having demonstrated that 3-chloro-substituted oxindoles could be 
asymmetrically added to nitroolefins, our next goal was to show that similar 
asymmetric processes may be applicable to various 3-heteroatom-substituted oxindole 
pronucleophiles. We envisioned that 3-chlorooxindole could serve as a versatile 
starting material to derivatize various 3-heteroatom containing oxindoles. It is 
noteworthy that a general method for the preparation of pronucleophilic oxindoles 
with a 3-substituted heteroatom is unknown in the literature.13 As illustrated in 
Scheme 5.3, when 3-chlorooxindole 5-1a reacted with a range of nucleophiles, 
nucleophilic substitutions took place readily to afford 3-sulfur, oxygen, or nitrogen 
substituted oxindoles (5-10-12). For the synthesis of 3-fluorooxindole, 
3-chlorooxindole 5-1a was subjected to an electrophilic fluorination, followed by 




13 For some isolated examples, see: a) P. L. Creger, J. Org. Chem. 1965, 30, 3610; b) L. A. McAllister, S. Brand, R. 
Gentile, D. J. Procter, Chem. Commun. 2003, 2380; c) M. Miller, W. Tsang, A. Merritt, D. J. Procter, Chem. Commun. 
2007, 498. 
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i: MeOH, reflux, 10 h; ii: BnOH, 100 oC, 3 h; iii: BnSH, K2CO3, DMF, 50 oC,













































(28% for 2 steps)
a: NFSI, DBU, CH2Cl2, 5 min; b: Pd/C, H2, EtOAc, 1 h;
c: Boc2O/DMAP, CH2Cl2,15 min; d: Pd/C, H2, EtOAc, 30 min.  
Scheme 5.3 Synthesis of various 3-heteroatom-substituted prochiral oxindoles 
 
5.2.4 Substrate Scope for the Synthesis of Chiral 3-Heteroatomoxindoles 
5-9 Catalyzed asymmetric conjugate additions of various above-prepared 
3-heteroatom-substituted oxindoles to nitroolefin 5-2a were then tested, and the 
results are summarized in Table 5.3. When 3-oxygenated oxindole 5-10a was 
employed, excellent yield, high diastereoselectivity and enantioselectivity were 
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attainable, although the reaction took 30 hours to complete (entry 1). With the 
employment of 3-OBn oxindole 5-10b, the reactivity was substantially improved, and 
product was obtained with very high diastereomeric ratio and nearly perfect ee value 
(entry 2). Sulfur-containing oxindoles also proved to be suitable pronucleophiles, and 
they reacted with nitroolefin to furnish the desired Michael products in high chemical 
yields, excellent diastereomeric and enantiomeric selectivities (entries 34). 
3-Fluoro-substituted oxindoles were found to be difficult substrates. With the 
employment of 3-F-oxindole 5-14, the adduct was obtained in high yield and with 
high diastereoselectivity, however, virtually no enantioselectivity was observed (entry 
5). With the employment of 3-fluorinated N-Boc protected oxindole 5-16, moderate 
enantioselectivity and decreased diastereoselectivity were obtained (entry 6). Another 
substrate unsuitable for the current catalytic system was 3-nitrogen-oxindole 5-12, 
and no reaction was observed, probably due to the low reactivity of 5-12 (entry 7). 
 
Table 5.3 Substrate Scope of the Conjugate Addition of 3-Heteroatom-substituted Oxindoles 
to Nitroolefinsa 
+ NO2















entry X, 5-17 t (h) yield (%)b drc ee (%)d 
1e OMe, 5-17a 30 94 9:1 86 
2 OBn, 5-17b 3 96 >20:1 98 
3 n-BuS, 5-17c 2 95 >20:1 91 
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4 BnS, 5-17d 1.5 98 19:1 97 
5e F, 5-17e 48 92 10:1 3 
6f F, 5-17f 4 87 4:1 55 
7g Bn2N 24 - - - 
a Reactions were performed with 3-X-oxindole (0.1 mmol), 5-2 (0.12 mmol) and the catalyst 5-9 
(0.005 mmol) in toluene (1.0 mL) at room temperature. b Isolated yield. c Determined by 1H NMR 
analysis of the crude products. d Determined by HPLC analysis on a chiral stationary phase, ee 
value of the major isomer. e 10 mol % 5-9 was used. f 5-16 was used in the reaction. g No reaction 
took place after 24 h. 
 
Sulfur-containing oxindoles showed the best reactivity and further study was 
conducted to optimize the reaction conditions (Table 5.4). Solvent screening showed 
CH2Cl2 and xylene were slightly inferior to toluene in terms of reaction time (entry 1) 
or enantioselectivity (entry 3). Surprisingly, THF showed to be unsuitable in this 
reaction, there was only very low conversion after 12 h (entry 2). Additive studies 
proved 4 Å molecular sieves was beneficial and could slightly improve the 
diastereoselectivity while maintain the ee value (entries 46). Catalyst loading could 
be reduced to as low as 1 mol % to promote the reaction efficiently without 
sacrificing the diastereoselectivity and enantioselectivity (entries 78).  Even lower 
catalyst loading 0.5 mol % could be reached with slightly lower dr and ee values 
(entry 9).  
 
Table 5.4 Asymmetric Conjugate Addition of 3-Sulfenyloxindole 5-11b to Nitroolefin 5-2a 
under Different Conditionsa 
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entry x solvent additive t (h) yield (%)b drc ee (%)d 
1 5 CH2Cl2 none 4 93 >20:1 97 
2 5 THF none 12 88 <10 n.d. 
3 5 xylene none 1.5 96 >20:1 96 
4 5 toluene 3Å MS 1.5 75 19:1 97 
5 5 toluene 4Å MS 1.5 72 >20:1 97 
6 5 toluene 5Å MS 1.5 78 >20:1 96 
7 2.5 toluene 4Å MS 3 85 >20:1 97 
8 1 toluene 4Å MS 8 96 >20:1 97 
9 0.5 toluene 4Å MS 15 97 19:1 95 
a Reactions were performed with 5-11a (0.1 mmol), 5-2a (0.12 mmol), and the 5-9 (x mol %) in 
solvent (1.0 mL) at room temperature b Isolated yield. c Determined by 1H NMR. d Determined by 
HPLC analysis on a chiral stationary phase, ee value of the major isomer. 
 
With the optimal reaction conditions in hand, we next examined the substrate 
scope of the conjugate addition of 3-sulfenyloxindole to nitroolefins 5-2. As shown in 
Table 5.5, different aryl nitroolefins could be employed, including aromatic rings with 
different halogen substitutions, substituents of different electronic nature, as well as 
different substitution patterns (entries 15). Aryls other than phenyls could also be 
employed in the nitroolefin structures (entries 67). The reaction was also applicable 
to 3-sulfenyloxindoles containing different aromatic moieties (entries 89) and thio 
substitutions (entries 1011). Moreover, alkyl nitroolefin could also be employed, and 
the desired product was obtained with excellent diastereoselectivity and 
enantioselectivity, although the yield was slightly lower (entry 1213). In all the 
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examples examined, very high diastereoselectivities (14:1 to >20:1 dr) and 
enantioselectivities (up to 99% ee) were attainable.  
 







5-9 (1 mol %)









entry R1/R2/R3, 5-17 t (h) yield (%)b drc ee (%)d 
1 H/Bn/C6H5, 5-17d 8 98 >20:1 97 
2 H/Bn/2-Br-C6H4, 5-17e 10 95 14:1 99 
3 H/Bn/3-Br-C6H4, 5-17f 12 98 >20:1 97 
4 H/Bn/4-Cl-C6H4, 5-17g 12 98 >20:1 97 
5 H/Bn/4-Me-C6H4, 5-17h 16 97 >20:1 97 
6 H/Bn/2-naphthyl, 5-17i 10 99 >20:1 98 
7 H/Bn/2-furyl, 5-17j 12 96 19:1 96 
8 5-Me/Bn/C6H5, 5-17k 12 97 >20:1 98 
9 6-Cl/Bn/C6H5, 5-17l 10 95 19:1 96 
10 H/n-Bu/C6H5, 5-17c 12 95 >20:1 91 
11 H/n-Bu/3-Br-C6H4, 5-17m 12 97 >20:1 90 
12e H/Bn/n-butyl, 5-17n 12 81 19:1 98 
13e H/Bn/phenethyl, 5-17o 12 84 16:1 98 
a Reactions were performed with 5-11 (0.1 mmol), 5-2 (0.12 mmol), 5-9 (0.001 mmol) and 4Å MS 
(10 mg) in toluene (1 mL) at room temperature. b Isolated yield. c Determined by 1H NMR. d 
Determined by HPLC analysis on a chiral stationary phase, ee value of the major isomer. e 5 mol % 
catalyst loading. 
 
5.2.5 Introducing a Heteroatom to 3-Chlorinated Oxindole Adduct 
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We reasoned the Michael adduct 5-3a, which contains a chlorine atom at the 
3-quaternary carbon, may be utilized to construct oxindoles with other heteroatoms, 
especially for those structures not accessible through the previous attempts (Table 5.3, 
entries 57). The chloride at the 3-position may undergo an SN2 displacement to yield 
other heteoatom-substituted oxindoles.14 Alternatively, the chlorine atom may be 
reductively cleaved, followed by reaction with a suitable electrophile for the 
installation of the desired heteroatom. As illustrated in Sheme 5.4, when chloride 5-3a 
was treated under hydrogenation conditions, cleavage of the chlorine atom occurred 
smoothly, and the subsequent reaction with electrophilic fluorinating NFSI yielded 
3-fluoro-substituted oxindole 5-17e with a 4:1 diastereomeric ratio and a 95% ee. 
Similarly, N-Boc-3-Cl-oxindole 5-18 was converted to 3-bromo-substituted oxindole 
5-19. Although 19 was obtained with a low dr ratio, but the diastereomers could be 
separated, and ee value was excellent. This type of 3-Br-oxindoles is a highly useful 
synthetic intermediate.15 The nucleophilic substitution of 3-chlorooxindole 5-3a with 
benzyl amine took place readily, furnishing oxindole 5-20 with a nitrogen-containing 
quaternary stereocenter at the 3-position (Scheme 5.4) 
 
                                                              
14 For a recent report on SN2 displacement of tertiary chlorides, see: K. Shibatomi, Y. Soga, A. Narayama, I. 
Fujisawa, S. Iwasa, J. Am. Chem. Soc. 2012, 134, 9836. 
15 a) L. Furst, J. M. R. Narayanam, C. R. J. Stephenson, Angew. Chem. Int. Ed. 2011, 50, 9655; b) M. Movassaghi, O. 
K. Ahmad, S. P. Lathrop, J. Am. Chem. Soc. 2011, 133, 13002; c) V. R. Espejo, X.-B. Li, J. D. Rainier, J. Am. Chem. 
Soc. 2010, 132, 8282. 
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(92% over two steps)
5-17e: 4:1 dr, 95% ee
BnNH2













5-3a: 99:1 dr, 95% ee  
Scheme 5.4 Introducing different heteroatoms to 3-chlorooxindole adduct 5-3a 
 
5.2.6 Synthetic Elaborations of Oxindoles with a 3-Substituted Heteroatom 
In addition to their potential biological significance in medicinal chemistry, the 
oxindole adducts containing a 3-heteroatom-substituted quaternary stereocenter are 
valuable synthetic intermediates.16 We carried out some simple derivatizations to 
demonstrate the values of these molecules in synthesis, which are summarized in 
Scheme 5.5. Treatment of 3-chlorooxindole 5-3a with sodium azide failed to produce 
the corresponding SN2 displacement product,14 but instead yielded spriocyclopropyl 
oxindole 5-21, a class of molecules of great biological significance.12b The reaction 
proceeded in excellent yield, and with complete retention of diastereoselectivity and 
enantioselectivity. Nucleophilic substitution of 5-3a with methanol yielded the 
3-OMe-oxindole, which was subjected directly to borane reduction to furnish 
                                                             
16 a) S. Ma, X. Han, S. Krishnan, S. C. Virgil, B. M. Stoltz, Angew. Chem. Int. Ed. 2009, 48, 8037; b) C. D. Grant, M. 
J. Krische, Org. Lett. 2009, 11, 4485; c) S. Krishnan, B. M. Stoltz, Tetrahedron Lett. 2007, 48, 7571. 
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3-substituted indole 5-22 in high yield and excellent enantiomeric excess.17 It is 
noteworthy that this transformation represents a new synthetic route to 
asymmetrically access 3-substitued indole derivatives, which are normally 
synthesized via FriedelCrafts alkylation reactions of indoles. 18  The 
3-heteroatom-substituted oxindoles can be further manipulated easily, pending on the 
need of inclusion of a specific atom in the bio-relevant molecules. As an illustrative 
example, the 3-BnS-substituted product 5-17d was subjected to further 
transformations. As the reduction of nitro group in oxindole adducts have been well 
practiced in the literature,11e,11g we oxidized 5-17d to the corresponding acid 5-23d,19 
and the subsequent esterification followed by reduction then afforded hydroxy group 
containing oxindole 5-25. However, the cyclization of hydroxyl with the amide 
carbonyl could not be realized. Alternatively, installation of a Boc group on the NH 
group of 5-24a, in combination with the subsequent LiAlH4 reduction, resulted in a 
smooth cyclization20 to yield furoindoline derivative 5-26, which is a core structure 
of an antitumor agent.2h 
 
                                                              
17 W. Wierenga, J. Griffin, M. A. Warpehoski, Tetrahedron Lett. 1983, 24, 2437. 
18 For selected reviews, see: a) S.-L. You, Q. Cai, M. Zeng, Chem. Soc. Rev. 2009, 38, 2190; b) M. Bandini, A. 
Eichholzer, Angew. Chem. Int. Ed. 2009, 48, 9608; c) T. B. Poulsen, K. A. Jorgensen, Chem. Rev. 2008, 108, 2903. 
19 C. Matt, A. Wagner, C. Mioskowski, J. Org. Chem. 1997, 62, 234. 
20 For a similar transformation, see: Z.-J. Jia, H. Jiang, J.-L. Li, B. Gschewnd, Q.-Z. Li, X. Yin, J. Grouleff, Y.-C. 
Chen, K. A. Jørgensen, J. Am. Chem. Soc. 2011, 133, 5053. 
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Scheme 5.5 Synthetic manipulations of oxindoles with a 3-substituted heteroatom 
 
5.3 Conclusions 
In conclusion, we have devised a convenient method to access various 
pronucleophilic 3-heteroatom-substituted oxindoles from 3-chlorooxindoles, which 
were readily prepared from the corresponding nitroolefins. By utilizing our amino 
acid-incorporating multifunctional catalysts, we showed that Michael addition of 
oxindoles containing 3-heteroatoms with nitroolefins proceeded in a highly 
stereoselective manner, affording the oxindoles with a 3-heteroatom-substituted 
quaternary stereogenic center in good diastereoselectivities and excellent 
enantioselectivities, and the synthetic values of oxindole adducts have also been 
demonstrated. The general implication of this report is that by careful selection of 
catalytic systems, chiral oxindoles with a 3-heteroatom containing quaternary centers 
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can be readily created by reactions of heteroatom substituted oxindole 
pronulceophiles with different electrophilic reaction partners, and progress in this 
direction is underway. Given the high importance of heteroatom-containing oxindole 
structures, synthetic potential of our methodology can be enormous, and we anticipate 
that our method could be used for practical asymmetric preparation of novel oxindole 
structures with a 3-heteroatom-substituted quaternary stereocenter.  
 
5.4 Experimental Section 
5.4.1 Material and General Methods 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. THF and diethyl ether were dried 
and distilled from sodium benzophenone ketyl prior to use. CHCl3 and CH2Cl2 were 
distilled from CaH2 prior to use. 1H and 13C NMR spectra were recorded on a Bruker 
ACF300 or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts 
per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as 
follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), br (broad singlet). Coupling constants were reported in Hertz (Hz). Low 
resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL- T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL- T spectrometer. For 
thin layer chromatography (TLC), Merck pre- coated TLC plates (Merck 60 F254) 
were used, and compounds were visualized with a UV light at 254 nm. Further 
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visualization was achieved by staining with iodine, or ceric ammonium molybdate 
followed by heating on a hot plate. Flash chromatographic separations were 
performed on Merck 60 (0.040- 0.063 mm) mesh silica gel. The enantiomeric 
excesses of products were determined by chiral-phase HPLC analysis. 
3-Cl-Oxindoles were synthesized following the literature procedure.10 
 













3-Cl-Oxindole 5-1a (167.5 mg, 1.0 mmol) was dissolved in methanol (5 mL), 
and the resulting solution was heated to reflux for 10 h. After removal of the solvent 
under reduced pressure, the residue was directly subjected to flash column 
chromatography (hexane/ethyl acetate = 2/1) to afford 5-10a as a light yellow solid 
(133.6 mg, 82% yield). 
1H NMR (500 MHz, CDCl3) δ 3.52 (s, 3H), 4.91 (s, 1H), 6.90 (d, J = 8.2 Hz, 1H), 
7.07 (t, J = 7.6 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.38 (d, J = 7.6 Hz, 1H), 9.06 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 55.9, 77.3, 110.5, 122.9, 125.1, 125.6, 130.0, 
141.6, 177.1; HRMS (ESI) m/z calcd for C9H8NO2 [M-H]- = 162.0408, found = 
162.0412. 
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3-Cl-Oxindole 5-1a (167.5 mg, 1.0 mmol) was dissolved in benzyl alcohol (5 
mL), and the resulting solution was heated to 100 oC for 3 h. The excess benzyl 
alcohol was removed by distillation under reduced pressure, and the residue was 
directly subjected to flash column chromatography (hexane/ethyl acetate = 2/1) to 
afford 5-10b as a light yellow solid (153.1 mg, 64% yield). 
1H NMR (300 MHz, CDCl3) δ 4.70 (s, 2H), 5.15 (s, 1H), 6.89 (d, J = 7.9 Hz, 1H), 
7.10 (t, J = 7.6 Hz, 1H), 7.27-7.42 (m, 7H), 8.85 (br s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 51.9, 65.3, 110.6, 123.4, 125.9, 126.2, 127.0, 127.6, 128.5, 130.5, 140.8, 




3-Cl-Oxindole (167.5 mg, 1.0 mmol) and 1-butanethiol (215 L, 2 equiv.) were 
dissolved in anhydrous DMF (5 mL) under N2 protection, K2CO3 (138 mg, 1 equiv.) 
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was added and the resulting mixture was heated at 60 oC for 1 h. After cooling to 
room temperature, water (20 mL) was added and the mixture was extracted with 
ethyl acetate (20 mL x 2). The combined organic phases were washed with brine (20 
mL x3), dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography (hexane/ethyl acetate 
= 3/1) to afford 5-11a as a yellow solid (194.5 mg, 88% yield).  
1H NMR (500 MHz, CDCl3) δ 0.84 (t, J = 7.6 Hz, 3H), 1.25-1.39 (m, 2H), 1.48-1.55 
(m, 2H), 2.44-2.50 (m, 1H), 2.65-2.70 (m, 1H), 4.30 (s, 1H), 6.92 (d, J = 7.6 Hz, 1H), 
7.06 (t, J = 7.3 Hz, 1H), 7.24 (t, J = 7.6 Hz, 1H), 7.36 (d, J = 7.6 Hz, 1H), 9.27 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 13.5, 21.9, 29.2, 31.0, 45.7, 110.1, 122.8, 125.2, 
126.8, 128.9, 141.3, 178.4; HRMS (ESI) m/z calcd for C12H14NOS [M-H]- = 220.0802, 












3-Cl-Oxindole (167.5 mg, 1.0 mmol) and benzyl thiol (176 L, 1.5 equiv.) were 
dissolved in anhydrous DMF (5 mL) under N2 protection, K2CO3 (138 mg, 1 equiv.) 
was then added and the resulting mixture was heated to 50 oC for 40 min. After 
cooling to room temperature, water (20 mL) was added and the mixture was 
extracted with ethyl acetate (20 mL x 2). The combined organic phases were washed 
Chapter 5 3-Heteroatom-substituted Oxindoles 
- 152 - 
 
with brine (20 mL x3), dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure. The residue was purified by column chromatography 
(hexane/ethyl acetate = 3/1) to afford 5-11b as a yellow solid (173.4 mg, 68% yield). 
1H NMR (500 MHz, CDCl3) δ 3.73 (d, J = 13.2 Hz, 1H), 4.09 (d, J = 12.6 Hz, 1H), 
4.23 (s, 1H), 6.91 (d, J = 7.6 Hz, 1H), 7.04 (t, J = 7.6 Hz, 1H), 7.19-7.34 (m, 7H), 
9.11 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 34.2, 44.4, 110.1, 122.7, 125.2, 126.1, 
127.3, 128.4, 129.0, 129.2, 137.1, 141.5, 178.3; HRMS (ESI) m/z calcd for 
C15H12NOS [M-H]- = 254.0645, found = 254.0639. 
 
3-(Benzylthio)-5-methylindolin-2-one 5-11c 
5-Me-3-Cl-Oxindole (91 mg, 0.5 mmol) and benzyl thiol (88 L, 1.5 equiv.) 
were dissolved in anhydrous DMF (2.5 mL) under N2 protection, K2CO3 (69 mg, 1 
equiv.) was then added and the resulting mixture was stirred at room temperature for 
1.5 h. Water (10 mL) was added and the mixture was extracted with ethyl acetate (10 
mL x 2). The combined organic phases were washed with brine (10 mL x3), dried 
over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The 
residue was purified by column chromatography (hexane/ethyl acetate = 3/1) to 
afford 5-11c as a yellow solid (108.9 mg, 81% yield). 
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1H NMR (500 MHz, CDCl3) δ 2.30 (s, 3H), 3.73 (d, J = 13.3 Hz, 1H), 4.11 (d, J = 
13.3 Hz, 1H), 4.18 (s, 1H), 6.78 (t, J = 3.8 Hz, 1H), 7.03 (d, J = 8.2 Hz, 1H), 7.07 (s, 
1H), 7.21 (t, J = 7.3 Hz, 1H), 7.28 (d, J = 6.9 Hz, 2H), 7.33 (d, J = 7.0 Hz, 2H), 5.56 
(br s, 1H); 13C NMR (125 MHz, CDCl3) δ 20.9, 34.2, 44.2, 109.7, 125.9, 126.0, 127.2, 
128.3, 129.2, 129.3, 132.3, 137.1, 138.8, 178.0; HRMS (ESI) m/z calcd for 














Same procedure as preparation of 5-11c. 70% yield, white solid. 
1H NMR (500 MHz, CDCl3) δ 3.74 (d, J = 13.2 Hz, 1H), 4.08 (d, J = 13.3 Hz, 1H), 
4.20 (s, 1H), 6.84 (d, J = 7.6 Hz, 1H), 7.20-7.23 (m, 3H), 7.28 (d, J = 7.0 Hz, 2H), 
7.32 (d, J = 8.2 Hz, 2H), 9.45 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 34.5, 44.4, 
111.2, 125.7, 127.5, 128.0, 128.2, 128.5, 129.1, 129.2, 136.8, 140.0, 178.3; HRMS 
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To a stirred solution of 3-Cl-oxindole 5-1a (167.5 mg, 1.0 mmol) in CH3CN (5 
mL) was added Bn2NH (970 L, 5 equiv.), and the resulting solution was brought to 
reflux for 3 h. Solvent was removed under reduced pressure, and the residue was 
purified by column chromatography (hexane/ethyl acetate = 4/1) to afford 5-12 as a 
light yellow solid (85.3 mg, 26% yield).  
1H NMR (500 MHz, CDCl3) δ 3.73 (d, J = 13.3 Hz, 2H), 4.02 (d, J = 13.3 Hz, 2H), 
4.36 (s, 1H), 6.86 (d, J = 7.6 Hz, 1H), 7.07 (t, J = 7.3 Hz, 1H), 7.21-7.25 (m, 3H), 
7.32-7.35 (m, 4H), 7.44-7.49 (m, 5H), 8.55 (br s, 1H); 13C NMR (125 MHz, CDCl3) 
δ 54.1, 61.1, 109.7, 122.6, 125.0, 127.1, 127.7, 128.3, 128.7, 128.9, 139.2, 141.6, 
178.9; HRMS (ESI) m/z calcd for C22H19N2O [M-H]- = 327.1503, found = 327.1515. 
 
3-Chloro-3-fluoroindolin-2-one 5-13 
To a stirred solution of 3-Cl-oxindole 5-1a (167.5 mg, 1.0 mmol) in CH2Cl2 (5 
mL) was added NFSI (347 mg, 1.1 equiv.), followed by addition of DBU (164 L, 
1.1 equiv.). The resulting solution was stirred at room temperature for 5 min. Solvent 
was removed under reduced pressure, and the residue was directly subjected to flash 
column chromatography (CH2Cl2) to afford 5-13 as a white solid (136.5 mg, 74% 
yield). 
1H NMR (500 MHz, CDCl3) δ 7.00 (d, J = 8.2 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 
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7.41 (t, J = 7.9 Hz, 1H), 7.58 (d, J = 7.6 Hz, 1H), 9.04 (br s, 1H); 13C NMR (125 
MHz, CDCl3) δ 99.6 (d, J = 254.2 Hz), 111.6, 124.2 (d, J = 1.8 Hz), 125.1 (d, J = 
20.0 Hz), 125.2, 133.0 (d, J = 1.8 Hz), 139.4 (d, J = 5.5 Hz), 169.2 (d, J = 25.5 Hz); 
19F NMR (282.38 MHz, CDCl3) δ -42.5 (s); HRMS (ESI) m/z calcd for C8H4ClFNO 
[M-H]- = 183.9971, found = 183.9966. 
3-Fluoroindolin-2-one 5-14 
To a solution of 3-Cl-3-F-oxindole 5-13 (55.6 mg, 0.3 mmol) in ethyl acetate (5 
mL) was added Pd/C (11 mg, 20%) and charged with hydrogen gas using a 
hydrogen balloon. The resulting mixture was stirred at room temperature for 1 h. 
The mixture was then filtered through celite, and the filtrate was concentrated and 
purified by column chromatography (hexane/ethyl acetate = 3/1) to afford 5-14 as a 
pink solid (45.2 mg, 51% yield). 
1H NMR (500 MHz, CDCl3) δ 5.70 (d, J = 51.1 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 
7.10 (t, J = 7.6 Hz, 1H), 7.34 (t, J = 7.9 Hz, 1H), 7.45 (d, J = 7.0 Hz, 1H), 8.90 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 85.9 (d, J = 187.7 Hz), 110.8, 123.2 (d, J = 16.4 
Hz), 123.3 (d, J = 2.7 Hz), 126.3, 131.5 (d, J = 3.7 Hz), 141.9 (d, J = 5.5 Hz), 173.2 
(d, J = 18.2 Hz); 19F NMR (282.38 MHz, CDCl3) δ -117.8 (d, J = 50.5 Hz); HRMS 
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tert-Butyl 3-fluoro-2-oxoindoline-1-carboxylate 5-16 
To a stirred solution of 3-Cl-3-F-oxindole 5-13 (55.6 mg, 0.3 mmol) in CH2Cl2 
(2.5 mL) under N2 protection were added DMAP (3.5 mg, 10 mol %) and Boc2O 
(72.0 mg in 0.5 mL CH2Cl2, 1.1 equiv.). After stirring at room temperature for 15 
min, the reaction solution was subjected to a short pad of silica gel (using CH2Cl2 as 
eluent). The filtrate was concentrated, and the residue was used for next step without 
further purification. The residue was dissolved in ethyl acetate (5 mL), Pd/C (17 mg, 
20%) was added and the reaction mixture was charged with hydrogen gas using a 
hydrogen balloon. The resulting mixture was stirred at room temperature for 0.5 h. 
The mixture was filtered through celite and the filtrate was concentrated and purified 
by column chromatography (hexane/ethyl acetate = 8/1) to afford 5-16 as a white 
solid (21.1 mg, 28% yield for two steps). 
A white solid; 1H NMR (500 MHz, CDCl3) δ 1.63 (s, 9H), 5.70 (d, J = 51.1 Hz, 1H), 
7.22 (t, J = 7.6 Hz, 1H), 7.43 (t, J = 7.9 Hz, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.87 (d, J 
= 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.0, 85.0 (d, J = 187.7 Hz), 85.1, 
115.6, 121.8 (d, J = 16.4 Hz), 125.0 (d, J = 2.7 Hz), 125.9, 131.7 (d, J = 2.7 Hz), 
140.9 (d, J = 4.6 Hz), 148.7, 169.0 (d, J = 17.3 Hz); 19F NMR (282.38 MHz, CDCl3) 
δ -111.1 (d, J = 51.6 Hz); HRMS (ESI) m/z calcd for C13H14FNO3Na [M+Na]+ = 
274.0850, found = 274.0860. 
 
5.4.3 Representative Procedure 
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+ NO2
















3-Cl-Oxindole 5-1 (0.1 mmol) was added to a solution of nitroolefin 5-2 (0.12 
mmol) and catalyst 5-9 (4.7 mg, 0.005 mmol) in toluene (1.0 mL) in a sample vial at 
0oC, and the resulting mixture was sealed and stirred at 0 oC for the time specified in 
Table 5.2. At the end of the reaction, the reaction solution was concentrated in vacuo 
to yield the crude product, which was purified by flash column chromatography 
(hexane/ethyl acetate = 5:2) to afford the desired adducts 5-3 (53%99% yield). The 
enantiomeric excessess of 5-3 were determined by chiral HPLC analysis.  
+ NO2















3-X-Oxindole (0.1 mmol) was added to a solution of nitroolefin 5-2a (0.12 mmol) 
and catalyst 5-9 (5 mol %) in toluene (1.0 mL) in a sample vial at room temperature, 
and the resulting mixture was sealed and stirred for the time specified in Table 5.3. At 
the end of the reaction, the reaction solution was concentrated in vacuo to yield the 
crude product, which was purified by flash column chromatography to afford the 
desired adducts 3-X-3-R-oxindoles 5-17. The enantiomeric excessess of products 
were determined by chiral HPLC analysis.  
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3-S-Oxindole 5-11 (0.1 mmol) was added to a mixture of nitroolefin 5-2 (0.12 
mmol), 4Å molecular seives (10 mg) and catalyst 5-9 (1 mol %) in toluene (1.0 mL) 
in a sample vial at room temperature, and the resulting mixture was sealed and stirred 
for the time specified in Table 5.5. At the end of the reaction, the reaction mixture was 
directly subjected to flash column chromatography (CH2Cl2 as the eluent) to afford 
the desired adducts 3-S-3-R-oxindoles 5-17. The enantiomeric excessess of products 
were determined by chiral HPLC analysis. 
 
5.4.4 Synthetic Manipulation of 3-Heteroatom Oxindole Products 
 
3-Cl-Oxindole 5-3a (31.6 mg, 0.1 mmol) in ethyl acetate (2 mL) was added Pd/C 
(6 mg, 20%) and charged with hydrogen gas using a hydrogen balloon. The resulting 
mixture was stirred at room temperature for 0.5 h. The mixture was filtered through 
celite, the filtrate was concentrated and used for next step without further purification. 
The residue was dissolved in CH2Cl2 (1 mL) and the resulting solution was cooled to 
0 oC, NFSI (34.7 mg, 1.1 equiv.) was added to the solution, followed by the addition 
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of DBU (16.5 L, 1.1 equiv.). After stirred at 0 oC for 5 min, the solution was 
concentrated and purified by column chromatography (hexane/ethyl acetate = 3/1) to 
afford 5-17e as a white solid (27.6 mg, 92% yield for two steps). 
1H NMR (500 MHz, CDCl3) δ 4.09-4.16 (m, 1H), 5.06 (dd, J = 10.1 Hz, 13.6 Hz, 1H), 
5.67 (dd, J = 4.5 Hz, 13.9 Hz, 1H), 6.57 (d, J = 7.6 Hz, 1H), 6.83 (d, J = 7.6 Hz, 1H), 
6.93 (t, J = 7.6 Hz, 1H), 7.05-7.13 (m, 2H), 7.23-7.33 (m, 4H), 8.32 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 48.6, 48.7, 74.2 (d, J = 3.6 Hz), 93.3 (d, J = 196.8 Hz), 
110.8, 123.1 (d, J = 2.7 Hz), 123.7 (d, J = 19.1 Hz), 126.4, 128.7, 128.9, 129.4 (d, J = 
1.8 Hz), 131.8 (d, J = 2.7 Hz), 132.5, 140. 9 (d, J = 6.4 Hz) 173.5 (d, J = 24.6 Hz); 19F 
NMR (282.38 MHz, CDCl3) δ -88.9 (d, J = 21.6 Hz); The ee value was 95%, tR 
(minor) = 25.98, 32.77 min, tR (major) = 19.49, 29.03 min (Chiralcel OD-H, λ = 254 
nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 































Under N2 protection, to a stirred solution of 5-3a (63.2 mg, 0.2 mmol) in 
CH2Cl2 (2.5 mL) at 0 oC were added DMAP (2.4 mg, 10 mol %) and Boc2O (48.0 
mg in 0.5 mL CH2Cl2, 1.1 equiv.). After stirring at 0 oC for 15 min, the reaction 
solution was concentrated and purified by column chromatography (hexane/ethyl 
acetate = 7:1) to afford the 5-18 as a colorless oil. 
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1H NMR (500 MHz, CDCl3) δ 1.52 (s, 9H), 4.32 (dd, J = 3.2 Hz, 11.4 Hz, 1H), 5.11 
(dd, J = 11.4 Hz, 13.3 Hz, 1H), 5.59 (dd, J = 3.8 Hz, 13.3 Hz, 1H), 6.87 (d, J = 7.6 
Hz, 2H), 7.00 (d, J = 7.6 Hz, 1H), 7.13-7.18 (m, 3H), 7.23 (t, J = 7.6 Hz, 1H), 
7.36-7.39 (m, 1H), 7.70 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 27.8, 
51.6, 66.5, 75.1, 77.2, 85.1, 115.4, 124.8, 125.2, 128.4, 129.0, 129.2, 131.1, 131.8, 
139.1, 147.9, 170.3; HRMS (ESI) m/z calcd for C21H21ClN2O5Na [M+Na]+ = 
439.1031, found = 439.1021. 
The Boc-protected product was dissolved in ethyl acetate (2 mL), Pd/C (17 mg, 
20%) was added and the reaction mixture was charged with hydrogen gas using a 
hydrogen balloon. The resulting mixture was stirred at room temperature for 1 h. 
The mixture was filtered through celite and the filtrate was concentrated to afford 
the de-chlorinated intermediate. The crude intermediate was used for next step 
without further purification. The residue was dissolved in CH2Cl2 (2 mL), DBU (3 
L, 10 mol %) was added followed by the addition of NBS (53.4 mg, 1.5 equiv.). 
After stirring at room temperature for 30 min, the reaction mixture was concentrated 
and purified by column chromatography (hexane/ethyl acetate = 6:1) to afford the 
5-19 as a light yellow oil (58.0 mg, 63% yield for three steps). 
1H NMR (500 MHz, CDCl3) δ 1.62 (s, 9H), 4.48 (dd, J = 3.8 Hz, 11.3 Hz, 1H), 
5.51-5.62 (m, 2H), 7.00 (d, J = 6.9 Hz, 2H), 7.06-7.10 (m, 3H), 7.16-7.22 (m, 2H), 
7.53 (t, J = 7.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 28.0, 52.2, 57.3, 77.1, 115.3, 
124.6, 124.9, 125.1, 127.4, 128.7, 129.3, 130.7, 132.4, 138.1, 148.2, 171.2; The ee 
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value was 94%, tR (minor) = 10.11 min, tR (major) = 9.06 min (Chiralcel ID, λ = 254 
nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C21H2179BrNaN2O5 [M+Na]+ = 483.0526, found = 483.0527; HRMS (ESI) m/z calcd 














2:1 dr, 93%, 92% ee99:1 dr, 95% ee
91%
5-3a 5-20  
To a stirred solution of 5-3a (0.1 mmol, 31.6 mg) in THF (2.0 mL) in a round 
bottom flask under N2 was added benzyl amine (55 L, 5 equiv.), and the resulting 
solution was brought to reflux for 4 h. The solution was diluted with ethyl acetate (5 
mL) and washed with brine (5 mL x 3). The combined organic phases were dried 
over anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 2:1) to afford the 5-20 as a light 
yellow oil (35.2 mg, 91% yield). 
1H NMR (500 MHz, CDCl3) δ (mixture of diastereoisomers) (0.06.0 ppm) major 
isomer: 2.06 (br s, 1H), 3.34 (d, J = 12.5 Hz, 2H), 4.14 (dd, J = 5.0 Hz, 10.1 Hz, 1H), 
5.18 (dd, J = 10.1 Hz, 13.2 Hz, 1H), 5.44 (dd, J = 4.7 Hz, 13.5 Hz, 1H); minor isomer: 
2.33 (br s, 1H), 3.43 (t, J = 10.4 Hz, 2H), 4.03 (dd, J = 4.7 Hz, 10.4 Hz, 1H), 4.93 (dd, 
J = 10.4 Hz, 12.9 Hz, 1H), 5.64 (dd, J = 4.7 Hz, 12.9 Hz, 1H); (6.010.0 ppm) 6.68 (d, 
J = 7.6 Hz, 1H), 6.73-6.76 (m, 3H), 7.03-7.14 (m, 10H), 7.19-7.36 (m, 16H), 7.44 (d, 
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J = 6.9 Hz, 1H), 8.11 (br s, 1H, minor isomer), 8.34 (br s, 1H, major isomer); 13C 
NMR (125 MHz, CDCl3) δ (mixture of diastereoisomers) 48.6, 48.7, 50.7, 50.9, 69.0, 
70.0, 74.8, 76.0, 110.1, 110.6, 122.8, 122.9, 124.3, 125.2, 125.9, 127.2, 127.3, 127.9, 
128.0, 128.1, 128.2, 128.3, 128.4, 128.7, 128.9, 129.4, 130.1, 133.5, 139.1, 139.3, 
140.3, 141.6, 178.6, 179.5; The ee value was 92% for major isomer, tR (minor) = 10.65, 
46.11 min, tR (major) = 13.24, 15.87 min (Chiralcel IB, λ = 254 nm, 7.5% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C23H20N3O3 
[M-H]- = 386.1510, found = 386.1516. 
 
To a stirred solution of 5-3a (0.1 mmol, 31.6 mg) in DMSO (1.2 mL) in a 
sample vial was added NaN3 (19.5 mg, 3 equiv.), and the resulting mixture was 
stirred at room temperature for 12 h. The solution was diluted with ethyl acetate (5 
mL) and washed with brine (5 mL x 3). The combined organic phases were dried 
over anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 2:1) to afford the 
3-spirocyclopropyl-2-oxindole 5-21 as a white solid (24.6 mg, 93% yield). 
1H NMR (500 MHz, CDCl3) δ 4.35 (d, J = 7.0 Hz, 1H), 5.46 (d, J = 7.0 Hz, 1H), 6.89 
(d, J = 7.6 Hz, 1H), 7.10 (t, J = 7.6 Hz, 1H), 7.29-7.34 (m, 6H), 7.38 (d, J = 7.6 Hz, 
1H), 8.29 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 40.4, 41.8, 72.0, 110.3, 122.5, 
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123.0, 123.4, 128.4, 128.6, 128.9, 129.1, 129.8, 141.4, 171.4; The ee value was 94%, 
tR (minor) = 8.35 min, tR (major) = 9.20 min (Chiralcel ID, λ = 254 nm, 20% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H11N2O3 


























3-Cl-Oxindole 5-3a (31.6 mg, 0.1 mmol) was dissolved in MeOH (5 mL) and 
the resulting solution was heated to reflux for 36 h. After removal of the solvent, the 
residue was purified by column chromatography (hexane/ethyl acetate = 2/1) to 
afford 3-OMe-oxindole intermediate as a colorless oil. 3-OMe-oxindole was 
dissolved in THF (1.8 mL) and a solution of borane dimethyl sulfide complex (0.2 
mL, 2M solution in THF) was added at 0 oC. The resulting solution was then 
brought to reflux for 3 h. After cooled down to room temperature, the reaction was 
quenched by addition of MeOH and the solution was diluted with ethyl acetate (5 
mL) and washed with brine (5 mL x 3). The combined organic phases were dried 
over anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 3:1) to afford 5-22 as a light yellow 
oil (22.3 mg, 84% yield for two steps). 
1H NMR (500 MHz, CDCl3) δ 4.95 (dd, J = 8.5 Hz, 12.3 Hz, 1H), 5.08 (dd, J = 2.5 
Hz, 10.1 Hz, 1H), 5.21 (t, J = 8.2 Hz, 1H), 6.99 (s, 1H), 7.10 (t, J = 8.1 Hz, 1H), 
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7.20-7.24 (m, 1H), 7.27 (t, J = 3.2 Hz, 1H), 7.28-7.35 (m, 5H), 7.47 (d, J = 7.6 Hz, 
1H), 8.08 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 41.5, 79.5, 111.4, 114.2, 118.8, 
119.9, 121.6, 122.6, 126.0, 127.5, 127.7, 128.9, 136.4, 139.1. The ee value was 92%, 
tR (minor) = 5.56 min, tR (major) = 6.26 min (Chiralcel IC, λ = 254 nm, 20% 
iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
5-17d (121.2 mg, 0.3 mmol) was dissolved in DMSO (0.75 mL) at room 
temperature under Ar protection, NaNO2 (62.1 mg, 3 equiv.) was added, followed by 
the addition of acetic acid (190 L, 10 equiv.). The resulting mixture was heated to 
40 oC and stirred at that temperature for 16 h. 1N aqueous HCl (6 mL) was added to 
the mixture, and the resulting mixture was extracted with ethyl acetate (10 mL x 3). 
The combined organic phases were washed with brine, dried over anhydrous 
Na2SO4, concentrated and purified by column chromatography (hexane/ethyl acetate 
= 2:1) to afford the acid 5-23d as a white solid (101.5 mg, 87% yield). 
1H NMR (500 MHz, CDCl3) δ 3.93 (dd, J = 11.4 Hz, 17.1 Hz, 2H), 4.63 (s, 1H), 6.69 
(d, J = 7.6 Hz, 1H), 7.06-7.23 (m, 12H), 7.96 (d, J = 7.6 Hz, 1H), 8.28 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 33.8, 55.3, 56.6, 110.0, 123.0, 126.9, 127.2, 127.3, 128.1, 
128.3, 128.4, 129.3, 129.4, 129.9, 132.2, 135.9, 140.3, 174.7, 177.0; HRMS (ESI) m/z 
calcd for C23H18NO3S [M-H]- = 388.1013, found = 388.1019. 
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5-23d 5-24a  
Acid 5-23d (77.8 mg, 0.2 mmol) was dissolved in MeOH (1.5 mL) and the 
resulting solution was cooled to 0 oC, and TMSCHN2 (1.0 mL, 2M solution in 
hexane, 10 equiv.) was added by portions (100 L every 15 min, 10 times). The 
reaction mixture was diluted with ethyl acetate (10 mL) and water (10 mL). The 
organic layer was separated and the aqueous layer was extracted with ethyl acetate 
(8 mL x 2). The combined organic phases were washed with brine and dried over 
anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 3:1) to afford the methyl ester 
5-24a as a yellow solid (67.7 mg, 84% yield). 
1H NMR (500 MHz, CDCl3) δ 3.75 (s, 3H), 3.90 (dd, J = 12.0 Hz, 15.8 Hz, 2H), 4.60 
(s, 1H), 6.70 (d, J = 7.6 Hz, 1H), 7.05-7.07 (m, 2H), 7.11-7.23 (m, 10H), 8.01 (d, J = 
7.6 Hz, 1H), 8.51 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 33.0, 52.1, 54.9, 56.8, 109.8, 
122.7, 126.8, 127.2, 127.4, 127.9, 128.0, 128.3, 129.3, 129.7, 132.4, 136.1, 140.5, 
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5-24a (20.2 mg, 0.05 mmol) was dissolved in THF (1.0 mL) under Ar 
protection and the resulting solution was cooled to 0 oC, LiAlH4 (9.5 mg, 5 equiv.) 
was then introduced. The resulting mixture was warmed up to room temperature and 
stirred for 3 h. The reaction was quenched by addition of 1N NaOH and extracted 
with ethyl acetate (5 mL x 3). The combined organic phases were dried over 
anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 2:1) to afford the alcohol 5-25 as a 
colorless oil (18.0 mg, 96% yield). 
1H NMR (500 MHz, CDCl3) δ 3.60 (dd, J = 5.0 Hz, 9.5 Hz, 1H), 3.70 (d, J = 12.0 Hz, 
1H), 4.18 (t, J = 10.2 Hz, 1H), 4.61 (dd, J = 5.0 Hz, 11.0 Hz, 1H), 6.69 (d, J = 7.6 Hz, 
1H), 6.89 (d, J = 7.6 Hz, 2H), 7.01-7.24 (m, 10H), 7.35 (d, J = 7.6 Hz, 1H), 7.70 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 33.6, 51.8, 58.1, 63.2, 110.0, 122.7, 125.8, 127.3, 
127.7, 128.0, 128.2, 128.4, 129.3, 129.4, 136.3, 136.4, 140.5, 145.6, 177.0; HRMS 
(ESI) m/z calcd for C23H20NO2S [M-H]- = 374.1220, found = 374.1217. 
 
5-24a (40.3 mg, 0.1 mmol) was dissolved in CH2Cl2 (2.0 mL) under N2 
protection at room temperature, Boc2O (26.2 mg, 1.2 equiv.) was added, followed by 
the addition of DMAP (1.2 mg, 10 mol %). The resulting mixture was stirred at 
room temperature for 30 min. The reaction mixture was then concentrated and the 
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residue was purified by column chromatography (hexane/ethyl acetate = 7:1) to 
afford 5-24b as a colorless oil (47.3mg, 94% yield). 
1H NMR (500 MHz, CDCl3) δ 1.56 (s, 9H), 3.73 (s, 3H), 3.79 (d, J = 12.0 Hz, 1H), 
3.87 (d, J = 12.0 Hz, 1H), 4.61 (s, 1H), 7.11-7.31 (m, 12H), 7.61 (d, J = 8.2 Hz, 1H), 
7.98 (d, J = 7.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.0, 34.3, 52.2, 56.0, 56.6, 
77.2, 114.7, 124.4, 125.4, 126.5, 127.3, 128.0, 128.2, 128.4, 129.3, 129.5, 130.0, 
132.2, 135.9, 139.4, 148.5, 170.7, 172.4; HRMS (ESI) m/z calcd for C29H29NO5SNa 
[M+Na]+ = 526.1659, found = 526.1674. 
5-24b (25.2 mg, 0.05 mmol) was dissolved in THF (1.0 mL) under Ar 
protection and the resulting solution was cooled to 0 oC. LiAlH4 (9.5 mg, 5 equiv.) 
was then introduced. The resulting mixture was warmed up room temperature and 
stirred for 4 h. The reaction was quenched by addition of 1N NaOH and extracted 
with ethyl acetate (5 mL x 3). The combined organic phases were dried over 
anhydrous Na2SO4, filtered and concentrated, and the residue was purified by 
column chromatography (hexane/ethyl acetate = 6:1) to afford 5-26 as a yellow solid 
(9.5 mg, 53% yield). 
1H NMR (500 MHz, CDCl3) δ 3.15 (d, J = 12.6 Hz, 1H), 3.26 (d, J = 12.6 Hz, 1H), 
3.62 (d, J = 3.8 Hz, 1H), 3.97 (dd, J = 5.4 Hz, 9.2 Hz, 1H), 4.11 (dd, J = 1.9 Hz, 8.9 
Hz, 1H), 4.49 (s, 1H), 5.61 (s, 1H), 6.65 (d, J = 8.2 Hz, 1H), 6.90-6.95 (m, 3H), 
7.13-7.18 (m, 4H), 7.31-7.37 (m, 3H), 7.41 (d, J = 7.6 Hz, 1H), 7.50 (t, J = 4.1 Hz, 
2H); 13C NMR (125 MHz, CDCl3) δ 34.5, 57.6, 67.2, 73.0, 100.8, 109.2, 120.0, 124.6, 
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126.8, 127.5, 128.0, 128.1, 129.0, 129.1, 130.2, 137.7, 139.5, 149.6; HRMS (ESI) m/z 
calcd for C23H21NNaSO [M+Na]+ = 382.1236, found = 382.1238. 
 
5.4.5 X-Ray Crystallographic Analysis and Determination of Configurations of 
the 3-Chlorooxindole and 3-Sulfenyloxindole Products 
 
X-Ray Crystallographic Analysis of 5-3b 
The absolute configuration of the product 5-3b was assigned based on the X-ray 
crystallographic analysis of a single crystal of 5-3b (Figure 5.2). The configurations 
of other Michael addition products were assigned by analogy. 
  
 
Figure 5.2 X-ray structure of 5-3b 
Table 5.6 Crystal Data and Structure Refinement for C321. 
Identification code  c321 
Empirical formula  C16 H12 Br Cl N2 O3 
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Formula weight  395.64 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 8.3011(7) Å = 90°. 
 b = 14.7678(12) Å = 90°. 
 c = 25.328(2) Å  = 90°. 
Volume 3104.9(4) Å3 
Z 8 
Density (calculated) 1.693 Mg/m3 
Absorption coefficient 2.836 mm-1 
F(000) 1584 
Crystal size 0.52 x 0.51 x 0.28 mm3 
Theta range for data collection 1.60 to 27.50°. 
Index ranges -10<=h<=10, -19<=k<=16, -31<=l<=32 
Reflections collected 22091 
Independent reflections 7096 [R(int) = 0.0409] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5040 and 0.3202 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 7096 / 0 / 423 
Goodness-of-fit on F2 0.976 
Final R indices [I>2sigma(I)] R1 = 0.0303, wR2 = 0.0607 
R indices (all data) R1 = 0.0356, wR2 = 0.0619 
Absolute structure parameter 0.002(5) 
Largest diff. peak and hole 0.724 and -0.493 e.Å-3 
 
X-Ray Crystallographic Analysis of 5-17e 
The absolute configuration of the product 5-17e was assigned based on the X-ray 
crystallographic analysis of a single crystal of a 5-23e-THF complex (Figure 5.3). 
The configurations of other products 5-17 were assigned by analogy.  
 
Following the procedure for preparation of 5-23a. 0.2 mmol scale, 75% yield. 
1H NMR (500 MHz, d6-DMSO) δ 3.49 (d, J = 11.4 Hz, 1H), 3.66 (d, J = 11.4 Hz, 1H), 
5.15 (s, 1H), 6.83 (d, J = 7.6 Hz, 1H), 7.07-7.09 (m, 3H), 7.17-7.30 (m, 5H), 
7.43-7.45 (m, 1H), 7.56 (d, J = 7.0 Hz, 1H), 7.63-7.65 (m, 1H), 10.56(s, 1H), 12.99 
(br s, 1H); 13C NMR (125 MHz, d6-DMSO) δ 33.2, 54.1, 55.6, 110.2, 122.3, 125.2, 
126.8, 127.5, 127.7, 128.9, 129.0, 129.6, 129.9, 130.3, 131.8, 133.1, 134.4, 136.4, 
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142.3, 171.3, 175.7; HRMS (ESI) m/z calcd for C23H1779BrNO3S [M-H]- = 466.0118, 
found = 466.0118; calcd for C23H1781BrNO3S [M-H]- = 468.0098, found = 468.0111.  
 
Figure 5.3 X-ray structure of 5-23e-THF complex 
Table 5.7 Crystal Data and Structure Refinement for D375. 
Identification code  d375 
Empirical formula  C27 H26 Br N O4 S 
Formula weight  540.46 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 9.2559(4) Å = 90°. 
 b = 7.6278(4) Å = 95.990(2)°. 
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 c = 17.5660(9) Å  = 90°. 
Volume 1233.43(10) Å3 
Z 2 
Density (calculated) 1.455 Mg/m3 
Absorption coefficient 1.785 mm-1 
F(000) 556 
Crystal size 0.41 x 0.39 x 0.25 mm3 
Theta range for data collection 2.21 to 27.49°. 
Index ranges -12<=h<=11, -9<=k<=9, -22<=l<=22 
Reflections collected 28018 
Independent reflections 5548 [R(int) = 0.0255] 
Completeness to theta = 27.49° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6211 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5548 / 164 / 340 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0244, wR2 = 0.0585 
R indices (all data) R1 = 0.0259, wR2 = 0.0589 
Absolute structure parameter 0.011(5) 
Largest diff. peak and hole 0.524 and -0.261 e.Å-3 
 
Absolute Configuration Assignment of Spirooxindole Product 5-21 
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To determine the absolute configuration of 5-21, the chiral 5-21 was 
transformed to the literature reported compound 5-21'. To a stirred solution of 5-21 
(0.05 mmol, 14.0 mg) in CH2Cl2 (1.0 mL) in a sample vial were added Boc2O (13.1 
mg, 1.2 equiv.) and DMAP (1.2 mg, 20 mol %), and the resulting mixture was 
stirred at room temperature for 15 min. The solution was concentrated, and the 
residue was purified by column chromatography (hexane/ethyl acetate = 7:1) to 
afford the 3-spirocyclopropyl-2-oxindole 5-21' as a colorless oil (17.5 mg, 92% 
yield). 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 1.59 (s, 9H), 4.33 (d, J = 6.9 Hz, 1H), 
5.49 (d, J = 6.9 Hz, 1H), 7.21-7.24 (m, 1H), 7.30-7.42 (m, 7H), 7.93 (d, J = 8.2 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 28.0, 41.3, 41.9, 72.8, 85.1, 115.3, 121.6, 120.0, 
124.8, 128.5, 128.6, 128.9, 129.1, 129.3, 140.5, 148.6, 167.8; MS (ESI) m/z calcd for 
C21H20N2O5Na [M+Na]+ = 403.1, found = 403.1. 
NMR data showed 5-21' is a diastereoisomer of our reported 
spirocyclopropane-oxindole product 5-21-1 & 5-21-212b and it has the same 1H 
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5-21-35-21-1 5-21-2  
The reported HPLC conditions (Daicel Chiralpak AD-H column, 90/10 
hexane/i-PrOH, flow rate 0.750 mL/min, λ = 254 nm: tmajor = 6.88 min, tminor = 11.22 
min) were followed for the analysis of compound 5-21'. 
 
(enantiomerically enriched 5-21') 
HPLC analysis showed that 5-21' is the enantiomer of 5-21-3. The absolute 
configuration of 5-21' was then assigned. This assignment is in agreement with the 
absolute configuration of 5-3a, as the chiral center at C1 of 5-3a did not change 
during the cyclopropane formation, thus the chiral center at C1' of 5-21 should be R, 
                                                             
21 See Chapter 4, ref. 8. 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 4.27 (dd, J = 3.5 Hz, 11.0 Hz, 1H), 5.14 
(dd, J = 11.3 Hz, 13.2 Hz, 1H), 5.67 (dd, J = 3.2 Hz, 13.2 Hz, 1H), 6.82 (d, J = 8.2 Hz, 
1H), 6.86 (d, J = 7.0 Hz, 1H), 6.98-7.05 (m, 3H), 7.15-7.32 (m, 4H), 8.55 (br s, 1H); 
13C NMR (125 MHz, CDCl3) δ 50.5, 66.1, 75.5, 110.9, 123.3, 125.8, 127.1, 128.5, 
129.0, 129.3, 131.0, 132.6, 139.9, 174.4; The ee value was 97%, tR (minor) = 27.23, 
41.15 min, tR (major) = 36.62, 48.54 min (Chiralcel OD-H, λ = 254 nm, 4% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H13ClN2O3Na 
[M+Na]+ = 339.0507, found = 339.0523. 
(R)-3-((S)-1-(2-Bromophenyl)-2-nitroethyl)-3-chloroindolin-2-one 5-3b 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 4.88 (dd, J = 3.2 Hz, 10.7 Hz, 1H), 5.15 
(dd, J = 5.7 Hz, 14.5 Hz, 1H), 5.87 (dd, J = 3.8 Hz, 13.9 Hz, 1H), 6.06 (d, J = 7.6 Hz, 
1H), 6.83 (t, J = 7.6 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 7.22-7.30 (m, 2H), 7.40 (t, J = 
7.6 Hz, 1H), 7.50 (d, J = 8.2 Hz, 1H), 7.66 (d, J = 7.6 Hz, 1H), 8.64 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 46.3, 65.8, 74.7, 110.6, 123.3, 126.1, 127.4, 127.7, 128.4, 
128.7, 130.4, 130.9, 133.2, 133.3, 139.4, 174.6; The ee value was 96%, tR (minor) = 
18.54 min, tR (major) = 30.18 min (Chiralcel OD-H, λ = 220 nm, 14% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H1179BrClN2O3 [M-H]- = 
392.9647, found = 392.9639; HRMS (ESI) m/z calcd for C16H1181BrClN2O3 [M-H]- = 
394.9627, found = 394.9613. 
(R)-3-((S)-1-(3-Bromophenyl)-2-nitroethyl)-3-chloroindolin-2-one 5-3c 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 4.28 (dd, J = 3.5 Hz, 11.1 Hz, 1H), 5.10 
(dd, J = 10.8 Hz, 13.6 Hz, 1H), 5.68 (dd, J = 3.8 Hz, 13.2 Hz, 1H), 6.87 (d, J = 8.2 Hz, 
1H), 6.92 (d, J = 7.6 Hz, 1H), 6.97 (d, J = 7.6 Hz, 1H), 7.08-7.12 (m, 2H), 7.14 (s, 
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1H), 7.37 (t, J = 7.6 Hz, 1H), 7.42-7.44 (m, 1H), 8.06 (br s, 1H); 13C NMR (125 MHz, 
CDCl3) δ 50.2, 65.7, 75.2, 110.9, 122.4, 123.5, 125.8, 126.7, 128.1, 130.0, 131.3, 
132.3, 132.4, 135.0, 139.8, 173.6; The ee value was 96%, tR (minor) = 19.22, 20.81 
min, tR (major) = 24.05, 28.35 min (Chiralcel IB, λ = 254 nm, 4% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H1179BrClN2O3 [M-H]- = 
392.9647, found = 392.9639; HRMS (ESI) m/z calcd for C16H1181BrClN2O3 [M-H]- = 










A white solid; 1H NMR (500 MHz, CDCl3) δ 4.27 (dd, J = 3.5 Hz, 11.0 Hz, 1H), 5.08 
(dd, J = 11.4 Hz, 13.3 Hz, 1H), 5.65 (dd, J = 3.5 Hz, 13.6 Hz, 1H), 6.83-6.86 (m, 3H), 
6.94 (d, J = 7.0 Hz, 1H), 7.07 (t, J = 7.6 Hz, 1H), 7.31-7.34 (m, 3H), 8.52 (br s, 1H); 
13C NMR (125 MHz, CDCl3) δ 50.0, 65.7, 75.2, 111.0, 123.3, 123.5, 125.7, 126.7, 
130.9, 131.2, 131.5, 131.7, 139.9, 174.0; The ee value was 93%, tR (minor) = 23.66, 
36.37 min, tR (major) = 28.22, 39.63 min (Chiralcel OD-H, λ = 254 nm, 5% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C16H1179BrClN2O3 [M-H]- = 392.9647, found = 392.9639; HRMS (ESI) m/z calcd for 
C16H1181BrClN2O3 [M-H]- = 394.9627, found = 394.9613. 
(R)-3-Chloro-3-((S)-1-(2-chlorophenyl)-2-nitroethyl)indolin-2-one 5-3e 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 4.89 (dd, J = 3.5 Hz, 11.0 Hz, 1H), 5.14 
(dd, J = 10.7 Hz, 13.9 Hz, 1H), 5.85 (dd, J = 3.8 Hz, 13.9 Hz, 1H), 6.12 (d, J = 7.0 Hz, 
1H), 6.85 (t, J = 7.6 Hz, 1H), 6.90-6.93 (m, 1H), 7.27-7.34 (m, 4H), 7.60 (t, J = 5.7 
Hz, 1H), 8.33-8.61 (br, 1H); 13C NMR (125 MHz, CDCl3) δ 43.7, 65.8, 74.7, 110.6, 
123.3, 125.9, 127.1, 127.5, 128.6, 130.0, 130.2, 130.9, 131.6, 136.9, 139.4, 174.5; The 
ee value was 94%, tR (minor) = 15.17 min, tR (major) = 27.37 min (Chiralcel OD-H, λ 
= 254 nm, 14% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C16H11Cl2N2O3 [M-H]- = 349.0152, found = 349.0156. 
(R)-3-Chloro-3-((S)-1-(3-chlorophenyl)-2-nitroethyl)indolin-2-one 5-3f 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 4.28 (dd, J = 3.8 Hz, 11.4 Hz, 1H), 5.11 
(dd, J = 11.4 Hz, 13.2 Hz, 1H), 5.69 (dd, J = 3.5 Hz, 13.9 Hz, 1H), 6.86 (d, J = 7.6 Hz, 
1H), 6.91 (d, J = 7.6 Hz, 1H), 7.00 (s, 1H), 7.09-7.17 (m, 2H), 7.27 (s, 1H), 7.34-7.37 
(m, 1H), 8.09 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 50.2, 65.7, 75.2, 110.9, 123.5, 
125.8, 126.8, 127.6, 129.3, 129.5, 129.7, 131.3, 134.4, 134.7, 139.8, 173.6; The ee 
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value was 98%, tR (minor) = 20.82 min, tR (major) = 14.88, 25.52 min (Chiralcel 
OD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z 










A white solid; 1H NMR (500 MHz, CDCl3) δ 4.28 (dd, J = 3.2 Hz, 11.4 Hz, 1H), 5.09 
(t, J = 12.6 Hz, 1H), 5.65 (dd, J = 2.8 Hz, 13.6 Hz, 1H), 6.82 (d, J = 7.6 Hz, 1H), 
6.91-6.93 (m, 3H), 7.06-7.17 (m, 3H), 7.33 (t, J = 7.9 Hz, 2H), 8.02 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 50.1, 65.8, 75.3, 110.9, 123.5, 125.8, 126.8, 128.8, 130.7, 
131.1, 131.2, 135.2, 139.8, 173.6; The ee value was 98%, tR (minor) = 21.24, 25.70 
min, tR (major) = 34.54, 37.13 min (Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H11Cl2N2O3 [M-H]- = 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 4.29 (dd, J = 2.6 Hz, 11.1 Hz, 1H), 5.08 
(t, J = 12.3 Hz, 1H), 5.64 (dd, J = 3.5 Hz, 13.5 Hz, 1H), 6.81 (d, J = 8.2 Hz, 1H), 6.86 
(t, J = 8.5 Hz, 2H), 6.93-6.97 (m, 3H), 7.08 (t, J = 7.6 Hz, 1H), 7.32 (t, J = 7.6 Hz, 
1H), 8.02 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 49.9, 65.9, 75.5, 110.8, 115.7 (d, 
J = 21.0 Hz), 123.5, 125.8, 126.8, 128.3, 131.1, 131.2 (d, J = 7.3 Hz), 139.8, 162.9 (d, 
J = 247.8 Hz), 173.7; The ee value was 94%, tR (minor) = 10.41, 14.22 min, tR (major) 
= 11.97, 14.80 min (Chiralcel IB, λ = 254 nm, 7.5% iPrOH/hexanes, flow rate = 1.0 




A yellow oil; 1H NMR (500 MHz, CDCl3) δ 2.00 (s, 3H), 4.54 (dd, J = 3.5 Hz, 11.0 
Hz, 1H), 5.13 (dd, J = 11.1 Hz, 13.6 Hz, 1H), 5.76 (dd, J = 3.8 Hz, 13.9 Hz, 1H), 6.42 
(d, J = 7.6 Hz, 1H), 6.85 (d, J = 7.6 Hz, 1H), 6.91 (t, J = 7.6 Hz, 1H), 7.07 (d, J = 7.6 
Hz, 1H), 7.12 (t, J = 7.3 Hz, 1H), 7.19-7.22 (m, 2H), 7.27-7.31 (m, 1H), 8.33 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 19.6, 43.9, 66.2, 75.7, 110.6, 123.3, 126.1, 126.6, 
127.5, 128.8, 130.9, 131.9, 139.0, 139.5, 174.6; The ee value was 98%, tR (minor) = 
8.73, 10.44 min, tR (major) = 9.74, 11.81 min (Chiralcel IB, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C17H15ClN2O3Na 
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A yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.99 (s, 3H), 4.53 (dd, J = 3.5 Hz, 10.7 
Hz, 1H), 5.14 (dd, J = 10.7 Hz, 13.9 Hz, 1H), 5.77 (dd, J = 3.2 Hz, 13.6 Hz, 1H), 6.41 
(d, J = 7.6 Hz, 1H), 6.86 (d, J = 7.6 Hz, 1H), 6.92 (t, J = 7.6 Hz, 1H), 7.07 (d, J = 7.6 
Hz, 1H), 7.12 (t, J = 7.6 Hz, 1H), 7.19-7.22 (m, 2H), 7.27-7.31 (m, 1H), 8.33 (br s, 
1H); 13C NMR (125 MHz, CDCl3) δ 19.6, 43.9, 66.2, 75.7, 110.6, 123.3, 126.1, 126.6, 
127.5, 128.8, 130.9, 131.9, 139.0, 139.5, 174.6; The ee value was 99%, tR (minor) = 
22.08, 26.88 min, tR (major) = 19.10, 27.70 min (Chiralcel IB, λ = 254 nm, 3% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C17H15ClN2O3Na 











A yellow oil; 1H NMR (500 MHz, CDCl3) δ 3.55 (s, 3H), 3.79 (s, 3H), 4.26 (dd, J = 
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3.2 Hz, 11.4 Hz, 1H), 5.08 (dd, J = 11.4 Hz, 12.6 Hz, 1H), 5.61 (dd, J = 3.8 Hz, 13.3 
Hz, 1H), 6.32 (d, J = 1.3 Hz, 1H), 6.57-6.60 (m, 1H), 6.66 (d, J = 8.9 Hz, 1H), 6.78 (d, 
J = 8.2 Hz, 1H), 7.04-7.10 (m, 2H), 7.29-7.32 (m, 1H) 7.94 (br s, 1H); 13C NMR (125 
MHz, CDCl3) δ 50.4, 55.6, 55.7, 66.1, 75.8, 110.8, 110.9, 111.5, 122.4, 123.3, 124.5, 
125.8, 127.3, 131.0, 140.2, 148.5, 149.3, 173.7; The ee value was 97%, tR (minor) = 
24.55 min, tR (major) = 20.83 min (Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C18H16ClN2O5 [M-H]- = 375.0753, 
found = 375.0767. 
4-((S)-1-((R)-3-Chloro-2-oxoindolin-3-yl)-2-nitroethyl)benzonitrile 5-3l 
 
A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 4.37 (dd, J = 3.8 Hz, 11.4 Hz, 1H), 
5.12 (dd, J = 11.7 Hz, 13.9 Hz, 1H), 5.68 (dd, J = 3.8 Hz, 13.9 Hz, 1H), 6.82 (d, J = 
7.6 Hz, 1H), 6.93 (d, J = 7.6 Hz, 1H), 7.08-7.14 (m, 3H), 7.32-7.36 (m, 1H), 
7.41-7.50 (m, 2H), 7.80 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 50.5, 65.3, 74.9, 
111.0, 113.2, 118.0, 123.7, 125.7, 126.4, 130.2, 131.5, 132.2, 138.0, 139.7, 173.0; The 
ee value was 98%, tR (minor) = 45.33 min, tR (major) = 57.71 min (Chiralcel IB, λ = 
254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C17H11CClN3O3 [M-H]- = 340.0494, found = 340.0479. 
(R)-3-Chloro-3-((S)-1-(naphthalen-1-yl)-2-nitroethyl)indolin-2-one 5-3m 
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A yellow oil; 1H NMR (500 MHz, CDCl3) δ 5.22-5.31 (m, 2H), 5.82 (dd, J = 2.8 Hz, 
12.9 Hz, 1H), 6.55 (d, J = 7.6 Hz, 1H), 6.74-6.79 (m, 2H), 7.19-7.22 (m, 2H), 7.28 (t, 
J = 7.6 Hz, 1H), 7.40-7.44 (m, 2H), 7.79 (d, J = 7.6 Hz, 1H), 7.94 (d, J = 8.2 Hz, 1H), 
8.06 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 42.9, 66.4, 76.2, 110.6, 123.0, 123.2, 
124.5, 125.1, 125.9, 126.5, 127.3, 128.6, 129.4, 129.7, 130.8, 132.5, 133.7, 139.8, 
174.1; The ee value was 99%, tR (minor) = 23.09 min, tR (major) = 34.53 min 
(Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 









A yellow oil; 1H NMR (500 MHz, CDCl3) δ 4.45 (dd, J = 3.2 Hz, 10.8 Hz, 1H), 5.25 
(t, J = 12.3 Hz, 1H), 5.72 (dd, J = 2.9 Hz, 13.6 Hz, 1H), 6.73 (d, J = 7.6 Hz, 1H), 6.95 
(d, J = 7.0 Hz, 1H), 7.03 (t, J = 7.3 Hz, 2H), 7.29 (t, J = 7.9 Hz, 1H), 7.42-7.49 (m, 
3H), 7.63 (t, J = 4.1 Hz, 1H), 7.75 (d, J = 7.6 Hz, 1H), 7.87 (br s, 1H); 13C NMR (125 
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MHz, CDCl3) δ 50.7, 66.1, 75.6, 110.8, 123.3, 125.9, 126.2, 126.4, 126.8, 127.2, 
127.5, 128.1, 128.2, 129.4, 130.0, 131.0, 132.8, 133.2, 139.8, 173.7; The ee value was 
96%, tR (minor) = 40.64 min, tR (major) = 36.78 min (Chiralcel AD-H, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 0.5 mL/min); HRMS (ESI) m/z calcd for C20H14ClN2O3 
[M-H]- = 365.0698, found = 365.0699. 
(R)-3-Chloro-3-((R)-1-(furan-2-yl)-2-nitroethyl)indolin-2-one 5-3o 
 
A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 4.43 (dd, J = 3.2 Hz, 10.7 Hz, 1H), 
5.16 (dd, J = 11.0 Hz, 13.5 Hz, 1H), 5.64 (dd, J = 3.7 Hz, 13.6 Hz, 1H), 6.23 (d, J = 
3.2 Hz, 1H), 6.27 (t, J = 1.6 Hz, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.88 (d, J = 7.6 Hz, 
1H), 7.03 (t, J = 7.6 Hz, 1H), 7.28-7.32 (m, 2H), 8.32-8.50 (br, 1H); 13C NMR (125 
MHz, CDCl3) δ 44.4, 64.8, 73.7, 110.7, 110.8, 123.5, 125.6, 127.4, 131.0, 139.4, 
143.1, 146.8, 174.1; The ee value was 99%, tR (minor) = 29.76, 36.05 min, tR (major) 
= 38.09, 39.36 min (Chiralcel IB, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.5 
mL/min); HRMS (ESI) m/z calcd for C14H10ClN2O4 [M-H]- = 305.0335, found = 
305.0340. 
(R)-3-Chloro-3-((R)-2-nitro-1-(thiophen-2-yl)ethyl)indolin-2-one 5-3p 
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A yellow oil; 1H NMR (500 MHz, CDCl3) δ 4.63 (dd, J = 3.5 Hz, 11.0 Hz, 1H), 5.02 
(dd, J = 10.7 Hz, 13.2 Hz, 1H), 5.70 (dd, J = 3.2 Hz, 13.3 Hz, 1H), 6.81 (d, J = 3.8 Hz, 
1H), 6.84-6.86 (m, 2H), 6.94 (d, J = 7.6 Hz, 1H), 7.08 (t, J = 7.6 Hz, 1H), 7.19 (d, J = 
5.1 Hz, 1H),7.32-7.36 (m, 1H), 8.00 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 46.6, 
65.4, 76.7, 110.8, 123.5, 125.9, 126.6, 126.7, 126.9, 129.4, 131.3, 134.4, 140.1, 173.5; 
The ee value was 97%, tR (minor) = 29.66 min, tR (major) = 25.88 min (Chiralcel IA, 
λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 










A white solid; 1H NMR (500 MHz, CDCl3) δ 4.55 (dd, J = 3.2 Hz, 12.0 Hz, 1H), 5.38 
(t, J = 11.3 Hz, 1H), 5.50 (dd, J = 3.2 Hz, 13.3 Hz, 1H), 6.65 (d, J = 8.2 Hz, 1H), 6.95 
(d, J = 7.6 Hz, 2H), 7.10-7.15 (m, 3H), 7.19-7.27 (m, 2H), 8.45-8.53 (br, 1H); 13C 
NMR (125 MHz, CDCl3) δ 52.1, 66.8, 77.6, 109.4, 124.1, 125.0, 128.5, 128.9, 129.1, 
131.8, 132.2, 142.1, 173.6; The ee value was 99%, tR (minor) = 22.09, 24.79 min, tR 
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(major) = 20.73, 34.34 min (Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexanes, flow 
rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H11Cl2N2O3 [M-H]- = 349.0152, 
found = 349.0156. 
(R)-3,5-Dichloro-3-((S)-2-nitro-1-phenylethyl)indolin-2-one 5-3r 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 4.22 (dd, J = 3.5 Hz, 11.1 Hz, 1H), 5.12 
(dd, J = 10.7 Hz, 13.2 Hz, 1H), 5.65 (dd, J = 3.5 Hz, 13.6 Hz, 1H), 6.68 (s, 1H), 6.78 
(d, J = 8.2 Hz, 1H), 7.03 (d, J = 7.6 Hz, 2H), 7.21-7.33 (m, 4H), 8.60 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 50.1, 65.7, 75.1, 111.8, 126.4, 128.6, 128.7, 128.8, 129.3, 
129.4, 131.0, 132.3, 138.2, 174.1; The ee value was 99%, tR (minor) = 12.75, 16.85 
min, tR (major) = 11.91, 16.85 min (Chiralcel ID, λ = 254 nm, 5% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C16H11Cl2N2O3 [M-H]- = 
349.0152, found = 349.0156. 
(R)-3-((S)-1-(2-Bromophenyl)-2-nitroethyl)-3,5-dichloroindolin-2-one 5-3s 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 4.87 (dd, J = 3.8 Hz, 10.1 Hz, 1H), 5.15 
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(dd, J = 10.4 Hz, 14.2 Hz, 1H), 5.84 (m, 2H), 6.89 (d, J = 8.9 Hz, 1H), 7.21-7.31 (m, 
2H), 7.47 (t, J = 7.6 Hz, 1H), 7.56 (d, J = 10.1 Hz, 1H), 7.70 (d, J = 6.3 Hz, 1H), 
8.89-9.07 (br, 1H); 13C NMR (125 MHz, CDCl3) δ 46.0, 65.4, 74.3, 111.7, 126.6, 
127.9, 128.4, 128.6, 128.7, 128.8, 130.7, 130.8, 132.7, 133.4, 137.8, 174.7; The ee 
value was 98%, tR (minor) = 13.54 min, tR (major) = 16.55 min (Chiralcel ID, λ = 254 
nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C16H10Cl279BrN2O3 [M-H]- = 426.9257, found = 426.9248, calcd for 









A white solid; 1H NMR (500 MHz, CDCl3) δ 1.62-1.66 (m, 1H), 1.91-1.98 (m, 1H), 
2.60 (t, J = 8.2 Hz, 2H), 3.30-3.35 (m, 1H), 4.57 (dd, J = 7.6 Hz, 13.3 Hz, 1H), 5.12 
(dd, J = 4.1 Hz, 13.6 Hz, 1H), 6.93 (d, J = 8.2 Hz, 1H), 7.07 (d, J = 7.0 Hz, 2H), 7.17 
(t, J = 7.6 Hz, 1H), 7.17-7.25 (m, 3H), 7.30 (t, J = 9.2 Hz, 1H), 7.34 (dd, J = 1.3 Hz, 
7.6 Hz, 1H), 8.02 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 31.3, 33.4, 44.5, 66.3, 
75.8, 111.1, 123.8, 125.1, 126.4, 127.5, 128.3, 128.6, 131.1, 139.8, 140.3, 174.2; The 
ee value was 99%, tR (minor) = 23.71, 45.93 min, tR (major) = 21.81, 36.32 min 
(Chiralcel OD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 
(ESI) m/z calcd for C18H16ClN2O3 [M-H]- = 343.0855, found = 343.0849. 
Chapter 5 3-Heteroatom-substituted Oxindoles 




A white solid; 1H NMR (500 MHz, CDCl3) δ 3.08 (s, 3H), 3.94 (dd, J = 4.4 Hz, 10.7 
Hz, 1H), 5.00 (dd, J = 10.4 Hz, 13.6 Hz, 1H), 5.58 (dd, J = 4.4 Hz, 13.3 Hz, 1H), 6.60 
(d, J = 7.6 Hz, 1H), 6.81 (d, J = 7.6 Hz, 1H), 6.94-7.00 (m, 3H), 7.15 (t, J = 7.6 Hz, 
2H), 7.22-7.29 (m, 2H), 8.47 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 50.1, 53.6, 
75.0, 84.3, 110.6, 122.7, 124.1, 126.0, 128.0, 128.1, 128.2, 128.4, 128.8, 129.5, 130.6, 
133.9, 141.1, 176.9; The ee value was 86%, tR (minor) = 12.34, 21.05 min, tR (major) 
= 30.31, 44.03 min (Chiralcel IC, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 




A white solid; 1H NMR (500 MHz, CDCl3) δ 4.27 (dd, J = 3.8 Hz, 11.4 Hz, 1H), 4.69 
(s, 2H), 5.14 (dd, J = 11.4 Hz, 13.3 Hz, 1H), 5.66 (dd, J = 3.5 Hz, 13.6 Hz, 1H), 6.76 
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(d, J = 8.2 Hz, 1H), 6.87 (d, J = 7.6 Hz, 1H), 6.98 (d, J = 7.6 Hz, 2H), 7.03 (t, J = 7.6 
Hz, 1H), 7.17 (t, J = 7.6 Hz, 2H), 7.24-7.32 (m, 3H), 7.36 (d, J = 4.5 Hz, 4H), 8.37 (br 
s, 1H); 13C NMR (125 MHz, CDCl3) δ 50.5, 65.2, 66.1, 75.5, 110.8, 123.2, 125.8, 
127.0, 127.1, 127.6, 128.4, 128.5, 129.0, 129.3, 131.0, 132.5, 139.9, 140.8, 174.1; The 
ee value was 98%, tR (minor) = 14.32, 17.22 min, tR (major) = 18.24, 21.01 min 
(Chiralcel IB, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) 







A white solid; 1H NMR (500 MHz, CDCl3) δ 0.84 (t, J = 7.6 Hz, 3H), 1.30-1.38 (m, 
2H), 1.43-1.50 (m, 2H), 2.60-2.66 (m, 2H), 4.22 (dd, J = 3.2 Hz & 12.0 Hz, 1H), 5.08 
(t, J = 12.4 Hz, 1H), 5.63 (dd, J = 3.2 Hz, 12.6 Hz, 1H), 6.77 (d, J = 8.1 Hz, 1H), 6.87 
(d, J = 8.2 Hz, 1H), 7.04-7.11 (m, 2H), 7.13-7.19 (m, 2H), 7.27 (d, J = 7.6 Hz, 1H), 
7.29 (dd, J = 1.3 Hz & 7.6 Hz, 1H), 8.29 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 
13.5, 21.9, 28.0, 30.5, 47.6, 56.7, 76.5, 110.4, 122.9, 124.8, 124.9, 127.3, 128.2, 128.4, 
128.9, 129.0, 129.8, 133.7, 140.4, 176.9; The ee value was 91%, []27D = -78.2 (c = 
0.85, CH2Cl2), tR (minor) = 10.07, 11.96 min, tR (major) = 13.49, 23.77 min (Chiralcel 
OD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z 
calcd for C20H21N2O3S [M-H]- = 369.1278, found = 369.1277. 
Chapter 5 3-Heteroatom-substituted Oxindoles 




A white foam; 1H NMR (500 MHz, CDCl3) δ 3.91 (d, J = 12.0 Hz, 1H), 3.96 (d, J = 
12.0 Hz, 1H), 4.27 (dd, J = 3.2 Hz, 12.0 Hz, 1H), 5.07 (t, J = 12.6 Hz, 1H), 5.62 (dd, J 
= 3.5 Hz, 12.9 Hz, 1H), 6.79 (d, J = 7.6 Hz, 1H), 6.87 (d, J = 7.6 Hz, 2H), 7.06 (t, J = 
7.6 Hz, 2H), 7.14 (dd, J = 7.6 Hz, 15.2 Hz, 2H), 7.20-7.25 (m, 6H), 7.30 (t, J = 7.9 Hz, 
1H), 8.59 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 33.3, 47.3, 57.2, 76.3, 110.4, 
123.0, 124.9, 126.7, 127.5, 128.2, 128.4, 128.6, 129.0, 129.2, 130.0, 133.6, 135.9, 
140.5, 176.1; The ee value was 97%, []27D = -26.4 (c = 1.02, CH2Cl2), tR (minor) = 
11.74, 14.32 min, tR (major) = 9.69, 16.22 min (Chiralcel IB, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C23H19N2O3S 
[M-H]- = 403.1122, found = 403.1117. 
(R)-3-(Benzylthio)-3-((S)-1-(2-bromophenyl)-2-nitroethyl)indolin-2-one 5-17e 
 
A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 3.71 (d, J = 12.0 Hz, 1H), 3.82 (d, J 
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= 12.0 Hz, 1H), 4.98 (dd, J = 10.4 Hz, 18.0 Hz, 2H), 5.61-5.66 (m, 1H), 6.79 (d, J = 
7.6 Hz, 2H), 6.89 (d, J = 7.6 Hz, 1H), 7.00-7.23 (m, 9H), 7.30-7.33 (m, 1H), 7.48 (dd, 
J = 1.6 Hz, 7.9 Hz, 1H), 8.48 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 33.6, 45.2, 
57.2, 75.9, 110.5, 123.1, 125.2, 126.8, 127.3, 127.5, 127.7, 128.5, 129.2, 129.9, 130.0, 
133.4, 134.2, 135.6, 140.5, 176.7; The ee value was 99%, []27D = -70.1 (c = 1.07, 
CH2Cl2), tR (minor) = 14.93, 15.93 min, tR (major) = 13.69, 22.47 min (Chiralcel IC, λ 
= 254 nm, 20% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C23H1879BrN2O3S [M-H]- = 481.0227, found = 481.0223; calcd for C23H1881BrN2O3S 











A yellow oil; 1H NMR (500 MHz, CDCl3) δ 3.92 (d, J = 12.0 Hz, 1H), 3.98 (d, J = 
12.0 Hz, 1H), 4.22 (dd, J = 2.6 Hz, 11.4 Hz, 1H), 5.00 (t, J = 12.6 Hz, 1H), 5.58-5.61 
(m, 1H), 6.82 (dd, J = 5.1 Hz, 7.0 Hz, 2H), 6.95 (t, J = 7.9 Hz, 1H), 7.01 (d, J = 1.9 
Hz, 1H), 7.14 (t, J = 7.6 Hz, 1H), 7.20-7.34 (m, 8H), 8.34 (br s, 1H); 13C NMR (125 
MHz, CDCl3) δ 33.4, 46.9, 57.1, 76.0, 77.3, 110.8, 122.2, 123.2, 124.8, 126.3, 127.6, 
127.7, 128.7, 129.2, 129.8, 130.3, 131.7, 132.2, 135.8, 136.0, 140.5, 176.2; The ee 
value was 97%, []27D = -8.3 (c = 1.15, CH2Cl2), tR (minor) = 14.36, 25.17 min, tR 
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(major) = 15.73, 17.96 min (Chiralcel ID, λ = 254 nm, 10% iPrOH/hexanes, flow rate 
= 1.0 mL/min); HRMS (ESI) m/z calcd for C23H1879BrN2O3S [M-H]- = 481.0227, 
found = 481.0223; calcd for C23H1881BrN2O3S [M-H]- = 483.0215, found = 483.0207. 
(R)-3-(Benzylthio)-3-((S)-1-(4-chlorophenyl)-2-nitroethyl)indolin-2-one 5-17g 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 3.93 (d, J = 12.0 Hz, 1H), 3.99 (d, J = 
12.0 Hz, 1H), 4.26 (dd, J = 3.2 Hz, 11.4 Hz, 1H), 5.01 (t, J = 12.6 Hz, 1H), 5.60 (dd, J 
= 3.2 Hz, 13.2 Hz, 1H), 6.80 (dd, J = 8.2 Hz, 13.3 Hz, 2H), 7.08 (d, J = 8.2 Hz, 2H), 
7.14 (t, J = 7.6 Hz, 1H), 7.22-7.27 (m, 6H), 7.32 (t, J = 7.6 Hz, 1H), 8.13 (br s, 1H); 
13C NMR (125 MHz, CDCl3) δ 33.3, 46.7, 57.0, 76.0, 77.2, 110.7, 123.1, 124.8, 126.3, 
127.6, 128.5, 128.6, 129.1, 130.1, 130.3, 132.1, 134.4, 135.8, 140.4, 176.0; The ee 
value was 97%, []27D = -19.4 (c = 1.03, CH2Cl2) tR (minor) = 12.36, 13.73 min, tR 
(major) = 10.25, 20.62 min (Chiralcel IB, λ = 254 nm, 10% iPrOH/hexanes, flow rate 
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A white foam; 1H NMR (500 MHz, CDCl3) δ 2.2 (s, 3H), 3.92 (d, J = 12.0 Hz, 1H), 
3.97 (d, J = 12.0 Hz, 1H), 4.25 (dd, J = 3.2 Hz, 11.4 Hz, 1H), 5.05 (t, J = 12.6 Hz, 1H), 
5.60 (dd, J = 3.5 Hz, 12.9 Hz, 1H), 6.77 (d, J = 7.6 Hz, 3H), 6.89 (d, J = 7.6 Hz, 2H), 
7.11 (t, J = 7.6 Hz, 1H), 7.21-7.30 (m, 7H), 8.14 (br s, 1H); 13C NMR (125 MHz, 
CDCl3) δ 21.1, 33.3, 47.0, 57.3, 76.5, 110.6, 123.0, 125.0, 126.9, 127.5, 128.6, 128.9, 
129.0, 129.2, 129.9, 130.6, 135.9, 138.2, 140.6, 176.4; The ee value was 97%, []27D 
= -30.9 (c = 0.94, CH2Cl2), tR (minor) = 16.46, 19.56 min, tR (major) = 20.21, 22.63 
min (Chiralcel ID, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS 










A white foam; 1H NMR (500 MHz, CDCl3) δ 3.94 (d, J = 12.0 Hz, 1H), 4.01 (d, J = 
12.7 Hz, 1H), 4.42 (dd, J = 3.2 Hz, 12.0 Hz, 1H), 5.14 (t, J = 12.6 Hz, 1H), 5.64 (dd, J 
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= 3.2 Hz, 12.6 Hz, 1H), 6.65 (d, J = 8.2 Hz, 1H), 6.94 (d, J = 8.2 Hz, 1H), 7.12 (t, J = 
7.6 Hz, 1H), 7.19-7.28 (m, 7H), 7.36-7.42 (m, 3H), 7.51 (d, J = 8.2 Hz, 1H), 7.57 (d, J 
= 8.2 Hz, 1H), 7.67 (d, J = 7.6 Hz, 1H), 7.85 (br s, 1H); 13C NMR (125 MHz, CDCl3) 
δ 33.4, 47.5, 57.2, 76.4, 77.3, 110.6, 123.0, 125.0, 126.1, 126.2, 126.5, 126.8, 127.5, 
127.6, 128.0, 128.1, 128.7, 129.0, 129.3, 130.0, 131.2, 132.8, 133.0, 135.9, 140.5, 
176.1; The ee value was 98%, []27D = -18.7 (c = 0.97, CH2Cl2), tR (minor) = 18.83, 
26.31 min, tR (major) = 20.56, 29.15 min (Chiralcel IA, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C27H21N2O3S 
[M-H]- = 453.1278, found = 453.1295. 
(R)-3-(Benzylthio)-3-((R)-1-(furan-2-yl)-2-nitroethyl)indolin-2-one 5-17j 
 
A white foam; 1H NMR (500 MHz, CDCl3) δ 3.93 (d, J = 12.6 Hz, 1H), 3.97 (d, J = 
12.6 Hz, 1H), 4.46 (dd, J = 1.3 Hz, 11.4 Hz, 1H), 5.08-5.14 (m, 1H), 5.56-5.59 (m, 
1H), 5.99 (d, J = 3.2 Hz, 2H), 6.12 (d, J = 1.9 Hz, 1H), 6.84 (dd, J = 2.2 Hz, 7.9 Hz, 
1H), 7.04-7.08 (m, 3H), 7.19-7.28 (m, 6H), 8.64 (br s, 1H); 13C NMR (125 MHz, 
CDCl3) δ 33.2, 41.3, 56.3, 74.3, 109.5, 110.4, 110.5, 123.0, 124.8, 127.0, 127.6, 128.6, 
129.2, 129.8, 135.7, 140.2, 142.7, 148.0, 176.6; The ee value was 96%, []27D = -21.4 
(c = 1.01, CH2Cl2), tR (minor) = 15.13, 21.03 min, tR (major) = 11.65, 13.82 min 
(Chiralcel IC, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 2.37 (s, 3H), 3.92 (d, J = 12.6 Hz, 1H), 
3.98 (d, J = 12.0 Hz, 1H), 4.25 (dd, J = 3.2 Hz, 12.0 Hz, 1H), 5.06 (t, J = 12.6 Hz, 
1H), 5.59 (dd, J = 3.2 Hz, 13.2 Hz, 1H), 6.66 (d, J = 8.2 Hz, 1H), 6.87 (d, J = 8.2 Hz, 
2H), 6.99 (s, 1H), 7.05-7.10 (m, 3H), 7.15 (t, J = 7.3 Hz, 1H), 7.20-7.25 (m, 5H), 8.10 
(br s, 1H); 13C NMR (125 MHz, CDCl3) δ 21.3, 33.4, 47.4, 57.3, 76.4, 110.3, 125.5, 
126.8, 127.5, 128.2, 128.4, 128.6, 129.1, 129.2, 130.4, 132.6, 133.7, 136.1, 138.1, 
176.3; The ee value was 98%, []27D = -49.9 (c = 0.90, CH2Cl2), tR (minor) = 27.82, 
37.31 min, tR (major) = 19.96, 32.74 min (Chiralcel IB, λ = 254 nm, 3% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C24H21N2O3S 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 3.90 (d, J = 12.6 Hz, 1H), 3.96 (d, J = 
12.0 Hz, 1H), 4.23 (dd, J = 3.5 Hz, 11.7 Hz, 1H), 5.04 (d, J = 12.6 Hz, 1H), 5.57 (dd, 
J = 3.5 Hz, 12.9 Hz, 1H), 6.70 (d, J = 8.2 Hz, 1H), 6.89 (d, J = 7.6 Hz, 1H), 7.09-7.12 
(m, 3H), 7.17-7.27 (m, 7H), 8.25 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 33.5, 47.3, 
57.4, 75.9, 111.4, 125.3, 127.7, 128.3, 128.4, 128.5, 128.6, 129.0, 129.1, 130.0, 133.2, 
135.5, 138.9, 176.0; The ee value was 96%, []27D = -46.0 (c = 0.98, CH2Cl2), tR 
(minor) = 21.47, 31.19 min, tR (major) = 16.42, 27.19 min (Chiralcel IB, λ = 254 nm, 
5% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C23H18ClN2O3S [M-H]- = 437.0732, found = 437.0750. 
(R)-3-((S)-1-(3-Bromophenyl)-2-nitroethyl)-3-(butylthio)indolin-2-one 5-17m 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 0.85 (t, J = 7.6 Hz, 3H), 1.31-1.39 (m, 
2H), 1.44-1.50 (m, 2H), 2.62-2.71 (m, 2H), 4.20 (dd, J = 3.2 Hz, 12.0 Hz, 1H), 5.02 (t, 
J = 12.6 Hz, 1H), 5.62 (dd, J = 3.2 Hz, 13.2 Hz, 1H), 6.81 (d, J = 7.6 Hz, 2H), 6.95 (t, 
J = 7.9 Hz, 1H), 7.00 (s, 1H), 7.14 (d, J = 7.6 Hz, 1H), 7.19 (d, J = 6.9 Hz, 1H), 7.30 
(dd, J = 7.0 Hz & 13.3 Hz, 2H), 8.16 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 13.5, 
22.0, 28.0, 30.4, 47.1, 56.4, 76.2, 110.6, 122.1, 123.1, 124.8, 126.8, 127.6, 129.7, 
130.1, 131.6, 132.1, 136.0, 140.3, 176.4; The ee value was 90%, []27D = -63.9 (c = 
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0.88, CH2Cl2), tR (minor) = 17.40, 20.11 min, tR (major) = 11.35, 13.58 min (Chiralcel 
AD-H, λ = 254 nm, 20% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z 
calcd for C20H2079BrN2O3S [M-H]- = 447.0383, found = 447.0384; HRMS (ESI) m/z 










A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 0.77 (t, J = 7.0 Hz, 3H), 1.17-1.23 
(m, 5H), 1.37-1.40 (m, 1H), 3.26-3.30 (m, 1H), 3.94 (d, J = 11.5 Hz, 1H), 4.05 (d, J = 
11.4 Hz, 1H), 4.55 (dd, J = 8.8 Hz, 13.2 Hz, 1H), 5.50 (dd, J = 2.5 Hz, 13.3 Hz, 1H), 
6.96 (d, J = 8.2 Hz, 1H), 7.04-7.11 (m, 2H), 7.20-7.31 (m, 6H), 8.54 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 13.7, 22.6, 29.1, 30.3, 32.8, 40.7, 57.4, 77.2, 110.6, 123.1, 
124.3, 127.0, 127.4, 128.6, 129.3, 129.7, 135.6, 140.4, 177.1; The ee value was 98%, 
[]27D = -22.1 (c = 1.05, CH2Cl2), tR (minor) = 7.89 min, tR (major) = 6.72 min 
(Chiralcel IC, λ = 254 nm, 20% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) 
m/z calcd for C21H23N2O3S [M-H]- = 383.1435, found = 383.1441. 
(R)-3-(Benzylthio)-3-((S)-1-nitro-4-phenylbutan-2-yl)indolin-2-one 5-17o 
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A light yellow oil; 1H NMR (500 MHz, CDCl3) δ 1.47-1.55 (m, 1H), 1.69-1.76 (m, 
1H), 2.50-2.61 (m, 2H), 3.33-3.38 (m, 1H), 3.94 (d, J = 12.0 Hz, 1H), 4.04 (d, J = 
12.0 Hz, 1H), 4.63 (dd, J = 8.8 Hz, 13.3 Hz, 1H), 5.52 (dd, J = 2.8 Hz, 12.9 Hz, 1H), 
6.94 (d, J = 7.6 Hz, 1H), 7.01-7.08 (m, 2H), 7.12-7.31 (m, 11H), 8.65 (br s, 1H); 13C 
NMR (125 MHz, CDCl3) δ 32.6, 32.8, 33.4, 40.7, 57.3, 77.1, 110.8, 123.2, 124.4, 
126.2, 126.8, 127.5, 128.2, 128.4, 128.6, 129.3, 129.9, 135.6, 140.4, 140.6, 177.0; The 
ee value was 98%, []27D = -28.8 (c = 1.05, CH2Cl2), tR (minor) = 10.42 min, tR 
(major) = 11.81 min (Chiralcel IB, λ = 254 nm, 20% iPrOH/hexanes, flow rate = 1.0 
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Chapter 6 Enantioselective Conjugate Addition of 
3-Fluoro-Oxindoles to Vinyl Sulfone: An Organocatalytic 
Access to Chiral 3-Fluoro-3-substituted Oxindoles 
 
6.1 Introduction 
Fluorinated molecules are of great importance in pharmaceutical industry, and 
their distinctive characteristics are mainly due to unique properties of the fluorine 
atom and resulting CF bonds.1 Not surprisingly, asymmetric synthesis of fluorinated 
molecules has drawn enormous attention from synthetic community in recent years.2 
Oxindoles are widely present in natural products and bioactive molecules, and 
oxindoles bearing a 3-fluorinated quaternary stereogenic center are structural motifs 
that have important applications in pharmaceutical industry. 3  Various synthetic 
strategies have been devised to target this important molecular structure over the years. 
In 2001, Shibata et al. described an enantioselective fluorination strategy by using a 
combination of stoichiometric amounts of cinchona alkaloid and Selectfluor.4 Shortly 
after, the Shibata group, and the Cahard group, independently reported an asymmetric 
synthesis of BMS-204352 (Figure 6.1) by using a stoichiometric amount of cinchona 
                                                             
1 For general reviews on fluorinated compounds in medicinal chemistry, see a) K. Muller, C. Faeh, F. Diederich, 
Science, 2007, 317, 1881; b) K. L. Kirk, Org. Process. Res. Dev., 2008, 12, 305. 
2 For reviews, see: a) H. Ibrahim, A. Togni, Chem. Commun., 2004, 1147; b) K. Mikami, Y. Itoh, M. Yamanaka, 
Chem. Rev., 2004, 104, 1; c) M. Oestreich, Angew. Chem. Int. Ed., 2005, 44, 2324; d) P. M. Pihko, Angew. Chem. Int. 
Ed., 2006, 45, 544; e) G. K. S. Prakash, P. Beier, Angew. Chem. Int. Ed., 2006, 45, 2172; f) V. A. Brunet, D. O'Hagan, 
Angew. Chem. Int. Ed., 2008, 47, 1179; g) J.-A. Ma, D. Cahard, Chem. Rev., 2008, 108, 1; h) C. Hollingworth, V. 
Gouverneur, Chem. Commun., 2012, 48, 2929. 
3 a) V. K. Gribkff, J. E. Starrett Jr., S. L. Dworetzky, P. Hewawasam, C. G. Boissard, D. A. Cook, S. W. Frantz, K. 
Heman, J. R. Hibbard, K. Huston, G. Johnson, B. S. Krishnan, G. G. Kinney, L. A. Lombardo, N. A. Meanwell, P. B. 
Molinoff, R. A. Myers, S. L. Moon, A. Ortiz, L. Pajor, R. L. Pieschl, D. J. Post-Munson, L. J. Signor, N. Srinivas, M. 
T. Taber, G. Thalody, J. T. Trojnacki, H. Wiener, K. Yeleswaram, S. W. Yeola, Nat. Med. (N. Y.), 2001, 7, 471; b) P. 
Hewawasam, V. K. Gribkoff, Y. Pendri, S. I. Dworetzky, N. A. Meanwell, E. Martinez, C. G. Boissard, D. J. 
Post-Munson, J. T. Trojnacki, K. Yeleswaram, L. M. Pajor, J. Knipe, Q. Gao, R. Perrone, J. E. Starrett Jr., Bioorg. 
Med. Chem. Lett., 2002, 12, 1023. 
4 N. Shibata, E. Suzuki, T. Asahi, M. Shiro, J. Am. Chem. Soc., 2001, 123, 7001. 
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alkaloid-derived fluorinating reagent. 5  Metal-based catalytic systems have been 
developed recently for the asymmetric fluorination of oxindoles, including: Shibata’s 
dbfoxPh/Ni(II) complex, 6  Sodeoka’s (S)-DM-BINAP-Pd complex, 7  Gade’s 
boxmi-Ni(II),8 Feng’s Sc(III)-N,N'-dioxide complex,9 and Dorta’s chiral NHC-Pd 
complex. 10  On the other hand, advance of organocatalytic enantioselective 
fluorination methods lagged well behind compared with their transition metal 
counterparts. To the best of our knowledge, there is only one such report in the 
literature. Shibata and co-workers employed bis-cinchona alkaloid as the catalyst to 
achieve enantioselective fluorination of oxindoles.11 The reported reaction, however, 
suffered from long reaction time, and there was also room for the improvement of 
enantioselectivity. 
 
Figure 6.1 Structure of BMS-204352 
Recently, organocatalytic synthetic methods utilizing fluorinated substrates for 
the CC bond formation have been shown to a viable approach for the synthesis of 
chiral fluorine-containing molecules. The true advantage of this approach is that 
challenging asymmetric construction of CF bond is turned into CC bond formation, 
                                                              
5 a) N. Shibata, T. Ishimaru, E. Suzuki, K. L. Kirk, J. Org. Chem., 2003, 68, 2494; b) L. Zoute, C. Audouard, J.-C. 
Plaquevent, D. Cahard, Org. Biomol. Chem., 2003, 1, 1833. 
6 N. Shibata; J. Kohno, K. Takai, T. Ishimaru, S. Nakamura, T. Toru, S. Kanemasa, Angew. Chem. Int. Ed., 2005, 44, 
4204. 
7 Y. Hamashima, T. Suzuki, H. Takano, Y. Shimura, M. Sodeoka, J. Am. Chem. Soc., 2005, 127, 10164. 
8 Q.-H. Deng, H. Wadepohl, L. H. Gade, Chem. Eur. J., 2011, 17, 14922. 
9 J. Li, Y. Cai, W. Chen, X. Liu, L. Lin, X. Feng, J. Org. Chem., 2012, 77, 9148. 
10 L. Wu, L. Falivene, E. Drinkel, S. Grant, A. Linden, L. Cavallo, R. Dorta, Angew. Chem. Int. Ed., 2012, 51, 2870. 
11 T. Ishimaru, N. Shibata, T. Horikawa, N. Yasuda, S. Nakamura, T. Toru, M. Shiro, Angew. Chem. Int. Ed., 2008, 
47, 4157. 
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which is very well studied and much easier to control in modern organic synthesis. In 
this context, we and others have developed a range of asymmetric reactions for the 
synthesis of fluorine-containing stereogenic centers using fluorinated 
pronucleophiles.12 To align with our interest of synthesizing biologically important 
structural scaffolds containing a quaternary stereogenic center, we became interested 
in developing an efficient strategy to access 3-fluoro-3-substituted oxindoles. Vinyl 
sulfones are valuable acceptors for conjugate addition reactions, mainly due to the 
high electron withdrawing ability of the sulfone group, and a variety of 
well-established post-synthetic manipulations of the sulfone functionality. 13  Our 
group has recently developed a number of asymmetric conjugate additions by 
utilizing vinyl sulfones as an acceptor.14 We envisioned that a conjugate addition of 
3-fluoro-substituted oxindoles to 1,1-bis(benzenesulfonyl)ethylene may represent a 
straightforward method to access enantiomerically enriched 3-fluoro-3-substituted 
oxindoles (Scheme 6.1). In this communication, we document the first organocatalytic 
                                                             
12 a) X. Han, J. Luo, C. Liu, Y. Lu, Chem. Commun., 2009, 2044; b) H. Li, S. Zhang, C. Yu, X. Song, W. Wang, Chem. 
Commun., 2009, 2044; c) Z. Jiang, Y. Pan, Y. Zhao, T. Ma, R. Lee, Y. Yang, K.-W. Huang, M. W. Wang, C.-H. Tan, 
Angew. Chem. Int. Ed., 2009, 48, 3627; d) X. Han, J. Kwiatkowski, F. Xue, K.-W. Huang, Y. Lu, Angew. Chem. Int. 
Ed., 2009, 48, 7604; e) G. K. S. Prakash, F. Wang, T. Stewart, T. Mathew, G. A. Olah, Proc. Natl. Acad. Sci. USA, 
2009, 106, 4090; f) B. K. Kwon, S. M. Kim, D. Y. Kim, J. Fluorine Chem., 2009, 130, 759; g) C. Ding, K. Maruoka, 
Synlett, 2009, 4, 664; h) X. Han, F. Zhong, Y. Lu, Adv. Synth. Catal., 2010, 352, 2778; i) M. Kamlar, N. Bravo, A.-N. 
R. Alba, S. Hybelbauerová, I. Císarová, J. Veselý, A. Moyano, R. Rios, Eur. J. Org. Chem., 2010, 5464; j) S. Hong, J. 
Lee, M. Kim, Y. Park, C. Park, M. Kim, S. Jew. H. Park, J. Am. Chem. Soc., 2011, 133, 4924; k) Y. Pan, Y. Zhao, T. 
Ma, Y. Yang, H. Liu, Z. Jiang, C.-H. Tan, Chem. Eur. J., 2010, 16, 779; l) H.-F. Cui, P. Li, X.-W. Wang, S.-Z. Zhu, G. 
Zhao, J. Fluorine Chem., 2012, 133, 120. 
13 For reviews, see: a) N. S. Simpkins, Tetrahedron, 1990, 44, 6951; b) C. Najera, M. Yus, Tetrahedron, 1999, 55, 
10547; c) M. Nielsen, C. B. Jacobsen, N. Holub, M. W. Paixão, K. A. Jørgesen, Angew. Chem., Int. Ed., 2010, 49, 
2668; d) Q. Zhu, Y. Lu, Aus. J. Chem., 2009, 62, 951. For recent examples, see: e) H. Li, J. Song, X. Liu, L. Deng, J. 
Am. Chem. Soc., 2005, 127, 8948; f) H. Li, J. Song, L. Deng, Tetrahedron, 2009, 65, 3139; g) S. Mossé, A. 
Alexakis, Org. Lett., 2005, 7, 4361; h) A. Quintard, C. Bournaud, A. Alexakis, Chem. Eur. J., 2008, 14, 7504; i) A. 
Quintard, A. Alexakis, Chem. Eur. J., 2009, 15, 11109; j) S. Sulzer-Mossé, A. Alexakis, J. Mareda, G. Bollot, G. 
Bernardinelli, Y. Filinchuk, Chem. Eur. J., 2009, 15, 3204; k) A. Quintard, S. Belot, M. Sebastien, E. Marchal, A. 
Alexakis, Eur. J. Org. Chem., 2010, 927; l) A. Quintard, A. Alexakis, Chem. Commun., 2010, 46, 4085; m) A. 
Landa, M. Maestro, C. Masdeu, A. Puente, S. Vera, M. Oiarbide, C. Palomo, Chem. Eur. J., 2009, 15, 1562; n) T. 
-Y. Liu, J. Long, B. -J. Li, L. Jiang, R. Li, Y. Wu, L. -S. Ding, Y. -C. Chen, Org. Biomol. Chem., 2006, 4, 2097; o) 
A.-N. R.Alba, X. Companyo, G. Valero, A. Moyano, R. Rios, Chem. Eur. J., 2010, 16, 5354. 
14 a) Q. Zhu, Y. Lu, Org. Lett., 2008, 10, 4803; b) Q. Zhu, L. Cheng, Y. Lu, Chem. Commun., 2008, 6315; c) Q. Zhu, 
Y. Lu, Org. Lett., 2009, 11, 1721; d) Q. Zhu, Y. Lu, Chem. Commun., 2010, 46, 2235; e) Q. Zhu, Y. Lu, Angew. Chem. 
Int. Ed., 2010, 49, 7753. 
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asymmetric conjugate addition of 3-fluoro-substituted oxindoles to a vinyl sulfone. 
 
Scheme 6.1 Catalytic asymmetric synthesis of 3-fluoro-3-substituted oxindoles 
 
6.2 Results and Discussion 
6.2.1 Reaction Optimization 
To promote the projected conjugate addition, tertiary amine catalysts with a 
Brønsted acid moiety are apparently excellent choice. We chose conjugate addition of 
3-fluorinated oxindole 6-1a to vinyl sulfone 6-2a as a model reaction, and examined 
the catalytic effects of a number of tertiary amine (thio)urea catalysts. The results are 
summarized in Table 6.1. 
 
Table 6.1 Conjugate Addition of 3-Fluorooxindole 6-1a to Vinyl Sulfone 6-2a Catalyzed by 
Different Organic Catalystsa 
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entry cat. solvent t (min) yield (%)b ee (%)c 
1 6-4 toluene 30 >95 -68 
2 6-5 toluene 10 >95 81 
3 6-6 toluene 5 >95 84 
4 6-7 toluene 5 54 86 
5 6-8 toluene 5 52 85 
6 6-9 toluene 5 >95 69 
7d 6-6 toluene 8 >95 86 
8d,e 6-6 toluene 60 >95 80 
9d 6-6 xylene 10 >95 81 
10d 6-6 THF 60 >95 82 
11d 6-6 CH2Cl2 30 >95 87 
12d 6-6 CHCl3 15 >95 90 
13d 6-6 DCE 15 >95 83 
14d,f 6-6 CHCl3 15 >95 91 
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15d,g 6-6 CHCl3 15 >95 93 
16d,h 6-6 CHCl3 15 >95 92 
17d,g,i 6-6 CHCl3 25 >95 93 
18d,g,j 6-6 CHCl3 120 >95 90 
a Reactions were performed with 6-1a (0.05 mmol), 6-2a (0.05 mmol) and the catalyst (0.005 
mmol) in solvent (0.5 mL) at room temperature. b Isolated yield. c Determined by HPLC analysis 
on a chiral stationary phase. d 1.0 mL solvent was used. e Reaction was performed at 0 oC. f 3Å 
Molecular sieves (10 mg) was added. g 4Å Molecular sieves (10 mg) was added. h 5Å Molecular 
sieves (10 mg) was added. i Catalyst loading was 5 mol %. j Catalyst loading was 2 mol %.  
 
Cinchonine-derived ficunctional tertiary aminethiourea catalyst 6-4 was found to 
be very effective, affording the desired product in excellent yield and with moderate 
ee (entry 1). Cinchonidine and quinine-derived catalysts 6-5 and 6-6 were more 
efficient, and the reactions proceeded faster and the desired adducts were obtained 
with higher enantioselectivities (entries 23). When our multifunctional catalysts 
were employed, slightly higher ee values could be obtained, the reaction, however, 
suffered from low yield (entries 45). Quinine-derived tertiary amine urea 6-9 proved 
to be inferior to catalyst 6-6 (entry 6). Overall, catalyst 6-6 offered the best results. 
Further optimizations using 6-6 as the catalyst of choice were then performed. 
Dilution of the reaction mixture was beneficial, and lowering temperature turned out 
to be detrimental (entries 78). Solvent screening revealed that chloroform was the 
best solvent (entries 913). Additive study led to further enhancement; 3a was 
obtained in >95% yield and with 93% ee when 4 Å molecular sieves were added 
(entries 1416). Moreover, the catalyst loading could be reduced to 5 mol % without 
sacrificing the enantioselectivity (entries 1718).  
6.2.2 Substrate Scope 
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With the optimal reaction conditions in hand, the substrate scope of this 
conjugate addition reaction was then investigated. As summarized in Table 6.2, 
fluorinated oxindoles with diverse substitution groups at different positions were 
examined, and consistent high yields and enantioselectivities could be obtained. 
Different halide substitutions on the aromatic ring were well tolerated (entries 26), 
and oxindoles with electron donating substitution groups as well as bis-substituted 
oxindole were also suitable substrates (entries 79). In general, all the reactions went 
to completion within one hour, affording the desired adducts in high yields and 
excellent ee values. The absolute configurations of the 3-fluoro-3-substituted 
oxindoles were assigned on the basis of the X-ray crystallographic analysis of 6-3e. 
 
Table 6.2 Substrate Scope of the Conjugate Addition of 3-Fluorooxindoles 6-1 to Vinyl 
Sulfone 6-2aa  





















entry R (6-3) t (min) yield (%)b ee (%)c 
1 H (6-3a) 25 >95 93 
2 5-Cl (6-3b) 20 >95 93 
3 6-Cl (6-3c) 25 >95 91 
4 5-Br (6-3d) 30 >95 93 
5 7-F (6-3e) 20 >95 89 
6 7-Cl (6-3f) 30 >95 87 
7 5-Me (6-3g) 45 >95 89 
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8 5-OMe (6-3h) 50 >95 90 
9 5,7-Me (6-3i) 60 >95 89 
a Reactions were performed with 6-1 (0.05 mmol), 6-2a (0.05 mmol), 6-6 (0.0025 mmol) and 4Å 
molecular sieves (10 mg) in CHCl3 (1.0 mL) at room temperature. b Isolated yield. c Determined 



































9:1 dr & 98% ee
(no reaction)
toluene, RT


















4 Å MS, 20 min (eq. 3)
6-2d 6-3k: 95% yield
78:22 dr & 46%, 28% ee  
Scheme 6.2 Reaction of 3-fluorooxindole with different electrophiles 
Different electrophiles were also tested. Olefin 6-2b with mono-sulfone 
activation was found to be unsuitable for the reaction (eq. 1). Substituted vinyl 
sulfone 6-2c was a good substrate. In the presence of multifunctional catalyst 6-7, the 
conjugate addition of 6-1a to 6-2b took place readily, affording the desired product in 
high yield, with high dr and near perfect ee value (eq. 2). Although mono-sulfone 
activated olefin showed no reactivity, mono-activated nitroolefin was reactive enough 
and applicable as the Michael acceptor. Bifunctional catalyst 6-6 catalyzed Michael 
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addition of 3-fluoro-oxindole 6-1a to nitroolefin 6-2d completed in twenty minutes 
and afforded the Michael product in high yield, moderate diastereoselectivity and 
enantioselectivity (eq. 3). 
 
6.3. Conclusions 
In summary, we have developed the first asymmetric conjugate addition of 
3-fluoro oxindoles to vinyl sulfones, promoted by tertiary amine thiourea bifunctional 
catalysts. The desired 3-fluoro-3-substituted oxindoles were prepared in excellent 
chemical yields and with very high enantiomeric excesses. The reported method is 
simple and efficient, representing a promising approach to access biologically 
important chiral oxindoles containing a 3-fluoro-quaternary stereogenic center. 
 
6.4 Experimental Section 
6.4.1 Material and General Methods 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. THF were dried and distilled 
from sodium benzophenone ketyl prior to use. CHCl3 and CH2Cl2 were distilled from 
CaH2 prior to use. 1H and 13C NMR spectra were recorded on a Bruker ACF300 or 
AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference: proton 
(chloroform δ 7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as 
follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), br (broad singlet). Coupling constants were reported in Hertz (Hz). Low 
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resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL- T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL- T spectrometer. For 
thin layer chromatography (TLC), Merck pre- coated TLC plates (Merck 60 F254) 
were used, and compounds were visualized with a UV light at 254 nm. Further 
visualization was achieved by staining with iodine, or ceric ammonium molybdate 
followed by heating on a hot plate. Flash chromatographic separations were 
performed on Merck 60 (0.040- 0.063 mm) mesh silica gel. The enantiomeric 
excesses of products were determined by chiral-phase HPLC analysis, using a Daicel 
Chiralcel IC-H column (250 x 4.6 mm), or Chiralpak OD-H ncolumn, or IA column 
(250 x 4.6 mm). 
 
6.4.2 Synthesis of Substrates 
 
 
The substrates 6-1 were synthesized following the general procudure: Boc-protected 
oxindole (1 mmol) was dissolved in dry THF (5 mL) under N2 protection and the 
solution was cooled to 0 oC. NaH (1 mmol) was added and the mixture was stirred at 
0 oC for 30 min. NFSI (1 mmol) was added to the mixture in one portion and the 
resulting mixture was stirred at 0 oC to room temperature for 15 min. The reaction 
mixture was quenched by addition of water (10 mL) and the mixture was extracted 
with CH2Cl2 (15 mL×3). The combined organic phase was dried over MgSO4, filtered 
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and concentrated in vacuo, which was purified by flash column chromatography 
(ethyl acetate/hexane = 1:7) to afford the desired monofluorinated product (38-46% 
yield), the bisfluorinated side product (8-13% yield) and the recovered Boc-protected 
oxindole ( 23-41% recovered). 







A white solid; 1H NMR (500 MHz, CDCl3) δ 1.63 (s, 9H), 5.70 (d, J = 51.1 Hz, 1H), 
7.22 (t, J = 7.6 Hz, 1H), 7.43 (t, J = 7.9 Hz, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.87 (d, J 
= 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.0, 85.0 (d, J = 187.7 Hz), 85.1, 
115.6, 121.8 (d, J = 16.4 Hz), 125.0 (d, J = 2.7 Hz), 125.9, 131.7 (d, J = 2.7 Hz), 
140.9 (d, J = 4.6 Hz), 148.7, 169.0 (d, J = 17.3 Hz); 19F NMR (282.38 MHz, CDCl3) 
δ -111.1 (d, J = 51.6 Hz); HRMS (ESI) m/z calcd for C13H14FNO3Na [M+Na]+ = 
274.0850, found = 274.0860. 








A white solid; 1H NMR (300 MHz, CDCl3) δ 1.63 (s, 9H), 5.68 (d, J = 50.9 Hz, 1H), 
7.40-7.44 (m, 1H), 7.48 (s, 1H), 7.85 (dd, J = 1.3 Hz, 8.7 Hz, 1H); 13C NMR (125 
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MHz, CDCl3) δ 28.0, 84.6 (d, J = 190.4 Hz), 85.4, 117.0, 123.3 (d, J = 16.4 Hz), 
126.1, 130.6 (d, J = 2.7 Hz), 131.7 (d, J = 2.7 Hz), 139.4 (d, J = 4.6 Hz), 148.5, 
168.1 (d, J = 18.2 Hz); 19F NMR (282.38 MHz, CDCl3) δ -112.2 (d, J = 52.6 Hz); 
HRMS (ESI) m/z calcd for C13H13FClNO3Na [M+Na]+ = 308.0460, found = 
308.0452. 
tert-Butyl 6-chloro-3-fluoro-2-oxoindoline-1-carboxylate 6-1c 
 
A white solid; 1H NMR (300 MHz, CDCl3) δ 1.64 (s, 9H), 5.68 (d, J = 51.1 Hz, 1H), 
7.21-7.24 (m, 1H), 7.43 (dd, J = 1.1 Hz, 7.9 Hz, 1H), 7.97 (s, 1H); 13C NMR (125 
MHz, CDCl3) δ 28.0, 84.4 (d, J = 189.5 Hz), 85.6, 116.5, 120.0 (d, J = 16.4 Hz), 
125.2 (d, J = 2.7 Hz), 126.8, 137.8 (d, J = 3.7 Hz), 141.9 (d, J = 4.6 Hz), 148.4, 
168.4 (d, J = 18.2 Hz); 19F NMR (282.38 MHz, CDCl3) δ -110.8 (d, J = 51.6 Hz); 
HRMS (ESI) m/z calcd for C13H13FClNO3Na [M+Na]+ = 308.0460, found = 
308.0452. 
tert-Butyl 5-bromo-3-fluoro-2-oxoindoline-1-carboxylate 6-1d 
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A white solid; 1H NMR (300 MHz, CDCl3) δ 1.63 (s, 9H), 5.69 (d, J = 50.9 Hz, 1H), 
7.55-7.59 (m, 1H), 7.63 (s, 1H), 7.76-7.82 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
28.0, 84.4 (d, J = 190.4 Hz), 85.5, 117.1, 117.3, 123.6 (d, J = 16.4 Hz), 128.9 (d, J = 
34.6 Hz), 134.7 (d, J = 3.7 Hz), 139.9, 148.5, 168.1 (d, J = 21.0 Hz); 19F NMR 
(282.38 MHz, CDCl3) δ -112.1 (dd, J= 2.1 Hz, 27.3 Hz); HRMS (ESI) m/z calcd for 
C13H13F79BrNO3Na [M+Na]+ = 351.9951, found = 351.9926, C13H13F81BrNO3Na 
[M+Na]+ = 353.9937, found = 353.9918. 








A white solid; 1H NMR (300 MHz, CDCl3) δ 1.61 (s, 9H), 5.75 (d, J = 50.8 Hz, 1H), 
7.17-7.24 (m, 2H), 7.31-7.34 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 27.6, 76.5, 84.6 
(d, J = 160.4 Hz), 86.1 (d, J = 2.2 Hz), 119.8 (d, J = 3.3 Hz), 120.1 (d, J = 2.7 Hz), 
121.8 (d, J = 3.3 Hz), 124.7 (d, J = 15.3 Hz), 126.2 (d, J = 2.7 Hz), 126.3, 146.7 (d, 
J = 14.2 Hz), 150.2, 168.4 (d, J = 18.5 Hz); 19F NMR (282.38 MHz, CDCl3) δ -111.0 
(d, J = 50.5 Hz), (-42.2) (t, J =7.2 Hz); HRMS (ESI) m/z calcd for C13H13F2NO3Na 
[M+Na]+ = 292.0761, found = 292.0753. 
tert-Butyl 7-chloro-3-fluoro-2-oxoindoline-1-carboxylate 6-1f 
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A white solid; 1H NMR (300 MHz, CDCl3) δ 1.63 (s, 9H), 5.74 (d, J = 50.8 Hz, 1H), 
7.15-7.21 (m, 1H), 7.41-7.44 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 27.7, 85.1 (d, 
J = 191.3 Hz), 86.3, 119.5, 124.5, 125.0 (d, J = 21.9 Hz), 125.8, 133.3, 138.2, 147.1, 
169.2 (d, J = 20.0 Hz); 19F NMR (282.38 MHz, CDCl3) δ -112.5 (d, J = 50.5 Hz); 
HRMS (ESI) m/z calcd for C13H13FClNO3Na [M+Na]+ = 308.0460, found = 
308.0452. 
tert-Butyl 3-fluoro-5-methyl-2-oxoindoline-1-carboxylate 6-1g 
 
A colorless oil; 1H NMR (300 MHz, CDCl3) δ 1.63 (s, 9H), 2.37 (s,3H), 5.68 (d, J = 
51.3 Hz, 1H), 7.24 (d, J = 8.4 Hz, 1H), 7.31 (s, 1H), 7.74 (d, J = 8.4 Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ 20.8, 28.0, 84.8, 85.1 (d, J = 187.6 Hz), 115.3 (d, J = 1.6 
Hz), 121.6 (d, J = 16.4 Hz), 126.3, 132.1 (d, J = 3.3 Hz), 134.8 (d, J = 2.7 Hz), 138.4 
(d, J = 5.5 Hz), 148.6, 169.0 (d, J = 17.5 Hz); 19F NMR (282.38 MHz, CDCl3) δ 
-110.8 (d, J = 51.6 Hz); HRMS (ESI) m/z calcd for C14H16FNO3Na [M+Na]+ = 
288.1006, found = 288.1020. 
tert-Butyl 3-fluoro-5-methoxy-2-oxoindoline-1-carboxylate 6-1h 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.63 (s, 9H), 3.83 (s,3H), 5.69 (d, J = 
51.1 Hz, 1H), 6.95-6.98 (m, 1H), 7.06 (s, 1H), 7.79 (dd, J = 1.3 Hz, 8.8 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 28.1, 55.8, 84.9, 85.2 (d, J = 188.6 Hz), 111.4, 116.7, 
117.0 (d, J = 3.6 Hz), 122.8 (d, J = 16.4 Hz), 134.1 (d, J = 3.6 Hz), 148.7, 157.2 (d, J 
= 3.7 Hz), 169.0 (d, J = 19.1 Hz); 19F NMR (282.38 MHz, CDCl3) δ -111.4 (t, J = 
25.8 Hz); HRMS (ESI) m/z calcd for C14H16FNO4Na [M+Na]+ = 304.0956, found = 
304.0965. 









A white solid; 1H NMR (300 MHz, CDCl3) δ 1.62 (s, 9H), 2.19 (s, 3H), 2.32 (s, 3H), 
5.67 (d, J = 51.3 Hz, 1H), 7.05 (s, 1H), 7.14 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 
19.3, 20.7, 27.7, 85.1, 85.6 (d, J = 188.7 Hz), 123.0 (d, J = 16.4 Hz), 124.0, 124.2 (d, 
J = 1.6 Hz), 134.7 (d, J = 3.3 Hz), 135.0 (d, J = 3.3 Hz), 136.8 (d, J = 4.9 Hz), 148.5, 
170.1 (d, J = 17.5 Hz); 19F NMR (282.38 MHz, CDCl3) δ -110.6 (d, J = 51.6 Hz); 
HRMS (ESI) m/z calcd for C15H17FNO3 [M-H]- = 278.0810, found = 278.0818.  
 
6.4.3 Representative Procedure for the Conjugate Addition Reactions 
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Oxindole 6-1 (0.05 mmol) was at room temperature added to a mixture of 
vinylsulfone 6-2a (0.05 mmol), catalyst 6-6 (1.5 mg, 0.0025 mmol) and 4 Å 
molecular sieves (10 mg) in CHCl3 (1.0 mL) in a sample vial, and the resulting 
mixture was sealed and stirred at room temperature for the time specified in Table 6.2. 
At the end of the reaction, the reaction mixture was filtered and concentrated in vacuo 
to yield the crude product, which was purified by flash column chromatography (ethyl 
acetate/hexane = 1:2) to afford the desired adducts 6-3. The enantiomeric excessess of 
6-3 were determined by chiral HPLC analysis.  
 
6.4.4 X-Ray Crystallographic Analysis and Determination of Configurations of 
the Conjugate Addition Products 
The absolute configuration of the product 6-3e was assigned based on the X-ray 
crystallographic analysis of a single crystal of 6-3e (Figure 6.2). The configurations of 
other products 6-3 were assigned by analogy. 
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Figure 6.2 X-ray structure of 6-3e 
Table 6.3 Crystal Data and Structure Refinement for c009. 
Identification code  c009 
Empirical formula  C27 H25 F2 N O7 S2 
Formula weight  577.60 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 8.2718(7) Å = 90°. 
 b = 13.6799(13) Å = 90°. 
 c = 23.831(2) Å  = 90°. 
Volume 2696.7(4) Å3 
Z 4 
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Density (calculated) 1.423 Mg/m3 
Absorption coefficient 0.258 mm-1 
F(000) 1200 
Crystal size 0.60 x 0.20 x 0.08 mm3 
Theta range for data collection 1.71 to 27.50°. 
Index ranges -10<=h<=10, -17<=k<=14, -28<=l<=30 
Reflections collected 19152 
Independent reflections 6196 [R(int) = 0.0465] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6628 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6196 / 0 / 355 
Goodness-of-fit on F2 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0402, wR2 = 0.0883 
R indices (all data) R1 = 0.0458, wR2 = 0.0910 
Absolute structure parameter 0.12(6) 
Largest diff. peak and hole 0.472 and -0.260 e.Å-3 
 
6.4.5 Analytical Data of the Conjugate Addition Products 
(S)-tert-Butyl 3-(2,2-bis(phenylsulfonyl)ethyl)-3-fluoro-2-oxoindoline- 
1-carboxylate 6-3a 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.62 (s, 9H), 3.00-3.08 (m, 1H), 3.10-3.23 
(m, 1H), 5.38 (t, J = 4.4 Hz, 1H), 7.24 (d, J = 7.6 Hz, 1H), 7.36 (d, J = 7.6 Hz, 1H), 7.48 
(t, J = 7.9 Hz, 1H), 7.51-7.58 (m, 4H), 7.65-7.71 (m, 2H), 7.86 (d, J = 7.6 Hz, 2H), 7.93 
(d, J = 8.2 Hz, 1H), 8.01-8.03 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 28.0, 31.2 (d, J = 
31.0 Hz), 76.8, 85.0, 89.2 (d, J = 189.5 Hz), 116.1, 123.7 (d, J = 18.2 Hz), 124.0, 125.2, 
129.1 (d, J = 23.7 Hz), 129.7 (d, J = 1.8 Hz), 132.2 (d, J = 2.7 Hz), 134.6 (d, J = 30.1 Hz), 
137.0, 138.3, 140.0 (d, J = 4.6 Hz), 148.3, 170.1 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, 
CDCl3) δ -75.6 (dd, J = 11.3 Hz, 32.0 Hz); The ee value was 93%, tR (minor) = 17.52 min, 
tR (major) = 20.04 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); HRMS (ESI) m/z calcd for C27H26FNO7S2Na [M+Na]+ = 582.1027, found = 











A white solid; 1H NMR (500 MHz, CDCl3) δ 1.62 (s, 9H), 2.98-3.09 (m, 1H), 3.13-3.19 
(m, 1H), 5.32 (t, J = 4.4 Hz, 1H), 7.30 (t, J = 1.9 Hz, 1H), 7.45 (d, J = 8.2 Hz, 1H), 
7.54-7.59 (m, 4H), 7.68-7.72 (m, 2H), 7.88-7.92 (m, 3H), 8.02 (d, J = 8.2 Hz, 1H); 13C 
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NMR (125 MHz, CDCl3) δ 28.0, 31.3 (d, J = 31.0 Hz), 85.4, 88.9 (d, J = 192.3 Hz), 117.6, 
124.2, 125.3 (d, J = 18.2 Hz), 129.2 (d, J = 23.7 Hz), 129.7 (d, J = 10.9 Hz), 130.8 (d, J = 
2.7 Hz), 132.2 (d, J = 1.8 Hz), 134.7 (d, J = 31.9 Hz), 136.8, 138.3, 138.5 (d, J = 4.6 Hz), 
148.2, 169.5 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, CDCl3) δ -76.5 (dd, J = 11.9 Hz, 
31.4 Hz); The ee value was 93%, tR (minor) = 14.51 min, tR (major) = 15.43 min 
(Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) 
m/z calcd for C27H25FClNO7S2Na [M+Na]+ = 616.0637, found = 616.0613; []27D = +23.4 




A white solid; 1H NMR (300 MHz, CDCl3) δ 1.62 (s, 9H), 2.94-3.23 (m, 2H), 5.33 (t, J = 
4.5 Hz, 1H), 7.22-7.32 (m, 2H), 7.51-7.59 (m, 4H), 7.65-7.73 (m, 2H), 7.84-7.87 (m, 2H), 
7.99-8.03 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 28.0, 31.3 (d, J = 31.9 Hz), 76.8, 85.6, 
89.0 (d, J = 190.4 Hz), 117.0, 122.1 (d, J = 19.1 Hz), 125.0, 125.4 (d, J = 2.7 Hz), 129.2 
(d, J = 23.7 Hz), 129.7 (d, J = 2.7 Hz), 134.7 (d, J = 28.2 Hz), 137.1, 138.3, 138.4 (d, J = 
3.7 Hz), 141.0 (d, J = 4.6 Hz), 148.2, 169.7 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, 
CDCl3) δ -75.2 (dd, J = 11.4 Hz, 32.0 Hz); The ee value was 91%, tR (minor) = 17.20 min, 
tR (major) = 20.55 min (Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); HRMS (ESI) m/z calcd for C27H25FClNO7S2Na [M+Na]+ = 616.0637, found = 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.62 (s, 9H), 2.99-3.19 (m, 2H), 5.30 (t, 
J = 4.7 Hz, 1H), 7.44 (t, J = 1.9 Hz, 1H), 7.55-7.62 (m, 5H), 7.68-7.73 (m, 2H), 
7.85-7.90 (m, 3H), 8.01-8.03 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 28.0, 31.3 (d, J 
= 31.0 Hz), 85.5, 88.9 (d, J = 191.3 Hz), 117.9, 118.1 (d, J = 2.7 Hz), 125.7 (d, J = 
17.3 Hz), 127.0, 129.2 (d, J = 22.8 Hz), 129.7 (d, J = 14.6 Hz), 134.8 (d, J = 32.8 Hz), 
135.2, 136.8, 138.3, 139.1 (d, J = 5.5 Hz), 148.2, 169.4 (d, J = 21.9 Hz); 19F NMR 
(282.38 MHz, CDCl3) δ -76.2 (dd, J = 12.4 Hz, 32.0 Hz); The ee value was 93%, tR 
(minor) = 15.53 min, tR (major) = 17.34 min (Chiralcel IA, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C27H25F79BrNO7S2Na [M+Na]+ = 660.0132, found = 660.0109, C27H25F81BrNO7S2Na 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.59 (s, 9H), 3.02-3.13 (m, 1H), 
3.19-3.25 (m, 1H), 5.36 (t, J = 4.4 Hz, 1H), 7.18 (t, J = 3.2 Hz, 1H), 7.25 (d, J = 6.9 
Hz, 2H), 7.52-7.59 (m, 4H), 7.65-7.72 (m, 2H), 7.86 (d, J = 7.6 Hz, 2H), 8.00 (d, J = 
8.2 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 27.6, 31.3 (d, J = 31.9 Hz), 77.2, 85.7, 
89.6 (d, J = 194.0 Hz), 119.9 (d, J = 3.7 Hz), 120.5, 120.7 (d, J = 2.7 Hz), 126.7 (d, J 
= 4.6 Hz), 126.9 (d, J = 10.0 Hz), 127.0, 129.1 (d, J = 18.2 Hz), 129.7 (d, J = 9.1 Hz), 
134.7 (d, J = 23.7 Hz), 137.1, 138.1, 146.3, 148.0, 150.6, 169.7 (d, J = 22.8 Hz); 19F 
NMR (282.38 MHz, CDCl3) δ -75.1 (dd, J = 12.1 Hz, 32.0 Hz), -40.1 (t, J = 7.7 Hz); 
The ee value was 89%, tR (minor) = 26.71 min, tR (major) = 31.00 min (Chiralcel IA, 
λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 





A white solid; 1H NMR (500 MHz, CDCl3) δ 1.60 (s, 9H), 3.01-3.12 (m, 1H), 
3.19-3.25 (m, 1H), 5.40 (t, J = 4.4 Hz, 1H), 7.21 (t, J = 7.6 Hz, 1H), 7.29 (d, J = 7.6 
Hz, 1H), 7.48 (d, J = 8.2 Hz, 1H), 7.51-7.58 (m, 4H), 7.65-7.72 (m, 2H), 7.86 (dd, J = 
1.3 Hz, 8.2 Hz, 2H), 8.00 (t, J = 4.1 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 27.6, 
31.4 (d, J = 31.0 Hz), 76.7, 86.1, 89.7 (d, J = 193.1 Hz), 120.6, 122.6, 126.2, 127.2 (d, 
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J = 19.1 Hz), 129.2 (d, J = 22.8 Hz), 129.7 (d, J = 17.3 Hz), 133.9 (d, J = 2.7 Hz), 
134.7 (d, J = 23.7 Hz), 137.3, 138.2, 146.5, 170.3 (d, J = 22.8 Hz); 19F NMR (282.38 
MHz, CDCl3) δ -76.7 (dd, J = 11.3 Hz, 33.0 Hz); The ee value was 87%, tR (minor) = 
27.51 min, tR (major) = 36.01 min (Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, 
flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for C27H25FClNO7S2Na [M+Na]+ = 











A white solid; 1H NMR (500 MHz, CDCl3) δ 1.62 (s, 9H), 2.38 (s, 3H), 2.98-3.23 (m, 
2H), 5.39 (t, J = 4.4 Hz, 1H), 7.14 (s, 1H), 7.28 (s, 1H), 7.52-7.58 (m, 4H), 7.65-7.71 
(m, 2H), 7.79 (d, J = 8.2 Hz, 1H), 7.86-7.88 (m, 2H), 8.01-8.03 (m, 2H); 13C NMR 
(125 MHz, CDCl3) δ 21.0, 28.0, 31.3 (d, J = 31.0 Hz), 76.9, 84.9, 89.4 (d, J = 190.4 
Hz), 116.0, 123.7 (d, J = 18.2 Hz), 124.4, 129.1 (d, J = 22.8 Hz), 129.7 (d, J = 2.7 Hz), 
132.7 (d, J = 1.8 Hz), 134.6 (d, J = 29.2 Hz), 135.2 (d, J = 2.7 Hz), 137.3, 137.7 (d, J 
= 4.6 Hz), 138.5, 148.5, 170.3 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, CDCl3) δ 
-75.3 (dd, J = 10.3 Hz, 32.0 Hz); The ee value was 89%, tR (minor) = 19.79 min, tR 
(major) = 22.86 min (Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); HRMS (ESI) m/z calcd for C28H28FNO7S2Na [M+Na]+ = 596.1183, found = 
596.1175; []27D = +17.3 (c = 0.98, CHCl3). 
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A white solid; 1H NMR (300 MHz, CDCl3) δ 1.62 (s, 9H), 2.96-3.25 (m, 2H), 3.85 (s, 
3H), 5.41 (t, J = 4.4 Hz, 1H), 6.92-7.01 (m, 2H), 7.50-7.58 (m, 4H), 7.61-7.73 (m, 
2H), 7.83-7.92 (m, 3H), 7.95-8.02 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 28.0, 31.3 
(d, J = 31.0 Hz), 55.9, 76.9, 84.9, 89.4 (d, J = 191.3 Hz), 109.8, 117.3 (d, J = 3.6 Hz), 
124.9 (d, J = 17.3 Hz), 129.1 (d, J = 23.7 Hz), 129.7 (d, J = 1.8 Hz), 133.1 (d, J = 4.6 
Hz), 134.6 (d, J = 31.9 Hz), 137.2, 138.4, 148.5, 157.4 (d, J = 2.7 Hz), 170.2 (d, J = 
22.8 Hz); 19F NMR (282.38 MHz, CDCl3) δ -76.2 (dd, J = 11.3 Hz, 31.9 Hz); The ee 
value was 90%, tR (minor) = 26.12 min, tR (major) = 32.68 min (Chiralcel IA, λ = 254 
nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 1.60 (s, 9H), 2.22 (s, 3H), 2.33 (s, 3H), 
2.98-3.22 (m, 2H), 5.39 (t, J = 4.4 Hz, 1H), 6.96 (s, 1H), 7.08 (s, 1H), 7.51-7.58 (m, 
4H), 7.64-7.71 (m, 2H), 7.87 (d, J = 7.6 Hz, 2H), 8.02 (d, J = 7.6 Hz, 2H); 13C NMR 
(125 MHz, CDCl3) δ 19.8, 20.8, 27.8, 31.5 (d, J = 31.9 Hz), 85.1, 90.1 (d, J = 189.5 
Hz), 121.9, 125.1 (d, J = 17.3 Hz), 125.5, 129.1 (d, J = 23.7 Hz), 129.7 (d, J = 9.1 Hz), 
134.6 (d, J = 26.4 Hz), 135.3 (d, J = 2.7 Hz), 135.7 (d, J = 2.7 Hz), 136.1 (d, J = 5.5 
Hz), 137.4, 138.5, 148.1, 171.3 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, CDCl3) δ 
-75.2 (dd, J = 11.4 Hz, 21.7 Hz); The ee value was 89%, tR (minor) = 17.12 min, tR 
(major) = 19.55 min (Chiralcel IA, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); HRMS (ESI) m/z calcd for C29H30FNO7S2Na [M+Na]+ = 610.1340, found = 













A white solid; 1H NMR (300 MHz, CDCl3) δ 1.62 (s, 9H), 4.66 (dd, J = 2.5 Hz, 31.5 
Hz, 1H), 6.39 (d, J = 1.9 Hz, 1H), 6.77 (d, J = 7.6 Hz, 1H), 6.95 (t, J = 7.6 Hz, 1H), 
7.28 (d, J = 6.9 Hz, 3H), 7.35-7.41 (m, 4H), 7.43-7.49 (m, 3H), 7.55-7.61 (m, 3H), 
7.85 (d, J = 7.6 Hz, 2H), 7.93 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
28.0, 48.0 (d, J = 26.4 Hz), 77.2, 80.6, 85.1, 92.4 (d, J = 199.5 Hz), 115.6, 123.5 (d, J 
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= 19.1 Hz), 124.5 (d, J = 1.8 Hz), 126.3, 128.0, 128.5, 128.9 (d, J = 30.1 Hz), 129.3 (d, 
J = 31.0 Hz), 129.9, 131.8 (d, J = 7.3 Hz), 133.3 (d, J = 2.7 Hz), 133.8, 134.1, 138.3, 
139.7, 140.0 (d, J = 18.3 Hz), 148.4, 170.7 (d, J = 22.8 Hz); 19F NMR (282.38 MHz, 
CDCl3) δ -40.4 (d, J = 20.6 Hz); The ee value was 98%, tR (minor) = 30.69 min, 52.43 
min tR (major) = 27.33 min, 33.48 min (Chiralcel AD-H, λ = 254 nm, 10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); HRMS (ESI) m/z calcd for 
C33H30FNO7S2Na [M+Na]+ = 658.1340, found = 658.1348. 
tert-Butyl- 3-fluoro-3-(2-nitro-1-phenylethyl)-2-oxoindoline-1-carboxylate 6-3k 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) The major isomer: δ 1.59 (s, 9H), 
4.12-4.19 (m, 1H), 5.06 (dd, J = 10.4 Hz, 13.6 Hz, 1H), 5.55 (dd, J = 4.7 Hz, 13.6 Hz, 
1H), 6.69 (d, J = 7.6 Hz, 1H), 7.00-7.14 (m, 3H), 7.22-7.31 (m, 3H), 7.40 (t, J = 15.8 
Hz, 1H), 7.77 (d, J = 8.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) The major isomer: δ 
28.0, 49.4 (d, J = 24.6 Hz), 73.9 (d, J = 3.6 Hz), 85.2, 92.9 (d, J = 198.6 Hz), 115.4 (d, 
J = 16.4 Hz), 124.6, 125.1 (d, J = 2.7 Hz), 125.6, 128.7 (d, J = 9.1 Hz), 129.2 (d, J = 
39.2 Hz), 131.7 (d, J = 3.7 Hz), 132.0 (d, J = 2.7 Hz), 140.1, 148.0, 170.0 (d, J = 22.8 
Hz); 19F NMR (282.38 MHz, CDCl3) The major isomer: δ -85.5 (d, J = 19.6 Hz); The 
ee value was 46% (major isomer), 28% (minor isomer), tR (minor) = 10.26 min, 11.78 
min tR (major) = 15.26 min, 17.90 min (Chiralcel ID, λ = 254 nm, 3% iPrOH/hexanes, 
flow rate = 1.0 mL/min); MS (ESI) m/z calcd for C21H21FN2O5Na [M+Na]+ = 423, 
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found = 423.1. 
 
 
 
 
